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Sulfur is an essential element found ubiquitously in living systems. However, 
there exist only a few sulfur-containing sugars in nature and their biosyntheses have not 
been well understood. On the other hand, a wide variety of sugar derivatives commonly 
found in natural products are often vital components for the efficacy and specificity of 
their parent molecules. Elucidation of such unusual sugar biosyntheses is important both 
for understanding their intriguing chemical mechanisms and creating unnatural 
compounds by altering their biosynthetic machineries, which could potentially exhibit 
enhanced or novel biological activities. This dissertation describes biosynthetic studies of 
two thiosugar-containing natural products, BE-7585A and lincomycin A, produced by 
Amycolatopsis orientalis and Streptomyces lincolnensis, respectively. While the former 
possess a C-2-thiosugar-containing disaccharide moiety, the latter contains a C-1-thio 
substituent on a characteristic eight-carbon backbone sugar. The focus of this research is 
to characterize the biological pathways and mechanisms responsible for the sulfur 
incorporation and the unique sugar scaffolds. 
 viii 
BE-7585A, an angucycline-type natural product, contains the rare C-2-thiosugar 
moiety. PCR-based screening of a cosmid library constructed from the genomic DNA of 
A. orientalis led to the identification of the BE-7585A biosynthetic gene cluster. A gene, 
bexX, was found to be a candidate for a thiosugar synthase with moderate sequence 
similarity to a thiazole synthase. The gene, bexX, and a glycosyltransferase homologue, 
bexG2, were heterologously expressed in Escherichia coli. A variety of biochemical 
experiments provided a wealth of evidence supporting the proposed biosynthetic pathway 
for the C-2-thiodisaccharide moiety. Finally, whole genome sequencing and a genome 
mining approach led to the identification of a sulfur carrier protein to accomplish the in 
vitro enzymatic synthesis of the C-2-thiosugar for the first time. 
Lincomycin A is a lincosamide antimicrobial natural product with a C-1 
methylthio substituent. Although the lincomycin A biosynthetic gene cluster has been 
reported, biochemical verification of the biosynthetic pathway has remained elusive. In 
this dissertation, the complete methlthiolincosamide biosynthetic pathway including the 
potential C-1 sulfur incorporation mechanism was proposed. Furthermore, two early 
intermediates of the pathway were characterized for the first time by demonstrating the 
LmbR (transaldolase) and LmbN (isomerase) reactions in vitro. 
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Chapter 1:  Background and Significance 
 
1.1  INTRODUCTION 
Natural products are commonly referred to small organic molecules with diverse 
structures produced by living organisms. Natural products often exhibit biological 
activities and play important physiological roles in the producer organisms.
1-5
 However, 
the exact biological functions of most natural products or secondary metabolites remain 
to be determined.
2
 Natural products have been a rich source for drug discovery. It is well 
documented that extracts of natural products were used as medicine by people in 
Mesopotamia (2600 BC), Egypt (1500 BC), China (1100 BC), India (1000 BC) and Greece 
(300 BC) long time ago.
6,7
 Since the discovery of penicillin in 1928, research on 
antibiotics produced by microorganisms has attracted much attention. Extensive 
screening of microorganisms during this era led to the discovery of many antibiotics, 
antiparasitics, antimalarials, lipid control agents, immunosuppressants, and anticancer 
drugs.
8
 More recently, advanced technologies including combinatorial synthesis and 
high-throughput screening have changed the drug discovery research from screening of 
natural products to screening of synthetic small molecule libraries. Nevertheless, natural 
products and their derivatives remain an important source of finding useful lead 
compounds. Indeed, 34% of the new drugs developed in small molecule entities between 
1981 and 2006 are natural products or their semisynthetic derivatives.
8-10
 
In addition to their pharmacological applications, studies of the chemistry of 
natural product syntheses have been a major area in chemical research for a long time.
10
 
Total synthesis of complex natural products is still a major research focus in current 




 On the other hand, in nature, construction of complex structures of natural 
products is mediated by enzymes. The regio- and stereospecific enzyme-catalysis ensures 
the production of complex natural products in a very efficient and specific manner. 
In this post-genomic era, metabolic engineering and synthetic biology have 
become powerful tools useful for drug development. In this context, thorough 
understanding of natural product biosyntheses including genetic, enzymatic, and 
mechanistic information could enable one to manipulate these biosynthetic machineries 
to generate new structural entities. Such combinatorial biosynthetic approach holds high 
potential in drug discovery in the future. 
 
1.2  UNUSUAL SUGAR BIOSYNTHESIS AND GLYCODIVERSIFICATION  
Carbohydrates in the Biological System 
Carbohydrates are one of the fundamental class of materials in the biological 
systems. Living organisms store sugar molecules as polysaccharides, glycogen or starch, 
and utilize them to generate energy in glycolysis. Carbohydrates also serve as structural 
components of many biological molecules. For instance, nucleic acids, DNA and RNA, 
are polymers of 2-deoxy-D-ribose (1-1) and D-ribose (1-2), with each monomer decorated 
with one of the five nucleobases, adenine, guanine, cytosine, thymine, and uracil. Equally 
important are glycoproteins and glycolipids in which sugar modifications play crucial 
roles in cellular communication and molecular recognition. In eukaryotes, nine sugars (1-
3−1-11) are known to exist in these surface glycans (Figure 1-1).
12,13
 In contrast, the 
surface polysaccharides of prokaryotes are composed of much more diverse sugar 
structures. Indeed, more than one hundred monosaccharide units, known as unusual 







Unusual Sugar Biosynthesis 
The unusual sugars, including deoxy-, amino-, nitro-, and branched-sugars, are 
also found in many bioactive secondary metabolites produced by plants and 
microorganisms. Importantly, these sugar moieties often serve as the key determinants 
responsible for the efficacy and specificity of their biological activities.
15
 Thus, 
elucidation of the biosyntheses of unusual sugars is important for the pathway 
reengineering effort to construct new glycosylated secondary metabolites having 
desirable biological activities, which may have clinical applications. 
 














































































The biosynthetic pathways of a series of deoxysugars and the mechanisms of 
enzymes involved in the pathways have been extensively studied over the past two 
decades. In general, the sugar substrates used in unusual sugar biosynthetic pathways 
need to be activated at C-1 by nucleoside diphosphate (NDP) modification. This C-1-
NDP group serves as the anchor which is recognized by the corresponding biosynthetic 
enzymes and glycosyltransferases in the pathways. Interestingly, the biosyntheses of a 
large portion of deoxysugars share a common intermediate, TDP-4-keto-6-deoxy--D-
glucose (1-14). For example, the structurally diverse sugars, TDP-D-mycaminose (1-17), 
TDP-D-desosamine (1-21), TDP-L-mycarose (1-26), TDP-L-eremosamine (1-30), TDP-






Glycosyltransfer and Glycodiversification 
The produced unusual sugars are transferred to their specific acceptors by 
glycosyltransferases. Since glycosyltransferases involved in the biosynthesis of 
 























































































































































secondary metabolites have been shown to have relatively relaxed substrate specificity, 
the reengineering of the sugar biosynthetic pathways described above can be coupled 
with appropriate glycosyltransferase to generate new glycosylation patterns. This 
approach, known as glycodiversification, is a powerful strategy, possibly leading to the 
creation of a large number of new glycoconjugates of secondary metabolites for the 




A few types of thiosugars exist in nature, however, they are rare. Only a handful 
of thiosugar-containing natural products have been identified to date, and they are 
described below in more detail. Because of the rarity of their natural occurrence, 
knowledge regarding the biosynthesis of thiosugars has been scarce thus far. On the other 
hand, sulfur is seen in several primary metabolites, and its unique chemical nature is 
often responsible for the specific function of these biomolecules. Thus, creation of 
unnatural thiosugar-containing compounds by reengineering the biosynthetic pathways of 
the parent molecules to include the thiosugar biosynthetic genes has great potential to 
produce biologically active novel compounds. 
 
1.3  SULFUR-CONTAINING BIOMOLECULES 
1.3.1  Occurrence and Importance 
Primary Metabolites 
Sulfur is an essential element found ubiquitously in living systems. Sulfur-
containing small molecules are distributed in a wide range of biomolecules in primary 
metabolism such as amino acids (1-37, 1-38), antioxidants (1-39, 1-40), nucleic acids (1-
 7 




Cysteine (1-37) and methionine (1-38) are the two amino acids containing a sulfur 
atom in their structures. They are not only essential components of proteins but also 
utilized for the biosyntheses of other important biomolecules. For example, the 
antioxidants, glutathione (1-39) and mycothiol (1-40), consist of the cysteine (1-37) 
structure, and S-adenosyl-L-methionine (1-49) is directly synthesized from methionine (1-
38). Indeed, cysteine (1-37) is a major sulfur donor in biological systems because the 
sulfur atom of cysteine (1-37) can be transferred to other compounds through enzymes 
called cysteine desulfurases, which are described below in more detail. On the basis of 
the chemical properties of sulfur, the thiol group of cysteine (1-37) can be used as an acid 
or base and can also readily form a disulfide bond, which is important for stabilizing 
many protein structures. In addition, the lone pairs of electrons on the sulfur atom can 
serve as a metal ligand as seen in the iron sulfur clusters (1-45−1-47), which are protein-
bound cofactors serving as redox centers. 
As shown in Figure 1-3, there are quite a few sulfur-containing enzyme cofactors. 
The characteristic chemical properties of sulfur contribute to their functions as 
coenzymes. For example, the two sulfur atoms of lipoic acid can be converted from the 
reduced dithiol form to the cyclic oxidized disulfide form during the catalysis of the 













































































































































































































Sulfur is also found in the structures of a number of secondary metabolites. 
Representative examples, including clinically useful antibiotics penicillin (1-56) and 
cephalosporine (1-57), an antitumor antibiotic leinamycin (1-62), highly modified peptide 































































































































































































Thiosugar-Containing Natural Products 
As described above, only a limited number of thiosugar-contaning natural 
products have been reported thus far. They are conveniently categorized into seven 
groups (group I−VII) based on their structures as described below. 
Group I contains a C-2-thio functional group in a glucose-like scaffold. There are 
only two such natural products known thus far, BE-7585A (1-67) from Amycolatopsis 
orientalis subsp. vinearia BA-07585 and rhodonocardin A (1-68) from Nocardia sp. 
(Figure 1-5).
26,27
 While the former shows a C-2-thioether linkage, the latter possesses a 
free C-2-thiol group. Interestingly, 1-67 and 1-68 are constitutional isomers to each other, 
and both are angucycline-type antibiotics. BE-7585A (1-67) was reported as a potential 




Group II contains a unique C8-sugar backbone with a C-1-thioether. This includes 
lincomycin (1-69) from Streptomyces lincolnensis and celesticetin (1-70) from 
Streptomyces caelestis (Figure 1-6).
28,29
 A few other celesticetin derivatives were also 
isolated from the same producer strain.
30
 This class of compounds exhibit antimicrobial 
 















































activity against Gram-positive bacteria. Notably, the semi-synthetic chlorinated 
lincomycin derivative, 7-chloro-7-deoxylincomycin known as clindamycin (1-71), is a 




Group III is composed of the endiyne class of natural products possessing a C-4-
thiosugar. Calicheamicins (1-72) from Micromonospora echinospora ssp. calichensis, 
esperamicins (1-73) from Actinomadura verrucosospora, namenamicin (1-74) from the 
marine ascidian Polysyncraton lithostrotum, and shishijimicins (1-75) from the ascidian 
Didemnum proliferum are in this group (Figure 1-7).
31-34
 While thio groups in compound 
1-72 is involved in a ester linkage, the other three compounds (1-73−1-75) possess a 
methyl-thio group at the C-4 position. More interestingly, the configuration of the thio 
functional groups is not always equatorial (1-72 and 1-73 and terminal sugar moiety of 1-
74) but can also be axial (internal sugar moiety of 1-74 and 1-75). This implicates that 
there may be more than one type of sulfur incorporation mechanism in the biosynthesis of 
this class of thiosugars. 
 
 
Figure 1-6. Thiosugar-containing natural products (group II). 
*
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Group IV of thiosugar-containing natural products possesses a thioribosyl 
pyrimidine moiety that exhibits tRNA synthetase inhibition activity. Albomycin (1-76) 
from Streptomyces subtropicus or several other Streptomyces species, and SB-217452 (1-
77) from Streptomyces sp. are categorized in this group (Figure 1-8).
35,36
 The former 
structure also contains a hydroxamate siderophore, which allows the compound to be 
taken up by the ferrichrome transport system of the target microorganisms such as 
Escherichia coli and related Gram-negative bacteria.
37
 In this way, albomycin (1-76) 
works as a Trojan horse antibiotic. 
 
 
















































































































   
Group V shows a 1-deoxy-4-thio-D-arabinofranosyl cation core forming a 
thiosugar sulfonium sulfate inner salt with a sulfate group of the polyhydroxylated 
acyclic chain. This unique structure was found in plant natural products, salacinol (1-78), 
kotalanol (1-79), ponkaranol (1-80), and salaprinol (1-81), produced from Salacia 
reticulate (Figure 1-9).
38-41
 Since this class of compounds exhibits -glucosidase 




Group VI is composed of diverse structures of glucosinolates (1-82) produced by 
plants, mainly, but not exclusively, by the order Capparales, including the Brassicaceae, 
Capparaceae, and Caricaceae (Figure 1-10).
42
 Approximately 120 glucosinolates are 
 




























































































known and share this 1-thio--D-glucopyranose core linked via a sulfur atom to a (Z)-N-
hydroximinosulfate ester. Upon hydrolysis of glucose moiety by a thioglucoside 
glucohydrolase (myrosinase), the unmasked aglycone moiety is rearranged to the 
chemically more active isothiocyanates, nitriles, or thiocyanate structures. These active 
compounds are known to be involved in plant defense. In fact, the distinct taste and 
flavors of cabbage, cauliflower, broccoli (Brassicaceae vegetables) and mustard, 







Lastly, group VII is a 5-thio-D-mannose (1-83) isolated from the marine sponge 
Clathria pyramida (the actual producer might be its symbiont) (Figure 1-11).
43
 
Interestingly, this C-5-thiosugar is the only naturally occurring example of this class 
known thus far. In contrast, a number of 5-thiopyranose and 4-thiofuranose derivatives, 
in which the endocyclic ring oxygen of regular sugar is replaced by a sulfur atom, have 

























Genes and Pathways for the Thiosugar Biosyntheses 
Among the thiosugar-containing natural products (1-67−1-83) described above, 
the biosynthetic gene clusters for lincomycin (1-69), celesticetin (1-70), calicheamicin (1-
72), and albomycin (1-76) have been identified from the producer microorganisms.
45-48
 
Although some of the genes found in the clusters have been experimentally investigated, 
the pathway and mechanisms of thiosugar biosynthesis in each case remain obscure.  
In contrast to the biosynthetic gene clusters found in the bacteria, genes involved 
in the same biosynthetic pathway of secondary metabolites are not clustered in plants. 
Thus, it is more challenging to study complex biosynthetic pathways of plants‟ secondary 
metabolites. Despite this disadvantage, most enzymes involved in the biosynthesis of 
glucosinolates (1-82) have been identified (Figure 1-12).
42
 Although the detailed 
mechanism of the key sulfur incorporation step (1-86  1-87) remains to be elucidated, 
cysteine (1-37) or glutathione (GSH, 1-39) has been proposed to be the sulfur donor, 
which is added to the reactive intermediate 1-86 via either a glutathione-S-transferase-
type reaction or a non-enzymatic route.
49
 Recently, a -glutamyl peptidase (GGP1) was 
found to be able to hydrolyze the GSH conjugate of 1-87.
50
 This result suggests that the 
direct sulfur donor may be GSH (1-39) rather than cysteine (1-37), and the CysGly 
conjugate obtained through the hydrolysis of the GSH conjugate may be the substrate for 
a C−S lyase (SUR1).
50,51
 The ensuing sulfur incorporation into the sugar moiety (1-88  
 









1-90) forming the thioglucoside linkage is a typical glycosyltransfer reaction utilizing 





Notably, a similar C-1-thioglucoside was recently identified as a new type of 
post-translational modification in a peptide natural product, sublancin (1-91), produced 
by Bacillus subtilis 168 (Figure 1-13).
53
 Based on the lessons learned from studies of 
glucosinolates (1-82) and sublancin (1-91) biosyntheses, S-glycosyltransfer reaction 
between UDP-glucose (1-89) and the cysteine thiol is likely a common strategy to form a 
C-1-thioglycoside. Thus, it is possible that a similar glycosyltransferase is involved in the 
biosyntheses of C-1-thiosugars found in lincomycin A (1-69) and celesticetin (1-70) 
although in these cases, the sugar donor is a highly modified NDP-sugar rather than a 
simple UDP-glucose (1-89). 
With the exception of the glucosinolates biosyntheses described above, sulfur 
incorporation pathways and mechanisms for the formation of thiosugars have not been 
studied at all. In view of the diverse structural categorization (group I−VII), there may be 
 






















































at least seven different classes of enzymes catalyzing the sulfur incorporation reactions. 
In this dissertation, the biosynthetic pathways and mechanisms of a C-2-thiosugar-
contaning natural product, BE-7585A (1-67) and a C-1-thiosugar-containing natural 




1.3.2  Sulfur Incorporation Mechanisms 
While most biosynthetic pathways of thiosugar formation have not been studied, 
two types of sulfur incorporation mechanisms have been elucidated in the biosyntheses of 
sulfur-containing primary metabolites (Figure 1-3). The first mechanism is an ionic 
mechanism involving a bisulfide (HS

), a thiocarboxylate group (R-COS

) or a cysteine 
persulfide group (R-S-S

) as sulfur donor. The second mechanism involves a radical 
intermediate catalyzed by radical-SAM enzymes containing an S-adenosyl-L-methionine 
(SAM, 1-49) cofactor and iron-sulfur clusters.
18,19,54-58
 The former mechanism is used in 
the biosyntheses of cysteine (1-37), thiamin (1-55), molybdopterin (1-54), 2- and 4-
thiouridine (1-42, 1-43). The latter is responsible for the production of biotin (1-53) and 
lipoic acid (1-52). 
 














































Ionic Mechanism Involving Bisulfide 
Plants and microorganisms can utilize bisulfide as a direct sulfur source in 
cysteine (1-37) biosynthesis, via catalysis by a pyridoxal 5‟-phosphate (PLP, 1-92)-
dependent enzyme, O-acetylserine sulfhydrylase (OASS). The reaction starts with 
binding of O-acetylserine (1-93) to an internal aldimine between a lysine residue of 
OASS and PLP (1-92). The resulting external Schiff base between O-acetylserine (1-93) 
and PLP (1-92) facilitates the elimination of an O-acetyl group of 1-93 to generate an -
aminoacrylate external Schiff base intermediate (1-94). The terminal alkene of this 
intermediate (1-94) is then attacked by a nucleophilic bisulfide to form the cysteine 
external Schiff base (1-95), which releases a cysteine (1-37) molecule via a 




































































Ionic Mechanism Involving Protein Persulfide 
Protein persulfides are thought to be the major source of sulfide equivalents in the 
synthesis of sulfur-containing biomolecules. The persulfide bound to a large protein has 
the advantage to react with a specific target because highly reactive free sulfide is toxic in 
vivo. Protein persulfide groups are generated by a family of cysteine desulfurases (e.g., 
NifS, IscS, SufS, and CsdA), which are pyridoxal 5‟-phosphate (PLP, 1-92)-dependent 
enzymes catalyzing the transfer of a sulfur atom from L-cysteine (1-37) to an active site 
cysteine residue of the desulfurase to yield the protein persulfide and L-alanine (1-96) 
(Figure 1-15A). The generated persulfidic sulfur (1-97) can be transferred to a cysteine 
residue of another protein to form a new protein persulfide (1-98) in a process known as 
sulfur relay (Figure 1-15B)
60
 or can react with the activated carboxy terminal of a sulfur 
carrier protein (1-99) to form a protein-protein acyl disulfide intermediate (1-100),
61
 
which is then reduced to yield a protein thiocarboxylate (1-101; Figure 1-15C). While the 
protein thiocarboxylate (1-100) is the sulfur donor in thiamin (1-55) and molybdopterin 
(1-54) biosyntheses, the persulfidic sulfur of the protein persulfide (1-96, 1-97) is directly 
introduced into the substrate in thionucleoside (1-42, 1-43) biosynthesis. In either case, 
cysteine desulfurases are the key enzymes responsible for the sulfur incorporation 





Figure 1-15. Protein persulfide and protein thiocarboxylate. 
(A) Mechanism of cysteine desulfurase (CD) to form protein persulfide (1-97). (B) 
Sulfur relay found in 2-thiouridine biosynthetic pathway. (C) An activation mechanism 





























































































































































The representative example of sulfur incorporation using a protein persulfide is 
seen in the 4-thiouridine (1-42) biosynthesis. The reaction employs ThiI and one of the 
cysteine desulfurases, IscS. As shown in the proposed mechanism (Figure 1-16),
62-64
 the 
persulfide formed on IscS (1-102) is first transferred to an active site cysteine residue of 
ThiI to generate the ThiI-persulfide (1-103). ThiI also catalyzes the adenylation of the 
substrate uridine using ATP. The persulfide group of 1-103 attacks this activated uridine 
to produce a disulfide intermediate (1-104). Upon the attack by another active site 
cysteine on the disulfide bond, 4-thiouridine (1-42) is released. The internal disulfide 




Ionic Mechanism Involving Protein Thiocarboxylate 
The sulfur incorporation mechanism in bacterial thiamin biosynthesis is the best 
characterized example of a reaction involving a sulfur carrier protein-thiocarboxylate (1-
 




























































 The sulfur carrier protein and its activation enzyme in this pathway 
are ThiS and ThiF, respectively. ThiF catalyzes the adenylation of the C-terminal 
carboxylate group of ThiS. Sulfur is then transferred to this position from a protein 
persulfide group of a cysteine desulfurase. The reactive thiocarboxylate generated on the 
C-terminus of ThiS attacks the substrate, 1-deoxy-D-xylulose 5-phosphate (DXP, 1-105), 
which forms a covalent complex with a thiazole synthase, ThiG (1-106) (Figure 1-17). 
18
O-labeling experiments revealed an S to O acyl shift (1-107  1-108) followed by the 
formation of a thioketone intermediate (1-109).
66
 The acyl modification on the C-4 
alcohol facilitates the elimination of the hydroxyl group from this position together with 
ThiS (1-110  1-111). The ThiG-bound substrate intermediate further reacts with 
dehydroglycine (1-112) to eventually form the thiazole ring (1-113). Recent studies using 
an optimized reconstitution procedure for ThiG revealed that the actual enzymatic 
product is a thiazole phosphate carboxylate tautomer (1-114) which shows unexpected 
stability.
67
 Aromatization of 1-114 is mediated by another enzyme, TenI, to produce 





Sulfur carrier proteins are a growing class of proteins consisting of 65100 amino 
acids with a characteristic GG sequence at their C-termini. The C-terminal carboxylate of 
a sulfur carrier protein is activated by a ThiF-like enzyme, and the resulting acyl 
adenylates is attacked by a sulfur donor to form a sulfur carrier protein thiocarboxylate 
(Figure 1-15C). This thiocarboxylate serves as a sulfur donor in the specific biosynthetic 
pathway, such as thiamin, as described above. Interestingly, structure and activation 






























































































































recent studies have shown an evolutionary linkage between bacterial sulfur carrier 
proteins and eukaryotic ubiquitin or ubiquitin-like proteins.
72-77
 Figures 1-18 and 119 
summarize the sulfur carrier proteins and their activating enzymes biochemically 
characterized thus far, including the thiamin (1-55, A),
61,66
 molybdopterin (1-54, B),
78-80
 
prydine dithiocarboxylic acid (pdtc, 1-116, C),
81,82





 L-methionine (1-38, F),
85









 biosynthetic pathways, 







































































































































Figure 1-19. Sulfur carrier proteins and their activating enzymes (II) and the 
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Sulfur can also be incorporated via a radical mechanism using radical-SAM 
enzymes. These enzymes, which contain S-adenosyl-L-methionine (SAM, 1-49) and iron-
sulfur clusters, catalyze a reductive cleavage of SAM to L-methionine (1-38) and a 5‟-
deoxyadenosyl 5‟-radical (1-120; Figure 1-20A).
18,54,56,89,90
 The reactive radical 
intermediate, 1-120, then functions to remove a hydrogen atom from an appropriate 
substrate. Biotin synthase and lipoyl synthase are the two best characterized radical-SAM 
enzymes involving sulfur incorporation (Figure 1-20B,C). Both reactions are similarly 
initiated by the formation of a 5‟-deoxyadenosyl 5‟-radical (1-120) and utilizing 
sacrificial iron-sulfur clusters as the sulfur sources. 
The proposed reaction mechanism of biotin synthase is shown in Figure 1-21.
54,91
 
Biotin synthase inserts a sulfur atom between carbons 6 and 9 of dethiobiotin (1-122) to 
form a thiophane ring. In this pathway, the sulfur atom is known to be derived from a 
nearby [2Fe-2S]
2+
 cluster (1-45) in the active site, and the first CS bond formation 
involves an electron transfer from the initially formed C-9 radical to one of the iron 




 Fe/S species (1-123). In the second cycle, another 
molecule of 5‟-deoxyadenosyl 5‟-radical (1-120) abstracts the 6-pro-S hydrogen atom of 
1-123. Upon the attack of the resulting C-6 radical to the sulfur atom coordinated to the 
Fe
(III)















Figure 1-20. Radical-SAM enzymes involved in sulfur incorporation. 
(A) Reductive cleavage of SAM to form a reactive 5‟-deoxyadenoyl 5‟-radical (1-120). 


















































































































1.4  SUMMARY AND THESIS STATEMENT 
Highly modified sugars commonly found in prokaryotic secondary metabolites 
are often the vital components determining the efficacy and specificity of the parent 
molecules. Thus, a thorough understanding of unusual sugar biosynthesis may enable the 
exploitation of the biosynthetic machineries to generate new therapeutic agents. Over the 
past 20 years, many deoxy-, amino- and branched-chain sugar biosynthetic pathways and 
their detailed mechanisms have been elucidated. However, knowledge regarding the 
biosynthesis of thiosugars has been scarce due to the rarity of its natural occurrence. On 
the other hand, mechanistic details of several biological sulfur insertion reactions 
involved in the biosyntheses of thiamin, molybdopterine, biotin, lipoic acid, and tRNA 
 





















































































modifications have recently been unraveled. Highly regulated reactive intermediates, 
including protein persulfides, protein thiocarboxylates, or S-adenosylmethionine (SAM)-
dependent radicals are often generated in the enzymes catalyzing these reactions. To 
investigate whether similar or different mechanisms are used to form the CS bond in 
thiosugar biosyntheses is the primary focus of this study. 
BE-7585A, an angucycline-type natural product, consisting of an angucycline 
core, a deoxysugar (rhodinose), and a 2-thiodisaccharide moieties, is one of the only two 
known natural products containing a C-2-thiosugar moiety. Described in Chapter 2 of this 
dissertation is the first report of the isolation of its biosynthetic gene cluster, which 
contains a candidate gene responsible for 2-thiosugar biosynthesis. This genetic 
information as well as the feeding experiments using 
13
C-labeled acetate led to a proposal 
of the biosynthetic pathway of BE-7585A. Biochemical verification of the proposed 
function of BexG2, a glycosyltransferase homologue, responsible for making the 
thiodisaccharide moiety is described in Chapter 3. The relaxed substrate specificity at the 
C-2 position of the glycosyl acceptor was unraveled during the course of substrate 
specificity assays, suggesting that BexG2 might have evolved from a trehalose 6-
phosphate synthase to accept the unusual 2-thioglucose 6-phosphate as the substrate. In 
addition, a model reaction demonstrating a nonenzymatic CS bond formation between 
the angucycline core and a thiosugar is documented in Chapter 3. Finally, detailed 
mechanistic studies of 2-thiosugar biosynthesis are described in Chapter 4. On the basis 
of a series of MS studies, a thiazole synthase homologue, BexX, was discovered to form 
a covalent adduct with glucose 6-phosphate with an active site lysine residue under 
physiological conditions. The most important finding in this study, obtained by genome 
mining, is that a sulfur carrier protein involved in a primary metabolite biosynthetic 
pathway is recruited to deliver a sulfur atom to produce the 2-thiosugar in the BexX-
 30 
catalyzed reaction. Surprisingly, despite the analogy of the proposed mechanism of the 
BexX reaction to thiazole synthesis, the sulfur carrier protein involved in thiamin 
biosynthesis is incapable of performing this function in 2-thiosugar biosynthesis. Instead, 
sulfur carrier proteins likely involved in cysteine and molybdopterin biosyntheses are 
effective in promoting sulfur addition to the C-2 keto group of the BexXglucose 6-
phosphate complex. 
Lincomycin A, a lincosamide antimicrobial natural product carrying a C-1 
methylthio substituent, is another thiosugar-containing natural product studied in this 
dissertation. Chapter 5 describes a detailed proposal of the complete biosynthetic 
pathway for the unique thiosugar moiety, methlthiolincosamide (MTL), in lincomycin A. 
A transaldolase homologue, LmbR, was identified to be responsible for the construction 
of the C8 sugar backbone of MTL. Although LmbR showed relatively relaxed substrate 
specificity, the physiologically relevant substrate pair in this pathway was found to be D-
ribose 5-phosphate and D-fructose 6-phosphate, and the enzymatic product is D-glycero-
D-altro-octulose 8-phosphate. In contrast, the next enzyme, LmbN, responsible for the 
subsequent C-1C-2 isomerization, showed strict substrate specificity. The product of 
LmbN, D-erythro-D-gluco-octose 8-phosphate, was verified by comparison with a 
synthetic standard. This work identified two key intermediates in the MTL biosynthetic 
pathway for the first time. The results are consistent with the proposed biosynthetic 
pathway. This work set the stage for future mechanistic studies of NDP-octose formation 






Chapter 2:  Biosynthetic Studies of BE-7585A (I): Structural and 
Genetic Analyses for the Biosynthetic Pathway 
 
2.1  INTRODUCTION 
BE-7585A (2-1), produced by Amycolatopsis orientalis subsp. vinearia BA-
07585, is an angucycline-type natural product possessing thymidylate synthase inhibition 
activity.
26
 The angucycline class of natural products, which have a characteristic fused 
four-ring frame assembled in an angular manner, are rich in antibacterial or anticancer 
activities.
92
 In addition to the benz[a]anthraquinone core, BE-7585A also contains the 
deoxysugar, rhodinose (2-2), and a disaccharide appendage (2-4) consisting of a glucose 
and a highly unusual 2-thioglucose (2-3). Notably, BE-7585A is one of only two 2-
thiosugar-continaing natural products reported thus far. The other compound, 
rhodonocardin A (2-5),
27
 is a constitutional isomer of BE-7585A (2-1), independently 































































BE-7585A (2-1) and rhodonocardin A (2-5) are closely related, having an 
identical benz[a]anthraquinone core structure and the same three sugar components, 
rhodinose, 2-thioglucose, and glucose. But they differ in the attachment of the 2-
thioglucose and glucose moieties on the core molecule. In BE-7585A (2-1), the 2-
thioglucose and glucose moieties are linked via their anomeric carbons, and the resulting 
disaccharide (2-4) is attached to the C-5 position of the aglycone through a thioether 
linkage. In contrast, the 2-thioglucose and glucose in 2-5 are separately attached to C-5 
and C-4a of the angucycline core via O-glycosidic bonds, leaving the 2-mercapto-
substituent in 2-3 as a free thiol group. The structure of rhodonocardin A (2-5) is fully 
documented, 
27
 but that of BE-7585A (2-1) is not because the structure is reported in a 
patent.
26
 Thus, in this chapter, isolation and characterization of 2-1 from Amycolatopsis 
orientalis subsp. vinearia BA-07585 are first described, and the glycosydic linkage of 
each sugar moiety is carefully analyzed using a series of 1D- and 2D-NMR experiments 
to confirm that the reported structure of BE-7585A (2-1) is indeed different from 
rhodonocaridn A (2-5) produced from Nocardia sp. 
The detailed NMR-characterization of BE-7585A (2-1) is also required in order to 
perform 
13
C-labeled acetate (2-6) feeding experiments, which is a well-established 
method to study the biosynthesis of polyketide-type natural products. In general, the 
angucycline core structures (2-8) are assembled with ten acetate units catalyzed by type II 
polyketide synthases (PKSs) via a decaketide intermediate (2-7) (Figure 2-2).
93
 For 
example, reported feeding experiments for vineomycin A1 (2-9) from Streptomyces 
matensis subsp. vineus,
94
 urdamycin A (or also known as kerriamycin B) (2-10) from 
Streptomyces fradiae (strain Tü 2717),
95
 PD 116740 (2-11) from Streptomyces WP 
4669,
96
 kinamycin D (2-12) from Streptomyces murayamaensis,
97,98
 gilvocarcin M (2-13) 
from Streptomyces griseoflavus Gö 3592,
99,100




 led to the determination of the biosynthetic origins of 
their core structures (Figure 2-3). In this chapter, similar feeding experiments were 
carried out for BE-7585A (2-1) to verify the involvement of an analogous type II PKS-
catalyzed angucycline core formation in its biosynthesis.   





Figure 2-3. Acetate incorporation patterns of angucycline-type or angucyline core-
















































































































Moreover, the highly deoxygenated sugar, rhodinose (2-2) and its derivatives 
have been found in several natural products in addition to BE-7585A (2-1) and 
rhodonocrdin A (2-5) described above. Those of whose biosynthetic gene clusters have 
been identified include aclarubicin (2-15) from Streptomyces galilaeus,
102
, urdamycin A 
(2-10) from Streptomyces fradiae,
103
 -rhodomycin IV (2-16) from Streptomyces 
galilaeus,
104
, landomycin A (2-17) from Streptomyces cyanogenus,
105
 and granaticin B 
(2-18) from Streptomyces violaceoruber (Figure 2-4).
106
 Homologous gene analyses and 
gene disruption experiments of these gene clusters have led to the identification of the 
genes responsible for rhodinose formation (Figure 2-5). Although in vitro biochemical 
verification of the functions of the corresponding gene products in the synthesis of TDP-
L-rhodinose (2-26) has not been performed, a similar set of sugar biosynthetic genes 
likely exists in the BE-7585A biosynthetic gene cluster. 
On the basis of the reported studies about the structurally similar angucycline-
type or rhodinose-containing natural products mentioned above, the biosynthetic pathway 
of BE-7585A (2-1) is predicted to include catalysis by type II PKS and TDP-sugar 
modifying enzymes in the formation of its angucyline core (2-8) and TDP-L-rhodinose 
(2-26), respectively. Although no information about 2-thioglucose biosynthesis is 
available, it is known that genes involved in post-PKS modifications are usually located 
around the PKS genes, forming a gene cluster responsible for the production of the 
targeted polyketide-derived natural product. Thus, in order to identify the unknown 
thiosugar biosynthetic genes, we decided to first locate the BE-7585A biosynthetic gene 
cluster by using probes designed based on the sequence of some predictable genes such 
as type II PKS or one of the TDP-sugar biosynthetic genes that are likely present in the 
cluster. In this chapter, identification of the BE-7585A biosynthetic gene cluster from A. 
orientalis genome is described. The approach is based on the PCR-based cosmid library 
 35 
screening, targeting genes encoding -ketoacyl synthase  subunit (KS), TDP-6-deoxy-
4-keto-D-glucose 2,3-dehydratase, and TDP-2,6-dideoxy-4-keto-D-glucose 3-dehydrase. 
Detailed sequence analysis combined with mechanistic consideration leads to the 
complete proposal of the biosynthetic pathway for BE-7585A (2-1) containing the highly 


























































































































2.2  EXPERIMENTAL PROCEDURES  
2.2.1  General 
Materials 
All chemicals and reagents were purchased from Sigma-Aldrich Chemical Co. 
(St. Louis, MO) or Fisher Scientific (Pittsburgh, PA), and were used without further 
purification unless otherwise specified. Enzymes and molecular weight standards used 
for the cloning experiments were products of Invitrogen (Carlsbad, CA) or New England 
Biolabs (Ipswich, MA). Kits for DNA gel extraction and spin minipreps were obtained 
from Qiagen (Valencia, CA). Gigapack III XL packaging extract was product of 
Stratagene (La Jolla, CA). Deep Vent (exo–) DNA polymerase was purchased from New 
England Biolabs. Growth medium components were acquired from Becton Dickinson 
(Sparks, MD). Sterile syringe filters were products of Fisher Scientific. Analytical C18 
HPLC columns were purchased from Varian (Palo Alto, CA). Oligonucleotide primers 
were prepared by Invitrogen or Integrated DNA Technologies (Coralville, IA). 
 






























































Bacterial Strains and Plasmids 
A. orientalis subsp. vinearia BA-07585 was generously provided by Banyu 
Pharmaceutical Co. (Tokyo, Japan). Escherichia coli DH5, acquired from Bethesda 
Research Laboratories (Gaithersburg, MD), was used for routine cloning experiments. E. 
coli XL-1 Blue MRF‟, purchased from Stratagene, was employed for cosmid 
manipulations. Plasmids pGEM-T Easy and pUC119, used for sub- cloning, were 
products of Promega (Madison, WI) and Takara Bio (Shiga, Japan), respectively. 





UV−vis spectra were recorded using a Beckman DU 650 spectrophotometer. 
NMR spectra were acquired on a Varian Unity 500 MHz spectrometer, and chemical 
shifts (in ppm) are reported relative to that of the solvent peak (H = 4.65 for deuterated 
water, H = 3.30 and C = 49.0 for deuterated methanol). HPLC was performed on a 
Beckman Coulter System Gold equipped with a UV detector. DNA concentrations were 
measured using a NanoDrop ND-1000 UV−vis instrument from Thermo Fisher 
Scientific. DNA sequencing was performed by the core facility of the Institute of Cellular 
and Molecular Biology at the University of Texas, Austin. Vector NTI Advance 10.1.1 
from Invitrogen was used for sequence alignments. Mass spectroscopy was performed at 
the Mass Spectrometry core facility in the Department of Chemistry and Biochemistry at 
the University of Texas, Austin.  
2.2.2  Production, Isolation, and Identification of BE-7585A. 
Spores of A. orientalis subsp. vinearia BA-07585 were inoculated into 100 mL of 
International Streptomyces Project (ISP) medium 2 and grown in a rotary incubator at 29 
 38 
°C and 250 rpm for 5 days. The resultant seed culture (25 mL) was transferred to 1 L of 
ISP-2 medium and grown under the same conditions for 10 days. The growth culture was 
centrifuged at 6000  g for 10 min to remove the cells and other insoluble materials. The 
supernatant was applied to a column of the synthetic polymeric adsorbent Diaion HP20 
(250 mL) and washed with water. The adsorbed compounds were then eluted with 500 
mL of methanol. The collected red fractions were pooled and concentrated by rotary 
evaporation in vacuo and further purified on a Diaion CHP20P column (50 mL) using 
5−20% of methanol in water as the eluent. The typical yield was 100−150 mg of BE- 











C]acetate Feeding Experiment 
Spores of A. orientalis subsp. vinearia BA-07585 were inoculated into 50 mL of 
ISP-2 medium and grown in a rotary incubator at 30 °C and 250 rpm for 5 days. The 
resultant seed culture (25 mL) was transferred to 1 L of ISP-2 medium and grown under 
the same conditions for 2 days. Sodium [1-
13
C]acetate, in an aqueous solution (4%, 5 
mL) sterilized by filtration through a syringe filter (0.2 µm), was added to the culture, 
which had a light red color. Additional [1-
13
C]acetate solution was added (4%, 5 mL × 4) 
to the growth culture every 13−20 h. The final concentration of labeled acetate was 0.1%. 
After a 10-day incubation period, the culture was centrifuged at 6000  g for 10 min. The 
13
C-labeled BE-7585A (2-1, 150 mg) was isolated from the supernatant by using Diaion 
HP20 and CHP20P columns as described above for the purification of the nonlabeled 2-1. 
The purified compound was analyzed by 
13




C2]acetate Feeding Experiment 
The feeding experiment was also performed with sodium [1,2-
13
C2]acetate in 1-L 
ISP-2 medium. A 25 mL aqueous solution containing both sodium [1,2-
13
C2]acetate 
(0.68%) and nonlabeled sodium acetate (1.3%) was prepared and sterilized by filtration 
through a syringe filter. The solution (10 mL) was then added to the culture, which had 
been grown for 2 days and had turned light red. The remaining solution (15 mL) was 
added 20 h after the first addition. The final concentration of the labeled acetate was 
0.017%. After a 10-day incubation period, the culture was centrifuged at 6000  g for 10 
min to remove cells and any insoluble materials. The 
13
C-labeled BE-7585A (2-1, 80 mg) 
was isolated from the supernatant using Diaion HP20 and CHP20P columns and analyzed 
by 
13
C NMR spectroscopy as described above. 
2.2.4  Construction of the Cosmid Library. 
Spores of A. orientalis subsp. vinearia BA-07585 were inoculated into 50 mL of 
tryptone soya broth (TSB) medium and grown in a rotary incubator at 30 °C and 250 rpm 
for 3 days. The mycelia were harvested by centrifugation at 5000  g for 30 min. The 
cells were disrupted by lysozyme and SDS, and the cell lysate was treated with proteinase 
K. The released genomic DNA was isolated by phenol-chloroform extraction followed by 
sodium acetate-isopropyl alcohol precipitation. The DNA was partially digested with 
Sau3AI restriction endonuclease in a time dependent manner, and ligated into the BamHI 
site of the pOJ446 vector.
108
 The ligated DNA was packaged into phage particles using a 
Gigapack III XL packaging extract and then introduced into E. coli XL1-Blue MRF‟ 
according to the manufacturer‟s instructions. Recombinants were selected on Luria-
Bertani (LB)-agar plates in the presence of apramycin (50 µg/mL). After incubation for 
16 h, the resulting transformants were spotted within grids on new plates. This resulting 
genomic library contains a total of 454 cosmids. 
 40 
2.2.5  PCR-Based Screening of the Cosmid Library. 
Polymerase chain reaction (PCR) primers for screening of type II PKS were 
designed based on multiple sequence alignments of 10 known -ketoacyl synthase  
subunits (KS) of actinomycetes including Streptomyces Venezuelae
109
 and Streptomyces 
coelicolor A3(2),
110,111
 which are available in the National Center for Biotechnology 
Information (NCBI) database. Similarly, the primers for deoxysugar genes, such as TDP-
6-deoxy-4-keto-D-glucose 2,3-dehydratase
112-114
 and TDP-2,6-dideoxy-4-keto-D-glucose 
3-dehydrase,
115
 were designed based on the reported gene sequences from eight 
actinomycete strains including Streptomyces fradiae
103
 and Streptomyces cyanogenus.
105
 
The sequences of the primers used for the PCR-based screening are listed in Table 1. 
PCR was performed using Deep Vent (exo–) DNA polymerase with these primers and 
the cosmid DNA from the genomic library. Amplified DNA fragments were ligated into 









M = AC, R =AG, W = AT, S = CG, Y = CT, K = GT, V = ACG, H = ACT, D = AGT, 










2.2.6  Sequencing and Gene Cluster Identification. 
Cosmids A108 and C006, which together span the entire BE-7585A biosynthetic 
gene cluster (bex cluster), were digested with either KpnI, NcoI, or PstI. The resulting 
2.5−12 kb DNA fragments were subcloned into a modified pUC119 vector, whose 
multiple cloning site harbors extra restriction sites.
116
 Both strands of the subclones were 
sequenced using M13 universal primers or by primer walking. Sequencing data were 
obtained using a capillary-based AB 3700 DNA analyzer and assembled using the Vector 
NTI Suite program. Open reading frame assignments were made with the assistance of 
FramePlot 2.3.2.
117
 Homologous protein sequences were identified in the NCBI database 
using the basic local alignment search tool (BLAST). 
2.2.7  Metyrapone-Feeding Experiments. 
Spores of A. orientalis subsp. vinearia BA-07585 were inoculated into 10 mL of 
the ISP-2 medium and grown in a rotary incubator at 30 °C and 230 rpm for 2 days. The 
resultant seed culture (100 L) was transferred to 10 mL of ISP-2 medium and grown 
under the same conditions for 1 day. Metyrapone (2-methyl-1,2-dipyrid-3-yl-1-
propanone), in a DMSO solution (1 M, 10 L), was added to the culture, and the cells 
were grown under the same conditions for 4 days. Additional metyrapone DMSO 
solution (1 M, 5 L) was added to the culture, which had a red color. The final 
concentration of metyrapone in the culture was 1.5 mM. After a 1-day incubation period, 
the culture was centrifuged, and the supernatant was subjected to HPLC analysis 
equipped with a C18 analytical column (4 × 250 mm). Control sample obtained from the 
culture without adding metyrapone was similarly analyzed. The sample (10 L) was 
eluted with a gradient of water (solvent A) and methanol (solvent B). The gradient was 
run from 20 to 90% B over 25 min, 90−20% B over 5 min, followed by re-equilibration 
at 20% B for 5 min. The flow rate was 0.8 mL/min, and the detector was set at 300 nm. 
 42 
The supernatant obtained from the culture containing metyrapone was also subjected to 
LC-MS analysis. The sample (100 L) was diluted with 400 L of deionized water and 
analyzed by LC-MS (positive ion detection mode) equipped with a C18 column and a 
photodiode array (PDA) detector using a gradient of water and acetonitrile. 
 
2.3  RESULTS AND DISCUSSION 
2.3.1  Production, Isolation, and Identification of BE-7585A. 
To determine that the A. orientalis subsp. vinearia BA-07585 strain can produce 
BE-7585A (2-1) in our hand and to verify the assigned structure, the bacterial strain was 
initially grown in the vegetative medium reported in the patent, which is composed of 
glycerin (2%), maltsyrup (1%), meat extract (0.2%), cotton seed meal (0.5%), yeast 
extract (0.1%), wheat germ (0.5%), MgSO4·7H2O (0.2%), NaCl (0.2%), CaCO3 (0.2%), 
KH2PO4 (0.1%), (NH4)2SO4 (0.1%), FeSO4·7H2O (0.001%), and ZnSO4·7H2O (0.001%), 
pH 6.7.
26
 Despite several trials, we could not detect the target compound, which should 
exhibit the maximum absorbance (λmax) at near 500 nm. Thus, ISP-2 medium, which is 
one of the typical media for Actinomycetes species composed of glucose (0.4%), yeast 
extract (0.4%) and malt extract (1%), pH 7.3, was tested. Interestingly, this bacterial 
culture growing in the ISP-2 medium gradually turned to red. The major product was 
then purified and subjected to spectroscopic analyses. 
Absorbance spectrum of the purified compound in an aqueous solution shows the 
λmax at 492 nm, consistent with that reported for BE-7585A (2-1) (Figure 2-6). In 
addition, the HRMS results (HRMS (ESI+) calculated for C37H46O20NaS [M + Na]
+
 
865.2201, found 865.2208; HRMS (ESI−) calculated for C37H45O20S [M − H]
− 
841.2225, 
found 841.2222) are also consistent with the structure of BE-7585A. Further verification 
 43 
of the structure of 2-1 relied on a series of NMR experiments (Figures 2-7−15). Based on 









































































































































C chemical shift of C-2‟ at  52.4 is further upfield than what is typically 
expected for an O-methine carbon and, thus, argues for the presence of a thiol substituent 































































Measured in CD3OD at 500 MHz (























1.98 (1H, d, J = 14.7 Hz)








7.29 (1H, d, J = 8.0 Hz)
7.70 (1H, t, J = 8.0 Hz)














































5.38 (1H, d, J = 3.1 Hz)
3.48 (1H, dd, J = 11.1 Hz, 3.1 Hz)
3.99 (1H, m)
3.56 (1H, t, J = 9.3 Hz)
3.96 (1H, m)
3.78 (1H, m)
3.86 (1H, dd, J = 11.7 Hz, 1.7 Hz)
5.15 (1H, d, J = 3.5 Hz)













0.52 (3H, d, J = 6.5 Hz)
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in the structure is established by HMBC analysis. The results clearly reveal the presence 
of a 1‟,1‟‟-O-glycosyl bond between the 2-thioglucose and the glucose moieties (Figure 
2-13). The 
3
JH-H values (3.1−3.5 Hz) of the anomeric protons (H-1‟, H-1‟‟, and H-1‟‟‟) 
and the NOESY experiment established an ,-linkage between the disaccharide, and an 
anomeric -configuration of the rhodinose moiety (2-2) to C-12b of the aglycone (Figure 
2-14). In addition, the observed HMBC correlation between H-2‟ and C-5 implicates a 
thioether linkage between the 2-thiosugar and the aglycone (Figure 2-13). These results 
clearly distinguish the structure of BE-7585A (2-1) from its constitutional isomer, 
rhodonocardin A (2-5), and, thus, exclude the possibility that 2-1 is identical to 














































The angucycline core structures are generally derived from the assembly of 10 
acetate units catalyzed by type II polyketide synthases (PKSs) as described above (Figure 
2-2).
93
 To confirm the biosynthetic origin of the ring carbons of BE-7585A (2-1), [1-
13
C]acetate (2-27) was added into a growing A. orientalis culture. The 
13
C-labeled 
product was purified and analyzed by 
13
C NMR spectroscopy. Enhanced signals for C-1, 
C-3, C-4a, C-6, C-7, C-8, C-10, C-11a, and C-12a of the ring structure of 2-1 are 
observed, indicating these carbons are derived from C-1 of acetate (Figure 2-15). To 
determine the orientation of these acetate units during assembly, [1,2-
13
C2]acetate (2-6) 




C spin couplings were observed for 
C-1/C-2, C-3/C-13, C-4a/C-12b, C-5/C-6, C-6a/C-7, C-7a/C-8, C-9/C-10, C-11/C-11a, 
and C-12/C-12a (Figure 2-16, Table 2-3), indicating that these pairs of carbons are 
derived from intact acetate units. This assignment was further confirmed by the 
INADEQUATE (incredible natural abundance double quantum transfer experiment) 
 























3JH-H = 3.1 Hz














3JH-H < 3.5 Hz
3JH-H < 3.5 Hz
 53 
spectrum (Figure 2-17). Thus, the position and orientation of acetate units in the 
angucycline core structure of 2-1 were unambiguously determined. 
Interestingly, the acetate incorporation pattern observed here is unusual for 
angucycline class natural products. As exemplified by the biosynthesis of urdamycin A 
(2-10),
95
 vineomycin A1 (2-9),
94,118
  PD116740 (2-11),
118





 in the typical ring closure reaction, the linear decaketide 
(2-7) formed through the action of PKS is cyclized into the benz[a]anthracene backbone 
(2-8) in a manner in which the head (C-20) and the tail (C-2) of the decaketide chain 
coincide with C-13 and C-2, respectively, in the cyclic product (2-7  2-8) (Figure 2-18, 
pathway A). A decarboxylation of the last acetate unit (at C-2 to release C-1) is a 
necessary step in this pathway to account for the incorporation pattern. 
While such a mode of skeletal assembly involving simple folding and 
condensation is found for most augucycline-type natural products studied thus far, an 
alternative pathway has been found in the biosynthesis of PD116198 (2-14).
101
 In this 
case, chain elongation and ring condensation lead to a linearly fused tetracyclic 
anthracyclinone intermediate (2-28). Subsequent oxidative bond cleavage between C-10a 
and C-11 followed by rearrangement and recylcization are proposed to give the angular 
angucyclinone core (2-28  2-29) (Figure 2-18, pathway B). Since BE-7585A (2-1) 
displays the same acetate incorporation pattern as PD116198 (2-14), an analogous ring 
reconstruction via an enzyme-catalyzed Baeyer-Villiger oxidation may also be operative 
in the biosynthesis of 2-1. Similar oxidative C−C bond cleavages of polyketide-derived 
tetracyclic substrates have also been proposed for the biosynthesis of gilvocarcin V (2-
30) and jadomycin A (2-31) based on gene disruption and gene complementation 
experiments.
121,122
 Enzymes responsible for this type of reaction are flavin-dependent 
monooxygenases. Notably, a flavin monooxygenase (MtmOIV) catalyzing the Baeyer-
 54 
Villiger ring-opening in the biosynthesis of mithramycin (2-32) was recently 







Figure 2-15. Sodium [1-
13
C]acetate feeding experiment. 
(A) 
13
C NMR spectrum of 2-1 (unlabeled). (B) 
13
C NMR spectrum of 2-1 labeled with 
13
C derived from 2-27. Incorporation ratio of 2-27 was estimated as 4%. The spectra 















































































Figure 2-16. Sodium [1,2-
13
C2]acetate feeding experiment. 
13





















































































































































































  74.4 or 74.6
  71.8



































C2]acetate feeding experiment.. (A) Entire spectrum. (B) Magnified 






















































































































































2.3.3  Identification of the Gene Cluster. 
As mentioned above, urdamycin A (2-10)
125
 is an angucycline class antibiotic 
having a similar structure as BE-7585A (2-1). It is composed of a benz[a]anthraquinone 
core, two L-rhodinose (2-2), and two D-olivose moieties, with one of the rhodinosyl 
groups attached at the C-12b position, as seen in the structure of 2-1 (Figure 2-4). The 
gene cluster of 2-10 has been identified and sequenced, and the biosynthetic pathway of 
2-10 has been studied.
126,127
 In view of the close resemblance between 2-10 and 2-1, 
homologous genes encoding the type II polyketide synthase (PKS), the aglycone tailoring 
enzymes, TDP-rhodinose biosynthetic enzymes, and a rhodinosyltransferase found in the 
urdamycin gene cluster are expected to exist in the gene cluster of 2-1 as well. 
To locate the BE-7585A biosynthetic gene cluster, a cosmid library was 
constructed from the genomic DNA of A. orientalis. This library was screened using PCR 
probes designed based on multiple sequence alignment of several KSs, TDP-hexose 2,3-
dehydratases and TDP-hexose 3-dehydrases found in the gene clusters of urdamycin A 
(2-10) and several other related compounds. Five cosmids were found to harbor these 
genes. Sequencing of these cosmids led to a contiguous DNA sequence of 48.4 kb, from 
which 42-open reading frames (ORFs) (orf1-42) were identified (Figure 2-20). Among 
 





























































them, orf9−36 are believed to be involved in BE-7585A biosynthesis based on BLAST 
searches (Table 2-4). As predicted, the cluster includes type II PKSs, post-PKS aglycone 
tailoring genes, and the deoxysugar biosynthetic genes. The remaining ORFs (orf1-8 and 
orf37-42) are likely boundary ORFs, since they appear to be the biosynthetic genes for 
primary metabolites (Table 2-5). Overall, the BE-7585A biosynthetic gene cluster (bex 
cluster) spans a region of 28.9 kb and contains 28 ORFs. The nucleotide sequences 





Figure 2-20. Organization of the BE-7585A biosynthetic gene cluster (bex cluster). 
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bexR1 regulator repressor-response regulator [Streptomyces sp. AM-7161] 56 / 68 BAC79018
bexE oxygenase putative oxygenase (Aur1A) [Streptomyces aureofaciens] 75 / 83 AAX57188
bexF cyclase putative cyclase (UrdF) [Streptomyces fradiae] 78 / 85 CAA60568
bexA ketosynthase  subunit putative ketoacyl synthase (UrdA) [Streptomyces fradiae] 92 / 85 CAA60569
bexB ketosynthase  subunit keto-acyl synthase beta [Streptomyces antibioticus] 74 / 83 CAG14966
bexC acyl carrier protein putative acyl carrier protein (SimA3) [Streptomyces antibioticus] 60 / 74 AAK06786
bexD ketoreductase ketoreductase [Streptomyces antibioticus] 81 / 89 CAG14968
bexL cyclase putative aromatase [Streptomyces sp. SCC 2136] 70 / 78 CAH10113
bexM oxygenase-reductase oxygenase-reductase (UrdM) [Streptomyces fradiae] 62 / 71 AAF00206
bexJ1 transporter Transporter (UrdJ2) [Streptomyces fradiae] 47 / 61 AAF00207
bexN carboxyl transferase decarboxylase (JadN) [Streptomyces sviceus ATCC 29083] 43 / 54 ZP_05020741
bexH
sugar epimerase / 
reductase
predicted nucleoside-diphosphate sugar epimerase 
[Streptosporangium roseum DSM 43021]
48 / 65 ZP_04471118
bexI oxygenase
putative anthrone monooxygenase (GilOII) [Streptomyces
griseoflavus]
27 / 38 AAP69583
bexK hydroxylase
cytochrome P-450-like enzyme [Saccharopolyspora erythraea NRRL 
2338]
41 / 54 YP_001107923
bexO ferredoxin ferredoxin [Streptomyces coelicolor A3(2)] 40 / 59 NP_625075
bexP methyltransferase
putative methyltransferase [Saccharopolyspora erythraea NRRL 
2338 ]
37 / 52 YP_001105373
bexG1 glycosyltransferase glycosyl transferase (UrdGT1a) [Streptomyces fradiae] 49 / 62 AAF00214
bexQ sugar 3-ketoreductase sugar 3-ketoreductase (KijD10)  [Actinomadura kijaniata] 52 / 65 ACB46498
bexS sugar 4,6-dehydratase
putative dNDP-glucose 4,6-dehydratase [Streptomyces
aureofaciens]
72 / 80 ACK77743
bexT sugar 3-dehydrase NDP-hexose 3,4-dehydratase homolog [Streptomyces cyanogenus] 78 / 86 AAD13547
bexU TDP-glucose synthase putative TDP-glucose synthase [Streptomyces nogalater] 69 / 82 AAF01820
bexV Sugar 2,3-dehydratase NDP-hexose 2,3-dehydratase [Frankia sp. CcI3] 58 / 72 YP_483211
bexR2 regulator
TetR family transcriptional regulator [Saccharopolyspora erythraea
NRRL 2338]
50 / 61 YP_001103502
bexW reductase putative reductase [Streptomyces griseoflavus] 67 / 74 AAP69587
bexJ2 transporter
EmrB/QacA family drug resistance transporter [Frankia sp. 
EAN1pec]
36 / 53 YP_001507963
bexX thiosugar synthase
Thiazole biosynthesis protein (ThiG) [Stigmatella aurantiaca
DW4/3-1]
58 / 75 ZP_01459245
bexJ3 transporter
major facilitator superfamily transporter [Mycobacterium 
vanbaalenii PYR-1]
36 / 50 YP_956695
bexG2 glycosyltransferase
,-trehalose-phosphate synthase [Methanothermobacter
thermautotrophicus str. Delta H]
30 / 47 NP_276863
 63 
 
2.3.4  Functional Predication of Genes Involved in Angucycline Core Formation. 
The deduced gene products of bexA, bexB, and bexC display high sequence 
similarities to the type II minimal PKS, KS, -ketoacyl synthase  subunit (KS), and 
acyl carrier protein (ACP), respectively. The minimal PKS (BexA, BexB, and BexC) 
assembles one acetyl-CoA and 10 malonyl-CoAs from 10 acetate units into a linear 
decaketide chain (2-7). To accommodate the unusual labeling pattern observed in the 
13
C-











1 carbamoyl-phosphate synthase large subunit [Saccharomonospora viridis DSM 43017] 88 / 94 ZP_04506718
2 orotidine 5'-phosphate decarboxylase, subfamily 2 [Saccharomonospora viridis DSM 43017] 72 / 80 ZP_04506717
3 hypothetical protein SvirDRAFT_1577 [Saccharomonospora viridis DSM 43017] 93 /97 ZP_04506716
4 guanylate kinase [Saccharomonospora viridis DSM 43017] 70 / 81 ZP_04506715
5 DNA-directed RNA polymerase omega subunit [Saccharopolyspora erythraea NRRL 2338] 96 / 98 YP_001104332
6
phosphopantothenoylcysteine synthase/decarboxylase [Saccharomonospora viridis DSM
43017]
80 / 87 ZP_04506713
7 methionine adenosyltransferase 1 [Saccharopolyspora erythraea NRRL 2338] 87 / 92 YP_001104334
8 primosomal protein N' [Saccharomonospora viridis DSM 43017] 71 / 80 ZP_04506710
37 secreted protein [Saccharopolyspora erythraea NRRL 2338] 48 / 60 YP_001105521
38 lysozyme M1 precursor [Saccharopolyspora erythraea NRRL 2338] 68 / 78 YP_001109221
39 putative gamma-glutamyltranspeptidase [Streptomyces roseosporus NRRL 15998] 66 / 77 ZP_04697280
40 methionyl-tRNA formyltransferase [Saccharopolyspora erythraea NRRL 2338] 75 / 86 YP_001104344
41 tRNA/rRNA cytosine-C5-methylase [Saccharomonospora viridis DSM 43017] 70 / 81 YP_003133431
42 flavoprotein [Streptomyces sp. AA4] 80 / 86 ZP_05478729
 64 
labeling experiments (Figure 2-18), 2-7 should be cyclized to a linear structure 2-28 
rather than an angular structure (i.e., 2-8). On the basis of the established biosynthesis of 
other angucycline type compounds, a ketoreductase homologue, BexD, and two cyclase 
homologues, BexL and BexF, are predicted to act together with PKS to construct the ring 
structure.
93
 Specifically, the reduction of the 9-keto group by BexD likely initiates the 
ring formation reaction catalyzed by BexL. Subsequent decarboxylation and cyclization 
by BexF yields 2-34 as a key intermediate (Figure 2-21). The resulting ring structure 2-34 
would then be tailored by a set of oxygenases to the angular angucyclinone core (2-40).  
Recent studies indicated that multioxygenase complexes are required to perform 
the oxidative C−C bond cleavage and ring rearrangement in both gilvocarcin (2-30) and 
jadomycin (2-31) biosyntheses.
122,128
 Since a similar oxidative ring-opening process (2-34 
 2-40) likely occurs in the formation of BE-7585A, a complex of oxygenases may also 
be involved. A few possible candidates include a flavin-dependent oxygenase 
homologue, BexE, a bifunctional oxygenase-reductase homologue, BexM, and the 
anthrone monooxygenase homologue, BexI, which displays sequence similarity to GilOII 
and JadG from the gilvocarcin and jadomycin pathways, respectively.
122,129
 Although it is 
difficult to define the cascade of the oxidation events solely based on sequence analysis, 
the identification of genes encoding these oxygenases (BexE, BexI, and BexM) in the bex 
cluster provides important leads for future biochemical experiments to address these 





Other genes likely involved in aglycone biosynthesis are bexK, bexN, and bexW. 
BexK is a cytochrome P450 hydroxylase homologue, which may be responsible for 
hydroxylation at C-2 of 2-39 to produce 2-40. This assignment is supported by an early 
observation that a cytochrome P450 inhibitor blocked C-2 hydroxylation in PD116198 
(2-14) biosynthesis, implicating C-2 hydroxylation in both pathways as a P450-dependent 
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 Similar in vivo experiments using a P450 inhibitor, metyrapone, is described 
below. BexN is an acetyl-CoA carboxylase homologue, which may be involved in 
supplying malonyl-CoA in PKS-catalyzed reactions. Precedence is found in the 
jadomycin pathway where a BexN homologue, JadN, is believed to play a similar role.
131
 
BexW is a NADPH-dependent FMN reductase homologue, which may serve as the 
reductase for the flavin-dependent oxygenases involved in the aglycone biosynthesis. 
2.3.5  Functional Prediction of Genes Involved in Rhodinose Formation and 
Rhodinosyltransfer. 
Rhodinose and rhodinose derivatives are found in several natural products whose 
biosynthetic gene clusters have been isolated and sequenced (Figure 2-4).
102,103,105,106,132
 
Sequence comparison of the putative sugar biosynthetic genes in these clusters and those 
in the bex cluster allowed the identification of the rhodinose biosynthetic genes. Figure 2-
22 shows the correlation of their proposed functions and the chemical transformation 
steps required to convert glucose 1-phosphate (2-19), which is the biosynthetic precursor 
for most deoxyhexoses, to TDP-L-rhodinose (2-26).
14,16
 The pathway is initiated by the 
activation of 2-19 to TDP-glucose (2-20), catalyzed by a TDP-glucose synthase 
homologue, BexU. The second step is the conversion of 2-20 to 2-21 catalyzed by a 
TDP-glucose 4,6-dehydratase homologue, BexS. Subsequent C-2 deoxygenation (2-21  
2-23) is catalyzed by a 2,3-dehydratase homologue, BexV, and a 3-ketoreductase 
homologue, BexQ. The resulting product 2-23 then undergoes C-3 deoxygenation to 2-24 
catalyzed by a [2Fe-2S]-containing and PMP-dependent BexT, which displays good 
sequence homology to hexose 3-dehydrase enzymes (78% identity to LanQ from S. 
cyanogenus; 73% identity to SpnQ from Saccharopolyspora spinosa).
115,133
 While this 
reaction typically requires an iron-sulfur containing flavoprotein reductase for coenzyme 
regeneration,
134,135
 no gene encoding such a specific reductase can be located in the bex 
 67 
cluster. It is possible that a general cellular reductase or BexO, which is a ferredoxin 






The bex cluster also contains the gene bexH that is believed to encode a sugar 
epimerase. Thus, a 5-epimerization reaction (2-24  2-25) followed by 4-ketoreduction 
(2-25  2-26) is proposed to complete the biosynthesis of TDP-L-rhodinose (2-26). 
However, no hexose 4-ketoreductase gene can be located in the bex cluster. Whether the 
4-ketoreduction of 2-25 is mediated by a nonspecific reductase in the cellular pool or 
BexH functions as a bifunctional epimerase-ketoreductase
137,138
 will be determined in 
future biochemical studies. Further support for the assignment of 2-26 as an L-sugar 
comes from another gene product in the bex cluster, BexG1. This glycosyltransferase 
homologue exhibits high sequence similarity to the TDP-L-rhodinosyltransferase, 
UrdGT1a, from the urdamycin pathway having 49% identity and 62% similarity.
139
 
Therefore, BexG1 is predicted to have a similar function in catalyzing the transfer of the 
 
Figure 2-22. Proposed pathway of the rhodinose formation and its transfer to the 























































L-rhodinosyl group of 2-26 to the C-12b position of the angucycline core (2-40) to 
generate 2-41. Since the UrdGT1a reaction proceeds with inversion of stereochemistry at 
the anomeric center of rhodinose and both BexG1 and UrdGT1a are members of the GT-
1 glycosyltransferase family of enzymes,
140
 BexG1 is expected to be an inverting enzyme 
as well. This implies that the TDP leaving group of the sugar donor should be -oriented 
as shown in 2-26, because the glycosidic linkage of the rhodinose moiety in 2-41 is in the 
-configuration. An epimerization at C-5 of 2-24 is, thus, necessary to fix the anomeric 
configuration as  in 2-25 and 2-26. 
2.3.6  Biosynthesis of the Thiosugar Moiety. 
Among all ORFs in the bex cluster, the bexX gene, which displays good sequence 
similarity to thiazole synthases, ThiG (58% identity to ThiG from Stigmatella aurantiaca 
DW4/3-1;
141
 38% identity to ThiG from Bacillus subtilis subsp. subtilis str 168
142
) is 
likely important for the biosynthesis of the thiosugar (2-3). ThiG is a key enzyme 
involved in the formation of thiazole of thiamine. Studies of thiamine biosynthesis in B. 
subtilis showed that the ThiG reaction is initiated by the Schiff base formation between 
one of lysine residues (Lys96) of ThiG and the 2-keto group of its substrate, 1-deoxy-D-
xylulose-5-phosphate (DXP) (see Chapter 1, Figure 1-16). The sulfur atom is transferred 
from the thiocarboxylate at the C-terminus of a sulfur carrier protein, ThiS, and 
incorporated into the ThiG-DXP adduct.
65,143
 Because of the presence of the bexX gene in 
the cluster, an analogous mechanism of sulfur incorporation can be proposed for the 
biosynthesis of 2-thioglucose (Figure 2-23). 
Accordingly, the putative substrate, glucose 6-phosphate (2-42), may form an 
imine adduct (2-43) with the active site lysine of BexX at the C-1 position. Deprotonation 
of C-2 of 2-43 followed by tautomerization via an enamine 2-44 generates a 2-keto 
 69 
intermediate 2-45, which can then react with a nucleophilic sulfur group to incorporate a 
sulfur atom at C-2 in 2-46. The reactive sulfur donor is likely a ThiS-thiocarboxylate or a 
protein persulfide equivalent. Dehydration of 2-46 to 2-47 followed by C-1 deprotonation 
gives an enamine intermediate 2-48, which can tautomerize to C-1 imine 2-49. Upon 
hydrolysis, the BexX-bound product 2-50 is released to give 2-thioglucose 6-phosphate 
(2-51). 
The sulfur atom of ThiS-thiocarboxylate has been shown to be derived from 
cysteine, mediated by a cysteine desulfurase.
65
 In B. subtilis (and E. coli), this sulfur 
loading reaction also requires ThiF, which plays a role in ThiS activation.
61,144
 
Unfortunately, neither a ThiS homologue nor a cysteine desulfurase homologue is found 
in the bex cluster. However, since the substrate and the function of ThiG and BexX are 
analogous, it is possible that the endogenous ThiS used in thiamin biosynthesis may be 
recruited to serve as the sulfur donor for thiosugar biosynthesis in A. orientalis. Further 




2.3.7  Pathway of the Disaccharide Formation and Its Transfer to the Aglycone. 
Once formed, the BexX product, 2-thioglucose 6-phosphate (2-51), is expected to 
accept a glucose moiety from UDP-glucose (2-52) to form 2-thiotrehalose 6-phosphate 
(2-53). This disaccharide moiety of BE-7585A (2-1) is structurally related to trehalose. 
The latter is commonly formed by linking the glucose moiety of UDP-glucose (2-52) to 
 
Figure 2-23. Proposed pathway and mechanism of 2-thiosugar formation in the 








































































































glucose 6-phosphate (2-42), and the reaction is catalyzed by trehalose 6-phosphate 
synthases (TPSs).
145
 Since the bexG2-encoded protein exhibits sequence similarity to 
TPSs (30% identity and 47% similarity to TPS from Methanothermobacter 
thermautotrophicus str. Delta H
146
), BexG2 is likely the 2-thiotrehalose 6-phosphate 
synthase catalyzing the coupling of 2-51 and 2-52 to form 2-53, whose 6-phosphate 





How the thiodisaccharide (2-53 or its hydrolyzed product without 6-phosphate 
group) is attached to C-5 of the benz[a]anthraquinone core is not clear. It is conceivable 
that the thioether bond formation may simply be a result of a nonenzymatic attack by the 
nucleophilic 2-thiol group of the disaccharide at the C-5 position of 
benz[a]anthraquinone (2-40 or 2-41). Functional characterization of BexG2 and the 
possible nonenzymatic C−S bond formation are described in Chapter 3. 
 
 








































2.3.8  Regulatory and Resistant Genes. 
The remaining genes in the BE-7585A gene cluster are mainly regulatory and 
resistance genes. Among them, BexR1 and BexR2 display sequence similarity to 
transcriptional regulators. BexJ1, BexJ2, and BexJ3 are transporter homologues and are 
possibly involved in self-resistance mechanisms.
147
 A methyltransferase homologue, 
BexP, may also be involved in the self-resistance mechanism by catalyzing methylation 
of rRNA. 
2.3.9  Metyrapone Feeding Experiments. 
 As described above, sequence analysis displayed that BexK is a putative 
cytochrome P450 hydroxylase homologue, which may be responsible for hydroxylation 
at C-2 of 2-39 to produce 2-40. Similar hydroxylation was predicted in PD 116198 (2-14) 
biosynthesis based on results from blocking the hydroxylation by feeding a cytochrome 
P450 inhibitor, metyrapone (2-54). The resulting cell culture of Streptomyces 
phaeochromogenes WP 3688 produced a less oxygenated compound 2-55 (Figure 2-
25)
130
 Thus, similar feeding experiments using metyrapone was performed with the BE-




































 Interestingly, HPLC analysis of the supernatant of A. orientalis culture containing 
metyrapone (2-54) showed clear suppression of the BE-7585A (2-1) production level 
compared to the control culture without metyrapone. More importantly, a large peak (2-
56), which is also seen as a very minor product in the control culture, was eluted about 2 
min after 2-1 (Figure 2-26). While the mass of this peak (2-56) was confirmed to be 16-
Da less than that of BE-7585A (2-1), the acquired UV-vis spectra from LC were almost 
identical for both 2-1 and 2-56 (Figure 2-27). These results are consistent with the 
predicted inhibition of C-2 hydroxylation in the biosynthesis of BE-7585A (2-1) and the 
resulting formation of less oxygenated 2-deoxy BE-7585A (2-56). Since BexK is the only 
P450 type hydroxylase homologue in the bex cluster, the results shown here strongly 
support the proposed function of BexK (C-2 hydroxylation of 2-39 to produce 2-40, 




Figure 2-26. Metyrapone Feeding Experiments (HPLC analysis). 
HPLC analyses of the supernatants from A. orientalis culture and the predicted structure 
of the product (2-56). A. Control culture without using metyrapone. B. Metyrapone-
























































Figure 2-27. Metyrapone Feeding Experiments (LC-MS analysis). 
LC-MS/PDA analyses of the supernatants from A. orientalis culture with metyrapone. 
BE-7585A (2-1) MS calcd for C37H46O20NaS
+
 [M + Na]
+ 
865.2, found 865.2. 2-56 MS 
calcd for C37H46O19NaS
+
 [M + Na]
+ 
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2.4  CONCLUSIONS 
In this chapter, the structure of BE-7585A (2-1) from A. orientalis was first 
characterized by a series of 1D- and 2D-NMR experiments. The determined three 
glycosydic linkages clearly show that 2-1 is a constitutional isomer of rhodonocardin A 
(2-5) but not an identical compound. The BE-7585A biosynthetic gene cluster (bex 
cluster) containing 28 ORFs was then identified by PCR-based cosmid screening of the 
genomic DNA of the producing strain. The cluster harbors genes typical for type II 
polyketide synthesis. Also contained in the cluster is a thiazole synthase (ThiG) 
homologue, BexX, which may catalyze the key reaction producing 2-thioglucose 6-
phosphate (2-51) from glucose 6-phoshate (2-42). On the basis of sequence analysis, a 
biosynthetic pathway is proposed for BE-7585A including the benz[a]anthraquinone core 
formation, rhodinose formation, and 2-thiosugar-containing disaccharide formation. 




C2]acetate revealed that the 
construction of the angucycline skeleton involves an unusual oxidative ring-opening and 
rearrangement. Moreover, feeding experiments using a P450 hydroxylase inhibitor 
provided good evidence that the C-2 hydroxylation on the angucycline core is likely 
catalyzed by BexK. 
Overall, this chapter described the structural and genetic analyses of BE-7585A 
(2-1) and proposed its biosynthetic pathway. These results set the stage to study the 
predicted functions of identified genes in the later chapters. Proposed disaccharide 
formation and C−S bond formation are described in Chapter 3. Studies of the molecular 
mechanism of the sulfur incorporation reaction are described in Chapter 4. Although the 
direct sulfur donor was not identified in the bex cluster, an endogenous sulfur carrier 
protein, such as ThiS used in thiamin biosynthesis, may be recruited for the thiosugar 
production, and this is also described in Chapter 4. 
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Chapter 3:  Biosynthetic Studies of BE-7585A (II): Investigation of the 
Glycosyltransferase, BexG2, and C−S Bond Formation  
 
3.1  INTRODUCTION 
A putative biosynthetic gene cluster (bex cluster) for the 2-thiosugar-containing 
natural product, BE-7585A (3-1), was identified in Chapter 2. A biosynthetic pathway of 
the unique disaccharide moiety of 3-1 was proposed involving reactions catalyzed by a 
putative 2-thioglucose 6-phosphate synthase (bexX) and a putative 2-thiotrehalose 6-
phoshate syntahse (bexG2) found in the gene cluster. The expected product, 2-
thiotrehalose 6-phosphate (3-4), is then transferred to the aglycone (3-2  3-3  3-4  
3-5, Figure 3-1, solid line). The last coupling step might be nonenzymatic since besides 
bexG1 the only other glycosyltransferase gene found in the bex cluster is a putative 
rhodinosyl transferase gene (bexG1), which is likely responsible for transferring the 
rhodinosyl moiety to the aglycone at the C-12b position. 
As discussed in the previous chapter, BexG2 exhibits moderate sequence 
similarity to trehalose 6-phosphate synthase (TPS, 30% identity and 47% similarity to 
TPS from Methanothermobacter thermautotrophicus str. Delta H). Thus, one may 
consider that BexG2 acts as a “regular” TPS to produce trehalose 6-phosphate (3-6) in the 
BE-7585A biosynthetic pathway. In this case, a sulfur atom must be introduced at the C-2 
position of the resulting disaccharide (3-6) to construct the 2-thiotrehalose moiety found 
in BE-7585A (3-1). However, the proposed sulfur incorporation mechanism using BexX, 
which is analogous to ThiG-catalyzed thiazole formation, cannot account for the latter 
transformation because the reaction mechanism of BexX requires a reducing sugar 
substrate to form a schiff base with an active site lysine residue of the enzyme (Figure 2-
23). Therefore, this second pathway (3-2  3-6  3-4  3-5) is less likely unless the 
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introduction of the sulfur atom into 3-6 can be catalyzed by BexX in a novel mechanism 





On the other hand, C−S bond formation between the generated thiosugar and C-5 
of the angucycline core may not be enzyme-catalyzed. In the previous chapter, a possible 
nonenzymatic attack by the nucleophilic 2-thiol group of the disaccharide at the C-5 
 
Figure 3-1. Possible biosynthetic pathways of the thiosugar-containing disaccharide 

























































































































position of benz[a]anthraquinone was discussed (3-4  3-5). This hypothesis is based on 
the fact that the C-5 site of the core structure is electrophilic and, thus, can function as a 
Michael acceptor. In fact, a similar pathway has been proposed in urdamycin E (3-10) 
biosynthesis (Figure 2-2).
148
 Urdamycin E (3-10), which is a minor product from 
Streptomyces fradiae (strain Tü 2712), possesses a methylthio substituent at C-5 on the 
angucycline core of urdamycin A (3-9). It was reported that the feeding experiment using 
200 mg/L L-methionine (3-11) to the fermentation medium showed a clear increase of the 
yield of 3-10 from 3% to 30%. It was also confirmed that urdamycin A (3-9) can readily 
react with sodium methanethiolate (3-12) to yield urdamycin E (3-10) in a dimethyl 






   
 
Figure 3-2. Proposed biosynthetic pathway of urdamycin E involving a nonenzymatic 























































 It is notable that though the observed thiolate addition to 3-9 occurred 
spontaneously at a neutral pH to produce urdamycin E (3-10), this C−S bond formation 
might be controlled by some enzyme(s) in vivo since 3-10 is the only product possessing 
a thioether substituent at C-5 of the angucyline core isolated from S. fradiae, and no 
adducts derived from other thiol-containing biomolecules in the cellular pool were 
reported. If this process is truly nonenzymatic in the biosyntehsis of BE-7585A (3-1), 
both 2-thioglucose 6-phosphate (3-3) and 2-thiotrehalose 6-phosphate (3-4) may attack 
the C-5 position of the benz[a]anthraquinone core. Although a monosaccharide 
thioadduct on the angucycline core (3-7) has not been isolated from A. orientalis, it is 
possible that formation of the disaccharide moiety catalyzed by BexG2 may take place 
after the C−S bond is formed (Figure 3-1, 3-3  3-7  3-5). 
  In this chapter, functional characterization of a TPS homologue, BexG2, is 
described. To test the proposed enzymatic reaction in vitro, the recombinant enzyme was 
heterologously expressed in E. coli, and the predicted substrate, 2-thioglucose 6-
phosphate (3-3), was chemoenzymatically synthesized. The substrate specificity of the 
BexG2-catalyzed reaction was investigated and several possible biosynthetic pathways as 
well as the timing of coupling to produce the disaccharide moiety in vivo were also 
sudied. Finally, the proposed C−S bond formation is tested with a model compound, 
urdamycin A (3-8), and a synthetic 2-thiosugar. 
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3.2  EXPERIMENTAL PROCEDURES 
3.2.1  General 
Materials 
All chemicals and reagents were purchased from Sigma-Aldrich Chemical Co. 
(St. Louis, MO) or Fisher Scientific (Pittsburgh, PA), and were used without further 
purification unless otherwise specified. Most materials used for molecular cloning were 
identical to those described in Chapter 2. In addition, PfuUltra DNA polymerase was 
purchased from Stratagene (La Jolla, CA). Ni-NTA agarose was obtained from Qiagen 
(Valencia, CA). Amicon YM-10 ultrafiltration membranes were purchased from 
Millipore (Billerica, MA). Reagents for sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) were purchased from Bio-Rad (Hercules, CA), with the 
exception of the protein molecular weight markers, which were obtained from Invitrogen 
or New England Biolabs. The CarboPac PA1 high-performance liquid chromatography 
(HPLC) column was acquired from Dionex (Sunnyvale, CA). Analytical C18 HPLC 
columns were products of Varian (Palo Alto, CA). 
Bacterial Strains and Plasmids 
Cosmid C006 was obtained from the A. orientalis genomic library as described in 
Chapter 2. E. coli DH5, acquired from Bethesda Research Laboratories (Gaithersburg, 
MD), was used for routine cloning experiments. The protein overexpression host E. coli 
BL21 star (DE3) was obtained from Invitrogen (Carlsbad, CA). Vector pET28b(+) for 
protein over-expression was purchased from Novagen (Madison, WI). Standard genetic 





UV−vis spectra were recorded using a Beckman DU 650 spectrophotometer. 
NMR spectra were acquired on a Varian Unity 500 MHz spectrometer, and chemical 
shifts (in ppm) are reported relative to that of the solvent peak (H = 4.65 for deuterated 
water, H = 3.30 and C = 49.0 for deuterated methanol) or an internal standard (dioxane, 
C = 67.4) for spectra taken in D2O solvent. HPLC was performed on a Beckman Coulter 
System Gold equipped with a UV detector or Corona CAD (charged aerosol detector). 
DNA concentrations were measured using a NanoDrop ND-1000 UV−vis instrument 
from Thermo Fisher Scientific. DNA sequencing was performed by the core facility of 
the Institute of Cellular and Molecular Biology at the University of Texas, Austin. Mass 
spectroscopy was performed at the Mass Spectrometry core facility in the Department of 
Chemistry and Biochemistry at the University of Texas, Austin.  
3.2.2  Cloning of BexG2. 
The bexG2 gene was PCR-amplified from cosmid C006 using primers with 
engineered NdeI and HindIII restriction sites. The sequences of the primers are shown in 
Table 3-1. The PCR-amplified gene fragments were purified, digested with NdeI and 
HindIII, and ligated into pET28b(+) vector digested with the same enzymes. The 
resulting plasmid, bexG2/pET28b(+), was used to transform E. coli BL21 star (DE3) 





3.2.3  Expression and Purification of BexG2. 
An overnight culture of E. coli BL21 star (DE3)-bexG2/pET28b(+), grown in the 
LB medium (10 mL) containing 50 µg/mL of kanamycin at 37 °C, was used to inoculate 
1L of the same growth medium. The culture was incubated at 37 °C with shaking (230 
rpm) until the OD600 reached ∼0.5. Protein expression was then induced by the addition 
of isopropyl -D-1-thiogalactopyranoside (IPTG) to a final concentration of 0.1 mM, and 
the cells were allowed to grow at 18 °C and 125 rpm for an additional 24 h. The cells 
were harvested by centrifugation at 4500  g for 15 min and stored at −80 °C until lysis. 
All purification steps were carried out at 4 °C using Ni-NTA resin according to the 
manufacturer‟s protocol with minor modifications. Specifically, the thawed cells (~3 g) 
were resuspended in the lysis buffer (15 mL) containing 10% (v/v) glycerol and 10 mM 
imidazole. After incubation with lysozyme (15 mg) for 30 min, the cells were disrupted 
by sonication using 10 × 10-s pulses with a 30-s cooling pause between each pulse. The 
resulting lysate was centrifuged at 10,000  g for 20 min, and the supernatant was 
subjected to Ni-NTA chromatography. Bound protein was eluted using buffer containing 
10% glycerol and 250 mM imidazole. The collected protein solution was dialyzed against 
3 × 1-L of 50 mM Tris·HCl buffer (pH 8.0) containing 300 mM NaCl and 15% glycerol. 
The protein solution was then flash-frozen in liquid nitrogen and stored at −80 °C until 




The engineered restriction sites are shown in bold, the start codon is shown in bold and also underlined, 
and the stop codon is italic. 
 
Primer name Sequence
bexG2 for pET28b(+)-forward 5'-GGTTAGGCATATGAGGATTCTGACCTGCAGC-3'
bexG2 for pET28b(+)-reverse 5'-GTAGAAGCTTAGGTCAGAGCCCGAAAACCCC-3'
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use. Protein concentration was determined by the Bradford assay
149
 using bovine serum 
albumin as the standard. The yield of BexG2 was 40 mg from 1 L culture. The molecular 
mass and purity of BexG2 were estimated by SDS-PAGE analysis. 




As shown in Figure 3-3, compound 3-15 was synthesized from D-mannose (3-13, 
16.5 g, 92 mmol) following a previously reported procedure with slight 
modifications.
150,151
 Specifically, to a small portion of 3-13 (∼30 mg) in acetic anhydride 
(63 mL) was added 70% perchloric acid (5 drops). The remaining 3-13 was slowly added 
to the reaction mixture over a 20 min period, keeping the reaction temperature at 
 






































































40−45 °C. The resulting mixture was stirred at room temperature for 1 h and then cooled 
to 15 °C. Phosphorus tribromide (13 mL) was added dropwise to the reaction with the 
reaction temperature kept at 20−25 °C. Cold water (8.3 mL) was slowly added to the 
resulting mixture, and the reaction was kept at room temperature for 1.5 h. After cooling 
to 10 °C, a chilled solution of sodium acetate trihydrate (50 g, 370 mmol) in water was 
slowly added with the temperature kept at 25−30 °C. The reaction mixture was stirred at 
room temperature for 20 min and poured onto ice. The resulting mixture was extracted 
with methylene chloride (100 mL × 2) and washed sequentially with cold saturated 
sodium bicarbonate and cold water. The solution was dried over anhydrous Na2SO4 and 
evaporated in vacuo. The obtained crude mixture, which contained 2,3,4,6-tetra-O-acetyl-
-D-mannopyranose (3-14) as a byproduct, was thoroughly washed with anhydrous 
diethyl ether to give the desired product 3-15 as a white powder (6.7 g, 19 mmol, 21%). 
The 
1




Compound 3-16 was synthesized from 3-15 using a previously reported procedure 
with minor modifications.
152,153
 Specifically, to a solution of 3-15 (3.5 g, 10 mmol) in 
anhydrous methylene chloride (100 mL) was added anhydrous pyridine (1.8 mL, 22 
mmol). The solution was cooled to −20 °C and treated with trifluoromethane-sulfonic 
anhydride (3.6 mL, 22 mmol), which was added dropwise in 1 h under N2. The resulting 
suspension was stirred at room temperature for an additional 1 h. The mixture was 
washed sequentially with cold water, saturated sodium bicarbonate, and water; dried over 
anhydrous Na2SO4; and concentrated in vacuo. The product 3-16 was obtained as a pale 
yellow solid (4.6 g, 9.6 mmol, 96%). The 
1






Compound 3-17 was prepared from 3-16 following a reported procedure with 
minor modifications.
154,155
 Accordingly, to a solution of 3-16 (4.1 g, 8.5 mmol) in 
anhydrous dimethylformamide (170 mL) was added potassium thioacetate (9.7 g, 85 
mmol). The resulting mixture was stirred at room temperature for 1 h under N2. After 
evaporation of the solvent in vacuo, the residue was mixed with methylene chloride and 
water. The organic layer was separated and washed sequentially with water and saturated 
sodium chloride, dried over anhydrous Na2SO4, and concentrated in vacuo. The residue 
was purified by silica gel column chromatography (hexanes−EtOAc, 2:1) and 
recrystallized from hexanes−EtOAc. The product 3-17 was obtained as a white powder 
(3.0 g, 7.4 mmol, 87%). The 
1





To a solution of 3-17 (510 mg, 1.25 mmol) in anhydrous methanol (15 mL) was 
added Dowex 50W X8 (∼200 mg). The reaction was gently refluxed for 15 h. The 
resulting solution was filtered and the filtrate was concentrated under reduced pressure to 
give an / mixture of 1-O-methyl-2-thio-D-glucopyranose (/) 1:3, determined by 
1
H 
NMR spectroscopy). The mixture was dissolved in water (20 mL) and stirred at 80 °C in 
the presence of Dowex 50W X8 for 20 h under N2. The resulting solution was filtered 
and lyophilized (260 mg). A part of the residue (100 mg) was used for further purification 
by silica gel column chromatography (water−acetonitrile, 1:50). The product 3-18 was 
obtained as a white powder (30 mg, 0.15 mmol, 32%). In solution, 3-18 exists as a 
mixture of  and  isomers (/) 9:10, under the 
1
H NMR conditions). 
1
H NMR (500 
MHz, D2O)  5.13 (d, J = 3.3 Hz, 1H, 1-H), 4.55 (d, J = 8.6 Hz, 1H, 1-H), 3.75 (dd, J = 
12.3, 2.3 Hz, 1H, 61-H), 3.74 (m, 1H, 5-H), 3.69 (dd, J = 12.3, 2.4 Hz, 1H, 61-H), 3.62 
 86 
(dd, J = 12.3, 5.1 Hz, 1H, 62-H), 3.58 (dd, J = 12.3, 5.9 Hz, 1H, 62-H), 3.48 (dd, J = 
10.7, 9.0 Hz, 1H, 3-H), 3.34 (ddd, J = 9.7, 5.9, 2.3 Hz, 1H, 52-H), 3.27 (m, 1H, 3-H), 
3.26 (m, 1H, 4-H), 3.23 (m, 1H, 4-H), 2.75 (dd, J = 10.7, 3.3 Hz, 1H, 2-H), 2.57 (dd, J 
= 10.2, 8.6 Hz, 1H, 2-H); 
13
C NMR (125 MHz, D2O)  98.2 (C-1), 94.5 (C-1), 77.2 
(C-3), 76.7 (C-5), 74.6 (C-3), 72.8 (C-5), 71.5 (C-4), 71.2 (C-4), 61.6 (C-6), 61.4 
(C-6), 48.5 (C-2), 45.8 (C-2); HRMS (ESI+) calcd for C6H12O5NaS
+
 [M + Na]
+
 
219.0298, found 219.0303. (ESI−) calcd for C6H11O5S
-
 [M − H] 
−
 195.0333, found 






H NMR spectrum (500 MHz, D2O) of 2-thio-D-glucose. 
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Figure 3-9. HMBC spectrum of 2-thio-D-glucose. 
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3.2.5  BexG2 in Vitro Activity Assay. 
As depicted in Figure 3-11, a typical BexG2 assay mixture (0.1 mL) contained 2-
thio-D-glucose (3-18, 1 mM), ATP (1 mM), UDP-D-glucose (3-8, 1 mM), MgCl2 (10 
mM), hexokinase (5 μg), and BexG2 (16 μM) in 50 mM Tris·HCl buffer, pH 8.0. The 
substrate for BexG2, 2-thio-D-glucose 6-phosphate (3-3), was produced in situ from 3-18 
and ATP by hexokinase. The reaction mixture was incubated at 30 °C for 1.5 h and 
filtered through a YM-10 membrane using an Amicon ultrafiltration unit to remove the 
 
Figure 3-10. NOESY spectrum (500 MHz, D2O) of 2-thio-D-glucose. 
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proteins. HPLC analysis was performed using a Dionex CarboPac PA1 analytical column 
(4 × 250 mm). The sample was eluted with a gradient of water (solvent A) and 1 M 
NH4OAc (solvent B). The gradient was run from 30 to 50% B over 10 min, 50−80% B 
over 5 min, with a 5 min wash at 80% B, and 80−30% B over 5 min, followed by re-
equilibration at 30% B for 10 min. The flow rate was 1 mL/min, and the detector was set 
at 276 nm. 
 
 
3.2.6  Isolation and Characterization of BexG2 Product. 
A large-scale BexG2 reaction (1 mL) containing 2-thio-D-glucose (3-18, 10 mM), 
ATP (12 mM), UDP-D-glucose (3-8, 12 mM), MgCl2 (3 mM), hexokinase (20 μg), and 
BexG2 (30 μM) in 100 mM Tris·HCl buffer, pH 8.0, was carried out. The reaction 
mixture was incubated at 30 °C for 6.5 h and filtered through a YM-10 membrane using 
 












































an Amicon ultrafiltration unit to remove the proteins. HPLC analysis and purification 
were performed using a Dionex CarboPac PA1 semipreparative column (9 × 250 mm). 
The sample (330 μL × 3) was eluted with 0.1 M NH4OAc at 5 mL/min. The resulting 
flow through was split into a collection fraction (4.85 mL/min) and a detection fraction 
(0.15 mL/min) by a splitter. The elution was monitored by a Corona CAD. The retention 
time of 3-4 was 10.4 min under the HPLC conditions. The fraction containing 3-4 was 
collected and lyophilized. 
1
H NMR (500 MHz, D2O)  5.11 (d, J = 3.5 Hz, 1H, 1-H), 5.06 
(d, J = 3.8 Hz, 1H, 1‟-H), 3.96 (m, 2H, 61,2-H), 3.93 (m, 1H, 5‟-H), 3.85 (m, 1H, 5-H), 
3.76 (dd, J = 12.5, 2.2 Hz, 1H, 6‟1-H), 3.68 (m, 1H, 3‟-H), 3.66 (m, 1H, 3-H), 3.65 (m, 
1H, 6‟2-H), 3.53 (dd, J = 9.9, 3.8 Hz, 1H, 2‟-H), 3.44 (dd, J = 9.9, 9.2 Hz, 1H, 4-H), 3.34 
(dd, J = 10.1, 9.2 Hz, 1H, 4‟-H), 2.90 (dd, J = 10.8, 3.5 Hz, 1H, 2-H); 
13
C NMR (125 
MHz, D2O)  94.8 (C-1), 93.4 (C-1‟), 73.8 (C-3), 72.9 (C-5‟), 72.7 (C-3‟), 71.9 (C-5), 
71.1 (C-2‟), 70.4 (C-4), 69.8 (C-4‟), 63.8 (C-6), 60.8 (C-6‟), 44.5 (C-2); HRMS (ESI−) 
calcd for C12H22O13SP
−
 [M − H] 
−









H NMR spectrum (500 MHz, D2O) of 2-thio-D-trehalose 6-phosphate. 
(acetate)





































Figure 3-17. HMBC spectrum of 2-thio-D-trehalose 6-phosphate. 
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3.2.7  Substrate Specificity of BexG2-Catalyzed Glycosyltransfer Reaction. 
D-Glucose 6-Phosphate as the Glycosyl Acceptor 
The reaction solution (0.5 mL  3) contained D-glucose 6-phosphate (3-2, 10 
mM), UDP-D-glucose (3-8, 10 mM), MgCl2 (20 mM), and BexG2 (29 μM) in 50 mM 
NH4·HCO3 buffer, pH 7.9. The protein stock solution of BexG2 was dialyzed against 
NH4·HCO3 buffer containing MgCl2 (20 mM) prior to use to remove excess glycerol. The 
 
Figure 3-18. NOESY spectrum of 2-thio-D-trehalose 6-phosphate. 
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reaction mixture was incubated at 30 ºC for 1, 2.5, or 5.8 h and quenched in boiling water 
for 5 min. Each reaction mixture was then centrifuged, lyophilized and redissolved in 
D2O for the NMR analysis. The resulting solution was also subjected to MS analysis: 
ESI−MS (low resolution) calculated for D-trehalose 6-phosphate (3-6), C12H22O14P
−
 [M – 
H]
−
 421.1, found 421.3. As a separate experiment, a similar reaction solution (1 mL) 
containing D-glucose 6-phosphate (3-2, 10 mM), UDP-D-glucose (3-8, 10 mM), MgCl2 
(20 mM), and BexG2 (16 μM) in 50 mM NH4·HCO3 buffer, pH 7.9 was prepared. The 
reaction was incubated at 30 ºC for 5 h, and then 37 ºC for 1 h after addition of calf 
intestinal alkaline phosphatase (CIP) (1 L, 10 units). After centrifugation to remove the 
precipitate, the solution was lyophilized, redissolved in D2O, and subjected to NMR 
analysis. To confirm the identities of the anomeric protons, a small amount of D-glucose 
(3-19) standard and D-trehalose (3-20) standard were added and subjected to NMR 
analysis successively. 
Investigation of Other Glycosyl Donors 
Various NDP-sugars were substituted for UDP-glucose (3-8) to test the substrate 
specificity of BexG2 towards the glycosyl donors. NDP-sugars tested were UDP-glucose 
(3-8, positive control), UDP-xylose (3-21), UDP-glucuronic acid (3-22), UDP-galactose 
(3-23), TDP-glucose (3-24), ADP-glucose (3-25) and GDP-glucose (3-26). The BexG2 
assay mixture (50 L) contained D-glucose 6-phosphate (3-6, 5 mM or 1 mM for the 
reaction with TDP-glucose), one of the NDP-sugars (1 mM for TDP-glucose, 5 mM for 
the others), MgCl2 (20 mM), and BexG2 (36 μM) in 100 mM Tris·HCl buffer, pH 8.0. 
The reaction mixture was incubated at 30 °C for 5 h and filtered through a YM-10 
membrane using an Amicon ultrafiltration unit to remove the proteins. HPLC analysis 
was performed using a Dionex CarboPac PA1 analytical column (4 × 250 mm). The 
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sample (5 L or 10 L for the reaction with TDP-glucose) was eluted with a gradient of 
water (solvent A) and 1 M NH4OAc (solvent B). The gradient was run from 30 to 50% B 
over 10 min, 50−80% B over 5 min with a 5 min wash at 80% B, and 80−30% B over 5 
min, followed by re-equilibration at 30% B for 10 min. The flow rate was 1 mL/min, and 
the detector was set at 260 nm. 
Investigation of Other Glycosyl Acceptors 
Various sugar-monophosphates were also substituted for the natural substrate, 2-
thioglucose 6-phosphate (3-3), to test the substrate specificity of BexG2 for the glycosyl 
donors. Glycosyl donors tested are D-glucose 6-phosphate (3-6, positive control), 2-
deoxy-D-glucose 6-phosphate (3-27), D-glucosamine 6-phosphate (3-28), and D-mannose 
6-phoshate (3-29). The BexG2 assay mixture (50 L) contained one of the glycosyl 
acceptors (5 mM), UDP-glucose (3-8), 5 mM), MgCl2 (20 mM), and BexG2 (36 μM) in 
100 mM Tris·HCl buffer, pH 8.0. The reaction mixture was incubated at 30 °C for 5 h 
and filtered through a YM-10 membrane using an Amicon ultrafiltration unit to remove 
the proteins. HPLC analysis was similarly performed as described above. 
3.2.8  Competitive Assay of BexG2-Catalyzed Glycosyltransfer Reaction. 
The reaction solution (0.3 mL) containing 2-thio-D-glucose (3-18, 10 mM), D-
glucose (3-19, 10 mM), ATP (24 mM), MgCl2 (20 mM), and hexokinase (0.05 mg/mL) 
was incubated in 100 mM Tris·HCl (pH 8.0) at 30 °C for 1 h. Complete conversion of 3-
18 and 3-19 to 2-thio-D-glucose 6-phosphate (3-3) and D-glucose 6-phosphate (3-2), 
respectively, was confirmed for similar reactions performed in a separate experiment. 
The resulting solution was filtered through a YM-10 membrane  using an Amicon 
ultrafiltration unit to remove the proteins. BexG2 and various concentration of UDP-
glucose (3-8) were then added to an aliquot of the solution (30 L). This reaction mixture 
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(60 L) contained 3-3 (5 mM expected), 3-2 (5 mM expected), ATP (1 mM expected), 
ADP (10 mM expected), MgCl2 (10 mM expected), BexX (26 M), 3-8 (0, 2.5, 3.75, 5, 
6.25, 7.5, 10, or 12.5 mM) in 50 mM Tris·HCl (pH 8.0). The reaction was incubated at 
30 °C for 8 h and filtered through a YM-10 membrane using an Amicon ultrafiltration 
unit to remove the proteins. HPLC analysis was performed using a Dionex CarboPac PA1 
analytical column (4 × 250 mm). The sample (10 L) was analyzed by two separate 
methods. The first method was designed for detecting the sugar monophosphates, in 
which the sample was eluted with 120 mM NH4OAc at 1 mL/min and monitored by a 
Corona CAD. The second method was designed for detecting ATP, ADP, UDP, and 
UDP-glucose (3-8). The sample (5 L) was eluted with a gradient of water (solvent A) 
and 1 M NH4OAc (solvent B). The gradient was run from 30 to 50% B over 10 min, 
50−80% B over 5 min with a 5 min wash at 80% B, and 80−30% B over 5 min, followed 
by re-equilibration at 30% B for 10 min. The flow rate was 1 mL/min, and the detector 
was set at 276 nm. 
3.2.9  Non-Enzymatic C−S Bond Formation Between a Thiosugar and Aglycon.  
HPLC and MS Analysis 
A reaction solution (50 L) containing urdamycin A (3-9, 0.5 mM) and 2-thio-D-
glucose (3-18, 1 mM) in 50 mM Tris·HCl buffer, pH 8.0 was incubated at room 
temperature for 3 min and subjected to HPLC analysis. As a control, D-glucose (3-19) 
was used instead of 3-18. HPLC analysis was performed using a C18 analytical column (4 
× 250 mm). The sample (10 L) was eluted with a gradient of water (solvent A) and 
methanol (solvent B). After 5 min at 20% B, the gradient was run from 20 to 80% B over 
10 min with a 5 min wash at 80% B, 80−20% B over 5 min, followed by re-equilibration 
at 20% B for 10 min. The flow rate was 1 mL/min, and the detector was set at 300 nm. 
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The product peak (3-30) was isolated and subjected to MS analysis. HRMS (ESI−) 
calculated for C49H65O22S
−
 [M − H]
−
 1037.3694, found 1037.3689. 
Absorbance Spectra Analysis 
The absorbance spectrum (220−650 nm) of urdamycin A (3-9, 0.2 mM) was measured in 
50 mM glycylglycine buffer (pH 8.0). To this solution, 1 L of a 10 mM 2-thio-D-
glucose stock solution (3-18, final concentration 0.1 mM) was added, and the absorbance 
spectrum was immediately measured. After a 2 min incubation at room temperature, the 
spectrum was measured again. Similarly, an additional 0.5 L of 100 mM 2-thio-D-
glucose stock solution (3-18, final total concentration 0.6 mM) was added, and the 
absorbance spectrum was immediately measured. After 2 min and 4 min incubations at 
room temperature, the spectra were measured repeatedly. 
 
3.3  RESULTS AND DISCUSSION 
3.3.1  BexG2 Activity Assay. 
To verify the proposed pathway for disaccharide formation (3-3  3-4, Figure 3-
1), the putative glycosyltransferase, BexG2, was expressed and purified to near 
homogeneity (Figure 3-19). The standard BexG2 assay contained 2-thioglucose (3-18), 
ATP, UDP-glucose (3-8), MgCl2, hexokinase, and BexG2 in Tris·HCl buffer. In this 
assay, the predicted substrate, 2-thioglucose 6-phosphate (3-3), was produced in situ from 
chemically synthesized 3-18 using hexokinase (Figure 3-11). HPLC analysis of the 
reaction mixture showed the consumption of ATP and 3-8 and the production of ADP 
and UDP (Figure 3-20A, trace c). This observation indicated that the tandem reactions 
carried out by hexokinase and BexG2 were successful. In the absence of BexG2, only 
consumption of ATP and the production of ADP were observed (Figure 3-20A, trace b). 
 105 
Therefore, the conversion of 3-8 to UDP must be BexG2-dependent. When both enzymes 




To confirm the identity of the reaction product, a Corona CAD was used to detect 
product formation. As shown in Figure 3-20B, a new peak was observed in the 
hexokinase-BexG2 reaction. The corresponding fraction was collected, and the isolated 
product was subjected to NMR and MS analyses. All data are consistent with the 
assigned structure, 3-4, which is linked by an ,-1‟,1‟‟-glycosidic bond (Figure 3-21). 
In archaea, bacteria, fungi, plants, and animals, the dephosphorylation of trehalose 
6-phosphate to trehalose is catalyzed by trehalose 6-phosphate phosphatase (TPP).
145
 In 
fact, the TPS- and TPP-encoding genes are clustered in Streptomyces avermitilis and 
Saccharopolyspora erythraea genomes.
156,157
 Although no TPP homologous gene is 
found in the bex cluster or in the boundary region, the phosphate group of 3-4 may be 
 
Figure 3-19. SDS-PAGE gel of the purified N-His6 tagged BexG2 
Calculated molecular weight of N-His6-BexG2 (482 aa) is 53.6 kDa. The molecular 
weight marks are 220, 160, 120, 100, 90, 80, 70, 60, 50, 40, 30, 25, 20, 15, and 10 kDa 













hydrolyzed by an endogenous phosphatase encoded elsewhere in the genome. The 
hydrolysis may occur on the disaccharide 3-4 or after the disaccharide has been attached 
to the aglycone. Recently, a new trehalose biosynthetic route (catalyzed by TreTs), which 
utilizes UDP-glucose (3-8) and glucose instead of glucose 6-phosphate (3-2), was also 
found.
158-161
 Although the poor sequence alignment results between BexG2 and these 
trehalose glycosyltransferring synthases (TreTs) renders this route less likely for the 
BexG2 reaction, we tested whether 2-thioglucose (3-18) could be processed by BexG2. 
The reaction conditions were the same as described above except for the omission 
of hexokinase and ATP. HPLC analysis of the reaction showed that no UDP was 
produced (Figure 3-20A, trace d). Thus, it appears that BexG2 cannot process 3-18 as a 
substrate, and phosphorylation at C-6 position of 2-thioglucose is necessary for the 
BexG2 reaction. This is consistent with the sequence analysis of BexG2, which exhibits 
higher sequence similarity to trehalose phosphate synthases (TPSs) than to trehalose 





Figure 3-20. BexG2 activity and substrate specificity assay 
(A) In situ production of 2-thioglucose 6-phosphate (3-3) from 2-thioglucose (3-18) 
using hexokinase was monitored by the consumption of ATP (21.4 min) and the 
production of ADP (16.5 min) at 276 nm. The conversion of 3-3 to 3-4 catalyzed by 
BexG2 was detected by the consumption of UDP-glucose (3-8) (6.1 min) and the 
production of UDP (10.5 min) at 276 nm. (a) Control reaction, no enzymes; (b) control 
reaction, no BexG2; (c) the complete reaction containing 3-18 (1 mM), ATP (1 mM), 3-
8 (1 mM), MgCl2 (10 mM), hexokinase (5 g), and BexG2 (16 M) in 50 mM Tris·HCl 
buffer, pH 8.0 (0.1 mL); (d) control reaction to investigate the substrate specificity, no 
ATP and hexokinase. (B) Isolation of BexG2 product 3-4. The large-scale reaction 
contained 3-18 (10 mM), ATP (12 mM), 3-8 (12 mM), MgCl2 (3 mM), hexokinase (20 
g), and BexG2 (30 M) in 100 mM Tris·HCl buffer, pH 8.0 (1 mL). The resulting 
product 3-4 (10.4 min, monitored by the Corona CAD) was collected and characterized. 




































3.3.2  BexG2 Substrate Specificity Assay. 
D-Glucose 6-Phosphate as the Substrate 
Based on the sequence similarity between BexG2 and trehalose 6-phosphate 
synthases (TPSs), the second possible pathway to form 2-thiotrehalose 6-phosphate can 
be considered (3-2  3-6  3-4, Figure 3-1). Although the transformation from 3-6 to 3-
4 is not consistent with the proposed function and mechanism of BexX (Figure 2-23), it is 
interesting to test if BexG2 can utilize glucose 6-phosphate (3-2) in addition to 2-
thioglucose 6-phosphate (3-3) to produce trehalose 6-phosphate (3-6). To address this 
question, the reaction solution containing 3-2 and UDP-glucose (3-8) was incubated with 
BexG2. The reaction was quenched in a time dependent manner (at 1 h, 2.5 h and 3.8 h) 
and analyzed by 
1
H NMR. As expected, the decrease of signals corresponding to the 
anomeric protons of glucose 6-phosphate (Figure 3-22, a and b) was observed along with 
an increase of the intensity of the new signals corresponding to the anomeric protons of 
trehalose 6-phosphate (Figure 3-22, c and d). To confirm the identity of the product, the 
 





















3JH-H = 3.1 Hz




reaction solution was treated with alkaline phosphatase, and the resulting 
dephosphorylated compounds were co-analyzed with D-glucose (3-19) and D-trehalose 
(3-20) standards by 
1
H NMR. Successive addition of each standard compound enhanced 
the NMR signals obtained from the reaction mixture (Figure3-23). These results clearly 
show that BexG2 can accept glucose 6-phosphate (3-2) as the substrate and can produce 







H NMR analysis of the BexG2-catalyzed reaction using glucose 6-














































Investigation of Other Glycosyl Donors 
Although UDP-glucose (3-8) was found to be an effective glycosyl donor for the 
BexG2-catalyzed reaction as described above, other NDP-sugars (UDP-xylose (3-21), 
UDP-glucuronic acid (3-22), UDP-galactose (3-23), TDP-glucose (3-24), ADP-glucose 
(3-25), and GDP-glucose (3-26)) were also used to test the substrate specificity of the 
enzyme (Figure 3-24). These NDP-sugars were incubated with glucose 6-phosphate (3-2) 
and BexG2, and the reaction was analyzed by HPLC. Successful glycosyl transfer was 
judged by detection of the released NDP. Among the tested NDP-sugars, only ADP-
glucose yielded the expected product, and the other NDP-sugars did not release NDP 




H NMR analysis of the BexG2-catalyzed reaction product using D-
glucose 6-phosphate and UDP-glucose as the substrates. 
The dephosphorylated compounds (A) were added D-glucose (3-19) standard (B) and 








































BexG2 possesses relatively strict substrate specificity for the glycosyl donor. In the 
literature, more relaxed substrate specificity for the trehalose 6-phosphate synthases 
(TPSs) OtsA from Thermus thermophilus RQ-1 and TPS from Mycobacterium 
tuberculosis were reported.
162,163
 The former enzyme can utilize UDP-glucose (3-8), 
TDP-glucose (3-24), ADP-glucose (3-25), and GDP-glucose (3-26) while it cannot take 
ADP-mannose, GDP-mannose, UDP-mannose, and UDP-galactose (3-23) as the 
substrate. The latter enzyme can take CDP-glucose in addition to the four NDP-glucoses 

















































































































Investigation of Other Glycosyl Acceptors 
Substrate specificity of BexG2-catalyzed reaction for the glycosyl acceptor was 
similarly examined. Various sugar monophosphates (Figure 3-26) were incubated with 
UDP-glucose (3-8) and BexG2, and the reaction were analyzed by HPLC. Interestingly, 
release of UDP from 3-8 was observed in all reactions (Figure 3-27). This indicates that 
2-deoxy-D-glucose 6-phosphate (3-27), D-glucosamine 6-phosphate (3-28), and D-
mannose 6-phoshate (3-29) in addition to D-glucose 6-phosphate (3-2) and the natural 
 
Figure 3-25. BexG2 glycosyl donor specificity assay. 
(a) UDP-glucose (3-8, positive control) (b) UDP-xylose (3-21) (c) UDP-glucuronic acid 
(3-22) (d) UDP-galactose (3-23) (e) TDP-glucose (3-24) (f) ADP-glucose (3-25) (g) 
GDP-glucose (3-26). Produced NDP were shown in red color (a and f). Experiments a–
c and e were done on the same day. Experiment d was done on a separate day. 
Experiments f and g were also done on a different day. Slight difference of the retention 
times on separate analyses was observed although the HPLC conditions were identical. 




































substrate, 2-thio-D-glucose 6-phosphate (3-3), are all possible glycosyl acceptors in the 
BexG2-catalyzed reaction. These results clearly suggest that modification of C-2 position 
of the glycosyl acceptor is tolerated for this enzyme while a phosphate group at C-6 is 
required as described above (Figure 3-20A, trace d). In the case of the reported trehalose 
6-phosphate synthase (TPS) OtsA from T. thermophilus RQ-1, D-glucose 6-phosphate (3-
2) could not be replaced by D-mannose 6-phoshate (3-29).
162
 The more relaxed substrate 
specificity of BexG2 at the C-2 position is interesting because it suggests the enzyme has 
evolved to accept 2-thio-D-glucose 6-phosphate (3-3) instead of D-glucose 6-phosphate 







































3.3.3  Competitive Assay of BexG2-Catalyzed Glycosyltransfer Reaction. 
 Although BexG2 can utilize both D-glucose 6-phosphate (3-2) and 2-thio-D-
glucose 6-phosphate (3-3), 3-3 was expected to be a more suitable substrate based on the 
predicted function of BexX (Figure 3-1). To test this hypothesis, a competitive assay 
using both 3-2 and 3-3 was designed. The substrates 3-2 (5 mM) and 3-3 (5 mM) were 
incubated with various concentration (0−12.5 mM) of UDP-glucose (3-8) in the presence 
of BexG2, and the reaction mixture was analyzed by HPLC with a Corona CAD detector 
(Figure 3-28). 
When low concentration of UDP-glucose (3-8, less than 1 equivalent of each 
glycosyl acceptor) was used, appearance of the signal corresponding to 2-thio-D-trehalose 
 
Figure 3-27. BexG2 glycosyl acceptor specificity assay 
(a) D-glucose 6-phosphate (3-2, positive control) (b) 2-deoxy-D-glucose 6-phosphate 
(3-27) (c) D-glucosamine 6-phosphate (3-28) (d) D-mannose 6-phoshate (3-29) 
Produced UDP was shown in red color. Experiments a–c were done on the same day. 
Experiment d was done on a different day. Slight difference of the retention times on 
























6-phosphate (3-4) was observed. Interestingly, the D-glucose 6-phosphate (3-2) peak was 
barely decreased under these conditions. This peak (3-2) was converted to D-trehalose 6-
phosphate (3-6) only when a higher concentration of UDP-glucose (3-8, more than 1 
equivalent of each glycosyl acceptor) was used. The peak integration of each compound 
was then converted to the corresponding concentration and replotted against the initial 
concentration of UDP-glucose (Figure 3-29). This figure clearly shows that BexG2 
utilizes 2-thio-D-glucose 6-phosphate (3-3) more preferably than D-glucose 6-phosphate 
(3-2) when both substrates exist in the solution. This substrate selectivity may explain the 
contradictory observation that BexG2 can take 3-2 as the substrate even though the 
product 3-6 is not likely involved in the biosynthetic pathway of BE-7585A (Figure 3-1). 
Moreover, under in vivo conditions D-glucose 6-phosphate (3-2) may be a much better 
substrate for BexX than for BexG2 and will thus be taken up by BexX and be converted 
to 2-thio-D-glucose 6-phosphate (3-3), which is a more preferential substrate for BexG2. 
Although kinetic experiments are required to investigate this substrate selectivity of 
BexG2 in more detail, the results shown here strongly support the function of the enzyme 
as the 2-thio-D-trehalose 6-phosphate synthase rather than an ordinary trehalose 6-






Figure 3-28. BexG2 competitive assay I 
Peaks observe are D-glucose 6-phosphate (3-2), D-trehalose 6-phosphate (3-6), and 2-
thio-D-trehalsoe 6-phosphate (3-4). One of the substrates, 2-thio-D-glucose 6-phosphate 
(3-3), was not shown because it could not be detected by Corona CAD under the tested 
conditions. Initial concentrations of UDP-glucose are (a) 0, (b) 2.50, (c) 3.75, (d) 5.00, 



















3.3.4  Non-Enzymatic C−S Bond Formation Between a Thiosugar and Aglycon  
How the thiodisaccharide (3-4 or its hydrolyzed product without 6-phosphate 
group) is attached to C-5 of the benz[a]anthraquinone core is not clear. A notable 
example is found in the literature addressing similar C−S bond formation in urdamycin E 
(3-10, Figure 3-2). 
148
 Their experiments showed that C-5 position of urdamycin A (3-9) 
is electrophilic enough to be nonenzymatically attacked by thiol-containing compounds 
such as methylmercaptan (3-12) or glutathione at physiological pH. 
To test this nonenzymatic Michael-type addition model, urdamycin A (3-9) was 
incubated with 2-thio-D-glucose (3-18) in an aqueous buffer at pH 8.0. Interestingly, the 
pale yellow color of the urdamycin A (3-9) solution was changed to a pale pink color 
within one minute after addition of 3-18. This color change was not observed when 3-18 
was replaced by D-glucose (3-19), suggesting that the thiol functional group is important. 
The reaction mixtures were then analyzed by HPLC. As expected, the solution containing 
 
Figure 3-29. BexG2 competitive assay II 
Data shown are D-glucose 6-phosphate (3-2), D-trehalose 6-phosphate (3-6), 2-thio-D-
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3-18 showed a new peak (3-30) while incubation with 3-19 did not affect the original 
urdamycin A (3-9) peak (Figure 3-30). MS analysis of the isolated peak (3-30) was 
consistent with the expected structure with a 2-thioglucose attached to urdamycin A. As a 
control, BE-7585A (3-1) was also incubated with 2-thio-D-glucose (3-18) under the same 
conditions. HPLC analysis showed that no conjugate was formed in this reaction. Since 
C-5 position of BE-7585A (3-1) already has the thiodisaccharide moiety installed, the 
result shown here is consistent with the proposed nucleophilic attack at the C-5 position 
of urdamycin A (3-9). 
The observed color change was then analyzed using a UV-vis spectrophotometer. 
Upon addition of 2-thio-D-glucose (3-18) into an urdamycin A (3-9) solution, an increase 
of absorbance and red shift of the wavelength of maximum absorbance (λmax) were 
observed (Figure 3-31). When a sufficient amount (3 equivalents of 3-9) of 3-18 was 
added, the spectrum exhibited broad absorbance over 400−600 nm with a λmax at 480 nm, 
which closely resembles that of BE-7585A (3-1, Figure 2-6). The similarity of the two 
absorbance spectra is consistent with the expected thiosugar addition at the same position 
of the benz[a]anthraquinone core, which influences the  conjugation system on the 
aromatic ring and yields the unique absorbance property. 
A proposed mechanism of the Michael-type addition of the thiosugar to the C-5 
site of the benz[a]anthraquinone core is shown in Figure 3-31. The C-5 site is expected to 
be electrophilic and can accept the nucleophilic attack from the thiodisaccharide. 
Subsequent deprotonation at C-5 leads to a hydroquinone intermediate (3-31), which can 






Figure 3-31. Absorbance analysis of the nonenzymatic C–S bond formation 
(a) urdamycin A (3-9, 0.2 mM) (b) addition of 2-thio-D-glucose (3-18, 0.1 mM) (c) 
repeat of b (2 min after the addition) (d) addition of 2-thio-D-glucose (3-18, 0.6 mM 























Figure 3-30. HPLC analysis of the nonenzymatic C–S bond formation 
(a) Control reaction containing urdamycin A (3-9) and D-glucose (3-19). (b) Reaction 
containing 3-9 and 2-thio-D-glucose (3-18). Expected structure of the urdamycinA–2-
thioglucose conjugate (3-30) is shown in right. 



















































Although it was confirmed that the C−S bond between a benz[a]anthraquinone 
core and a thiosugar was easily formed nonenzymatically, whether this process is 
controlled by an enzyme or not under in vivo condition remains unresolved question. 
Based on the BE-7585A biosynthetic gene cluter (bex) described in Chapter 2, no 
candidate gene possibly responsible for this transformation can be found, indicating a 
nonenzymatic process. On the other hand, BE-7585A derivatives containing other 
thioconjugates or no thioadduct are not found in A. orientalis. This suggests that there 
may be some regulating mechanism in vivo to prevent other thionucleophiles to compete 
with 3-4 for the benz[a]anthraquinone core. One possible mechanism is that a specific 
interaction exists between protein(s) responsible for angucycline core biosynthesis and 
those responsible for thiosugar biosynthesis including BexG2. This interaction may allow 
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2-thiotrehalose 6-phosphate (3-4) to be delivered directely to the site where the 
benz[a]anthraquinone core is produced, leading to spontaneous bond formation before 
they diffuse in the cell to react with other thiol-containing compounds.  
Even in this case, however, 2-thioglucose 6-phosphate (3-4) released from BexX 
must be captured by BexG2 rapidly before it reacts with the core structure unless BexG2 
can accept the benz[a]anthraquinone−monothiosugar conjugate as the substrate (Figure 
3-1, 3-7  3-5). Although the observed relaxed substrate specificity at C-2 position of 
the glycosyl acceptor in the BexG2-catalyzed reaction supports this possibility, further 
experiments are clearly necessary to verify this hypothesis. To address this question, a 
more appropriate angucycline core structure may be required rather than the model 
compound, urdamycin A (3-8). To obtain the substrate involved in the thio-coupling step 
in the BE-7585A biosynthetic pathway, enzymatic total synthesis of 
benz[a]anthraquinone core moiety (using BexA, BexB, BexC, BexD, BexL, BexF, BexI, 
BexE, BexM and BexK, see Figure 2-21) and the rhodinose moiety (using BexU, BexS, 
BexV, BexQ, BexT, BexO, BexH and BexG1, see Figure 2-22) are in progress (all genes 
have been cloned, many enzymes have been expressed and purified, and some of their 
functions have been confirmed). In addition, structural analysis is a powerful approach to 
examine how a large modification at C-2 of the glucose 6-phosphate moiety can be 
accommodated by the enzyme. The observed substrate selectivity for 2-thio-D-glucose 6-
phosphate (3-4) over D-glucose 6-phosphate (3-2) may be explained if the structural data 
is obtained and compared with the reported data of a trehalose 6-phosphate synthase 





3.4  CONCLUSIONS  
In this chapter, BexG2, one of the key enzymes responsible for the production of 
the unique thiodisaccharide moiety of BE-7585A (3-1), was heterologously expressed in 
E. coli, and its glycosyl transfer activity was investigated using a variety of substrates. 
The predicted natural substrate 2-thio-D-glucose 6-phosphate (3-3) was 
chemoenzymatically prepared and utilized for the reaction with UDP-glucose (3-8). The 
product was isolated and fully characterized using spectroscopic methods to confirm the 
identity of 2-thio-D-trehalose 6-phosphate (3-4). The BexG2-catalyzed reaction was 
found to exhibit relatively strict substrate specificity for the glycosyl donor as compared 
to other reported TPSs from T. thermophilus or M. tuberculosis.
162,163
 In contrast, 
remarkable substrate tolerance at the C-2 position of the glycosyl acceptor was found. All 
C-2 modification examined, including 2-hydroxy- (both equatorial and axial), 2-thio- 
(equatorial), 2-amino- (equatorial), and 2-deoxysugars were accepted by the enzyme 
although a phosphate group at C-6 position is essential. The extended substrate 
specificity at C-2 position of BexG2 as compared to a reported TPS from T. 
thermophilus
162
 suggests that the BexG2 active site must have evolved to accept the 
unusual thio-modification at that position. Whether this enzyme can accept more 
sterically demanding substrates, such as benz[a]anthraquinone−thioglucose 6-phosphate, 
is not clear at this point. However, the apparent substrate selectivity observed for 2-thio-
D-glucose 6-phosphate (3-3) over D-glucose 6-phosphate (3-2) strongly supports the 
enzyme‟s function as a 2-thio-D-trehalose 6-phosphate synthase. 
A thioether bond connecting the benz[a]anthraquinone core to thiodisaccharide 
moiety is another unnsual structure observed in BE-7585A (3-1). Although a similar 
thioether bond found in urdamycin E (3-10) had been studied before,
148
 we first 
confirmed that a thiosugar (3-18) can spontaneously form a conjugate with the model 
 123 
compound urdamycin A in a buffer (pH 8.0) without any organic cosolvent. These 
results, including additional control experiments using D-glucose (3-19) or BE-7585A (3-
1) and the absorbance property of the conjugate (3-30), are all consistent with the 
proposed nonenzymatic formation of the C−S bond between the benz[a]anthraquinone 
core at C-5 and thiol functional group of 3-18. Whether this nonenzymatic process is 
physiologically relevant or not remains to be verified. Neverthless, we have proposed that 
specific protein−protein interactions among the BE-7585A biosynthetic enzymes may 
help enrich the local concentrations of the angucycline core and thiosugar to an 
appropriate level to prevent formation of other thioadducts. Verification of this 
hypothesis requires further experiments including the functional investigation of the 
enzymes involved in the construction of the benz[a]anthraquinone core. Preparation of 
the enzymes involved in the biosyntheses of the angucycline core and the rhodinose 










Chapter 4:  Biosynthetic Studies of BE-7585A (III): Mechanistic 
Studies of the 2-Thiosugar Synthase, BexX 
 
4.1  INTRODUCTION 
In the previous chapters, the biosynthetic pathway of BE-7585A (4-1) was 
proposed based on genetic, structural, and enzymatic functional analyses (Figure 4-1). 
For the 2-thiosugar biosynthesis, a key enzyme, BexX, which shares sequence similarity 
with thiazole synthases (ThiGs), was found to be a putative 2-thio-D-glucose 6-phosphate 
synthase. The expected thiosugar product (4-3) of BexX would then be coupled with a 
glucose moiety by BexG2 to form the unique thiodisaccharide structure of BE-7585A (4-
1). 
 
The proposed reaction for BexX-catalyzed thiosugar formation is analogous to 
that of ThiG during thiazole biosynthesis and is based on the sequence similarity of BexX 
and ThiG (Chapter 2). ThiG from B. subtilis initiates the reaction by forming an imine 
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complex between the active site lysine residue and the C-2 keto group of 1-deoxy-D-
xylulose-5-phosphate (DXP, 4-4; Figure 4-2).
168
 A sulfur carrier protein, ThiS, then acts 
as the sulfur donor for sulfur incorporation at C-3 of the DXP−lysine−ThiG adduct (4-
5).
66
 Since ThiG is a key enzyme in the biosynthesis of the thiazole phosphate (4-6) 
moiety of thiamin, we predicted that the bexX gene may also play a key role in the 
biosynthesis of the 2-thiosugar moiety of BE-7585A in A. orientalis. 
 
 
One hypothesis is BexX utilizes D-glucose 6-phosphate (4-2) as the substrate with 
the mechanism of sulfur incorporation to form the 2-thiosugar resembling that of the 
ThiG reaction in thiamin biosynthesis (Figure 4-3, pathway A). However, an alternative 
hexose monophosphate substrate may be D-fructose 6-phosphate (4-7), which could form 
a Schiff base with the active-site lysine at C-2, thereby directly activating the target 
position for sulfur incorporation (4-14; Figure 4-3, pathway B). In fact, an analogous C-2 
activation has been demonstrated for the D-glucosamine 6-phosphate synthase (GlmS)-





















































GlmS from E. coli is composed of a glutaminase domain that supplies ammonia from L-
glutamine (4-19) and a synthase domain that catalyzes the amination and isomerization of 
4-7 to D-glucosamine 6-phosphate (4-21; Figure 4-4). Structural analysis has revealed the 
existence of a channel by which ammonia passes between the active sites of the two 
GlmS domains.
169
 Although BexX shares no sequence similarity with GlmS and possess 
no additional domain, endogenous cysteine desulfurase-type proteins, which transfer 
bisulfide to several in vivo targets such as iron-sulfur proteins, may act as the sulfur donor 

































































































































 In addition to mechanistic studies of 2-thiosugar biosynthesis, identification of the 
sulfur donor is another focus of this chapter. In the pathway proposed in Figure 4-3, 
sulfur incorporation is expected to proceed via an ionic mechanism. This is because the 
C-2 position exists as a ketone or an imine, it is activated and susceptible to nucleophilic 
attack (4-10 in the pathway A or 4-14 in the pathway B). Potential sulfur donors for this 
pathway may be an inorganic bisulfide or a protein persulfide (see Figure 4-5). Protein 
persulfides have been identified as a part of cysteine desulfurase-type proteins, in which 
they originate from L-cysteine. Protein persulfides are also found in rhodanese-type 
proteins, in which they are generated from thiosulfate. A sulfur carrier protein, which 
harbors a reactive thiocarboxylate at its C-terminus as ThiS in the thiamin biosynthetic 
pathway, could likewise play the role of a nucleophilic sulfur donor. Although no genes 
related to any of these sulfur delivery systems are found in the BE-7585A biosynthetic 
(bex) gene cluster, it is possible that an endogenous sulfur transfer protein from pathways 
of primary metabolism may be recruited for production of the 2-thiosugar (Figure 4-5). 
 















































In this chapter, MS analyses of recombinant BexX from E. coli are described. A 
substrate molecule that forms a covalent bond with BexX was identified. The amino acid 
residue involved in this covalent linkage was determined by mutagenesis studies and LC-
MS/MS analysis of the trypsin digested BexX fragments. Strong evidence for the 
 













































































































proposed reaction mechanism was obtained by detecting the stable keto form of the 
BexX−substrate complex using carbonyl-directing chemical reagents. Genome mining of 
the entire sequenced genome of A. orientalis was also performed to identify potential 
sulfur donors. The protein candidates responsible for the endogenous sulfur transfer 
reaction were individually examined in vitro for their ability to incorporate a sulfur atom 
into the BexX−substrate complex. Lastly, the in vitro enzymatic synthesis of the 2-
thiosugar was accomplished for the first time.   
 
4.2  EXPERIMENTAL PROCEDURES 
4.2.1  General. 
Materials 
All chemicals and reagents were purchased from Sigma-Aldrich Chemical Co. 
(St. Louis, MO) or Fisher Scientific (Pittsburgh, PA), and were used without further 
purification unless otherwise specified. Sequencing grade modified trypsin was a product 
of Promega (Madison, WI). Adenylate kinase (AK), pyruvate kinase (PK), and lactate 
dehydrogenase (LDH) were purchased from Sigma-Aldrich Chemical Co. Calf intestinal 
alkaline phosphatase (CIP) was a product of New England Biolabs (Ipswich, MA). 
Materials used for molecular cloning were identical to those described in Chapter 2 
except the PureLink Genomic DNA Mini Kit from Invitrogen (Carlsbad, CA) used for 
genomic DNA extraction. Materials used for protein expression and purification were 
identical to those described in Chapter 3 with the exception of Pre-cast gels (NuPAGE 
Novex 4-12% Bis-Tris Gel from Invitrogen) used for the pull-down assay. The CarboPac 
PA1 high-performance liquid chromatography (HPLC) column was obtained from 
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Dionex (Sunnyvale, CA). Analytical C18 HPLC columns were purchased from Varian 
(Palo Alto, CA). 
Bacterial Strains and Plasmids 
A. orientalis subsp. vinearia BA-07585 was generously provided by Banyu 
Pharmaceutical Co. (Tokyo, Japan). Cosmid C006 was obtained from an A. orientalis 
genomic library as described in Chapter 2. E. coli DH5, acquired from Bethesda 
Research Laboratories (Gaithersburg, MD), was used for routine cloning experiments. 
The protein overexpression hosts E. coli BL21 star (DE3) and E. coli Rosetta 2 (DE3) 
were obtained from Invitrogen (Carlsbad, CA) and Novagen (Madison, WI), respectively. 
Vectors pET24b(+) and pET28b(+) for protein over-expression were purchased from 





.UV−vis spectra were recorded using a Beckman DU 650 spectrophotometer. 
Evaporation of solution samples in 1.5 mL microcentfiguge-tubes was performed using a 
Savant Speedvac SC100 equipped with a Savant refrigerated condensation trap RT100 
and Gel Pump GP100. HPLC was performed on a Beckman Coulter System Gold 
equipped with a UV detector. DNA concentrations were measured using a NanoDrop 
ND-1000 UV−vis instrument from Thermo Fisher Scientific. DNA sequencing was 
performed by the core facility of the Institute of Cellular and Molecular Biology at the 
University of Texas, Austin. Vector NTI Advance 10.1.1 from Invitrogen was used for 
sequence alignments. Mass spectroscopy was performed at the Mass Spectrometry core 
facility in the Department of Chemistry and Biochemistry and in the College of 
Pharmacy at the University of Texas, Austin. 
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4.2.2  Cloning of BexX. 
The bexX gene was PCR-amplified from cosmid C006 using primers with 
engineered NdeI and HindIII restriction sites. The sequences of the primers are shown in 
Table 4-1. The PCR-amplified gene fragments were purified, digested with NdeI and 
HindIII, and ligated into both pET24b(+) and pET28b (+) vectors, which had also been 
digested with the same restriction enzymes. The resulting plasmids, bexX/pET24b(+) and 
bexX/pET28b(+), were sequenced using the T7 or T7 terminal universal primer and used 
to transform the E. coli BL21 star (DE3) strain for protein overexpression. 
 
 
4.2.3  Expression and Purification of C-His6-BexX and N-His6-BexX. 
An overnight culture of E. coli BL21 star (DE3)-bexX/pET24b(+) or E. coli BL21 
star (DE3)-bexX/pET28b(+), grown in the LB medium (10 mL) containing 50 g/mL of 
kanamycin at 37 °C, was used to inoculate 1 L of the same growth medium. The culture 
was incubated at 37 °C with shaking (230 rpm) until the OD600 reached ~0.5. Protein 
expression was then induced by the addition of isopropyl β-D-1-thiogalactopyranoside 
(IPTG) to a final concentration of 0.1 mM, and the cells were allowed to grow at 18 °C 
and 125 rpm for an additional 24 h. The cells were harvested by centrifugation at 4500  




The engineered restriction sites are shown in bold, the start codon is shown in bold and also underlined, 
and the stop codon is italic. 
 
Primer name Sequence
bexX for pET24/28b(+)-forward 5'-TCTTAAACATATGACCATTCCGCACATCGGC-3'
bexX for pET24b(+)-reverse 5'-ATATAAGCTTGACCGCCGCTGCTACCTC-3'
bexX for pET28b(+)-reverse 5'-TTACAAGCTTCAGACCGCCGCTGCTACCTC-3'
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g for 15 min and stored at –80 °C until lysis. All purification steps were carried out at 
4 °C using Ni-NTA resin according to the manufacturer‟s protocol with minor 
modifications. Specifically, the thawed cells (~5 g) were resuspended in the lysis buffer 
(20 mL) containing 10% (v/v) glycerol and 10 mM imidazole. After incubation with 
lysozyme (20 mg) for 30 min, the cells were disrupted by sonication using 10 × 10-s 
pulses with a 30-s cooling pause between each pulse. The resulting lysate was centrifuged 
at 20,000  g for 20 min, and the supernatant was subjected to Ni-NTA chromatography. 
Bound protein was eluted using 250 mM imidazole buffer containing 10% glycerol. The 
collected protein solution was dialyzed against 3 × 1-L of 50 mM Tris·HCl buffer (pH 8) 
containing 300 mM NaCl and 15% glycerol. The protein solution was then flash-frozen 
in liquid nitrogen and stored at −80 °C until use. Protein concentration was determined by 
the Bradford assay using bovine serum albumin as the standard.
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 The yield of C-His6-
BexX and N-His6-BexX were approximately 50 mg and 30 mg from 1 L cultures, 
respectively. The molecular mass and purity (> 90%) of the protein were estimated by 
SDS-PAGE analysis. 
4.2.4  Construction of K110A-BexX Mutant. 
The site-specific K110A-bexX mutant was constructed according to the 
QuikChange site-directed mutagenesis protocol (Stratagene) using the plasmid, 
bexX/pET24b(+) or bexX/pET28b(+) as the template. The PCR primers are shown in 
Table 4-2. The resulting plasmids K110A-bexX/pET24b(+) and K110A-bexX/pET28b(+) 




4.2.5  Expression and Purification of the C-His6-K110A-BexX Mutant. 
Overexpression and protein purification of the C-His6-K110A-BexX mutant were 
performed using the plasmid K110A-bexX/pET24b(+) according to the same procedure 
described above for the wild type enzyme. Expression of the N-His6-K110A-BexX 
mutant using the plasmid bexX/pET24b(+) was not very successful; and thus, the 
corresponding protein was not purified. The yield of mutant protein, C-His6-K110A-
BexX, was approximately 120 mg per 1 L culture. The molecular mass and purity (> 
90%) of the protein were estimated by SDS-PAGE analysis. 
4.2.6  Construction of Other BexX Mutants. 
The site-specific D112A-bexX, E194A-bexX, D112E-bexX, and E194D-bexX 
mutants were similarly constructed according to the QuikChange site-directed 
mutagenesis protocol (Stratagene) using the plasmids bexX/pET24b(+) and 
bexX/pET28b(+) as the template. In addition, a D112E-E194D-bexX double mutant was 
also prepared using D112E-bexX/pET24b(+) and D112E-bexX/pET28b(+) as templates. 
The PCR primers used in this work are shown in Table 4-3. The resulting plasmids were 
used to transform the E. coli BL21 star (DE3) strain or the E. coli Rosetta 2(DE3) strain 
for protein overexpression. 
 










4.2.7.  Expression and Purification of the Other BexX Mutants. 
The overexpression and protein purification of the various BexX mutants were 
performed using the mutated plasmids bexX/pET24b(+) according to the same procedure 
described above for the wild type enzyme except for the presence of 50 g/mL 
chloramphenicol in the overnight culture (10 mL) when the E. coli Rosetta 2(DE3) strain 
was used. The majority of the mutant constructs did not express well or the expressed 
proteins resulted in formation of inclusion bodies. In these cases they were not further 
purified. One exception was the C-His6-D112A-BexX mutant, which was partially 
purified. 
4.2.8  ESI-MS Analysis of C-His6-BexX. 
The purified C-His6-BexX protein stock solution was added to 50 mM Tris·HCl 
buffer (pH 7.5) containing 10 mM MgCl2 (final concentration of protein was 13 μM) and 
incubated at 30 °C for 2 h. The resulting solution (200 μL) was cooled on ice. To this 
solution was added 20 μL of cold NaBH4 solution in methanol (530 mM; final 
concentration of NaBH4 was 50 mM). The mixture was incubated on ice for 1 h. The 















excess salts and glycerol were removed at 4 °C using an Amicon ultrafiltration unit 
through a YM-10 membrane. The resulting protein solution was subjected to ESI-MS 
analysis.  
4.2.9  ESI-MS Analysis of C-His6-BexX with Various Sugars. 
Similarly, the purified C-His6-BexX protein (13 μM final) was mixed with 5 mM 
of either D-glucose 6-phosphate (4-2), D-fructose 6-phosphate (4-7), D-glucose (4-33), or 
1-deoxy-D-xylose 5-phosphate (DXP, 4-4) in 50 mM Tris·HCl buffer (pH 7.5) containing 
10 mM MgCl2. The resulting solution (200 μL) was incubated at 30 °C for < 2 h and 
cooled on ice. A shorter incubation time (0.5 h) was used for 4-33- and 4-4-containing 
mixtures because protein started to precipitate beyond this time period. An aliquot of 20 
μL of cold NaBH4 solution in methanol (530 mM; final concentration of NaBH4 was 50 
mM) was added to each reaction, and the resulting mixture was incubated on ice for 1 h. 
The excess salts and glycerol were removed at 4 °C using Amicon ultrafiltration units 
through YM-10 membranes. The resulting protein solutions were subjected to ESI-MS 
analysis.  
4.2.10  ESI-MS Analysis of the C-His6-K110A-BexX Mutant. 
Similar ESI-MS analysis was performed for the C-His6-K110A-BexX mutant. 
The purified mutant protein (30 μM final) was incubated with or without 5 mM of D-
glucose 6-phosphate (4-2) in 50 mM Tris·HCl buffer (pH 7.5) containing 10 mM MgCl2. 
To prevent protein precipitation, the mixture (400 μL each) was incubated at room 
temperature for 10 min (similar conditions as for the wild-type enzyme caused significant 
precipitation of the K110A mutant). An aliquot of 40 μL of a cold solution of NaBH4 in 
methanol (530 mM; final concentration of NaBH4 was 50 mM) was added to each 
reaction, and the resulting mixture was incubated on ice for 1 h. The excess salts and 
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glycerol were removed by using an Amicon ultrafiltration unit through a YM-10 
membrane at 4 °C. The resulting protein solution was subjected to ESI-MS analysis. 
4.2.11  Protein Sequence Alignment and Active Site Prediction. 
The protein sequence of BexX was aligned with ThiG from Bacillus subtilis using 
Vector NTI Advance 10.1.1. The sequence of ThiG was obtained from the National 
Center for Biotechnology Information (NCBI) database. (Gene ID: 936422).
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4.2.12  Trypsin Digestion and LC-MS/MS Analysis of the Protein−Substrate 
Complex. 
The purified C-His6-BexX protein (13 μM final) was incubated with or without 5 
mM of D-glucose 6-phosphate (4-2) in 50 mM Tris·HCl buffer (pH 7.5) containing 10 
mM MgCl2 at 30 °C for 1 h. An aliquot of 20 μL of cold NaBH4 solution in methanol 
(530 mM; final concentration of NaBH4 was 50 mM) was added to 200 μL of each 
protein solution, and the resulting mixture was incubated on ice for 1 h. The excess salts 
and glycerol were removed by using an Amicon ultrafiltration unit through a YM-10 
membrane at 4 °C. An aqueous dithiothreitol solution (14 μL, final concentration 10 
mM), acetonitrile (15 μL), and trypsin stock solution (5 μL containing 2 μg of trypsin) 
were sequentially added to each of the protein solutions and the resulting mixtures were 
incubated at 37 °C overnight. The reactions were then frozen and stored at –20 °C prior 
to analysis. Frozen samples were submitted to the Mass Spectrometry core facility and 
subjected to LC-ESI-MS/MS analysis on a nanoACQUITY UPLC (Waters) in 
conjunction with a Q-TOF premier mass spectrometer (Waters).  
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4.2.13  Preparation of the 2,4-Dinitrophenylhydrazine Derivative of the BexX–
Substrate Complex. 
The trypsin digests of C-His6-BexX–D-glucose-6-phosphate were prepared 
according to the procedure described above. The digest mixture (40 μL) was added to a 
2,4-dinitrophenylhydrazine (DNPH, 4-36) solution in DMSO (160 μL, final 
concentration of DNPH was 80 mM). The resulting mixture was acidified to pH ~ 4 by 
adding 8 μL of 10% trifluoroacetic acid (TFA) and incubated at 37 °C overnight. The 
reaction solution was then subjected to LC-ESI-MS analysis as described above. 
4.2.14  Preparation of the Hydroxylamine Derivative of the BexX–Substrate 
Complex. 
The purified C-His6-BexX protein (75 μM final concentration) was incubated 
with 5 mM of D-glucose 6-phosphate (4-2) in 50 mM Tris·HCl buffer (pH 7.5) 
containing 10 mM MgCl2 at 30 °C for 0.5 h. An aqueous solution of hydroxylamine 
(NH2OH) (10 μL, final concentration 20 mM) was added to the protein mixture (90 μL) 
and the resulting mixture was incubated at room temperature for 1 h. After cooling on 
ice, the excess salts and glycerol were removed by using an Amicon ultrafiltration unit 
through a YM-10 membrane at 4 °C. The resulting protein solution was then subjected to 
ESI-MS analysis. 
4.2.15  Investigation of Bisulfide, Thioacetate, and Glutathione as the Direct Sulfur 
Donor. 
Bisulfide and Thioacetate 
The purified C-His6-BexX protein (13 μM final concentration) was incubated 
with 5 mM D-glucose 6-phosphate (4-2) in 100 mM Tris·HCl buffer (pH 7.5) containing 
10 mM MgCl2 at 30 °C for 0.5 h. The buffer of the solution (400 μL) was then exchanged 
with 100 mM Tris·HCl buffer (pH 7.5) containing 20 μM of D-glucose 6-phosphate (4-2) 
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by using an Amicon ultrafiltration unit equipped with a YM-10 membrane at 4 °C. To 
this solution was added dithiothreitol (DTT, 1 mM) and sodium bisulfide (4-25, 50 mM) 
or potassium thioacetate (4-39, 50 mM). The resulting mixture (400 μL) was incubated 
at 30 °C for 1 h and then cooled on ice. A 40 μL aliquot of cold NaBH4 solution in 
methanol (530 mM; final concentration of NaBH4 was 50 mM) was added to each 
reaction, and the resulting mixture was incubated on ice for 2 h. The excess salts and 
glycerol were removed by using an Amicon ultrafiltration unit through a YM-10 
membrane at 4 °C. The resulting protein solution was subjected to ESI-MS analysis. 
Glutathione 
For glutathione (GSH, 4-40), a mixture of the purified C-His6-BexX and N-His6-
BexX proteins (100 μM each) was incubated with 5 mM of D-glucose 6-phosphate (4-2) 
in 100 mM Tris·HCl buffer (pH 7.5) at 4 °C for 1 h. To this solution (90 μL) was added 
10 μL of 4-40 (0.2 M; final concentration of 4-40 was 20 mM), and the mixture was 
incubated at room temperature for 1 h. This mixture was analyzed by ESI-MS without 
further purification.  
4.2.16  H/D exchange experiment in D2O. 
 The purified C-His6-BexX and N-His6-BexX proteins (100 μM each final) were 
mixed with 50 mM NH4·HCO3 buffer (pH 8.0) containing 1 mM D-glucose 6-phosphate 
(4-2) prepared in D2O. To reduce the amount of H2O from the protein stock solution, the 
solution (200 μL) was concentrated to half of the original volume (100 μL) using an 
Amicon ultrafiltration unit equipped with a YM-10 membrane. The same volume of the 
buffer containing 4-2 in D2O was added to the concentrated protein solution. This cycle 
was repeated 10 times (theoretical ratio of D2O / H2O in the solution was over 1000 in the 
final solution). The resulting protein solution was incubated at room temperature for 12 h. 
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The protein was removed by YM-10 membrane filtration, and the filtrate containing D-
glucose 6-phosphate was lyophilized, redissolved in H2O, and subjected to ESI-MS 
analysis.  
4.2.17  Pull-Down Assay. 
Preparation of the A. Oreintalis Cell Free Extracts 
Cell free extracts from A. orinetalis subsp. vinearia BA-07585 were prepared by a 
previously reported method with some modification.
172
 Spores of A. orientalis were 
inoculated into 10 mL of International Streptomyces Project (ISP) medium 2 and grown 
in a rotary incubator at 30 °C and 220 rpm for 2 days. The resultant seed culture (3 mL) 
was transferred to 1 L of ISP-2 medium and grown under the same conditions for 6 days. 
The growth culture, which had a light red color, was centrifuged at 4,500  g for 10 min 
at 4 °C, and the cells were washed with 300 mL of 50 mM potassium phosphate buffer 
(pH 7.5) containing 30% (v/v) glycerol. After another centrifugation, the cells (40 g) 
were resuspended in 50 mL of protein-extraction buffer, which is composed of potassium 
phosphate buffer (50 mM, pH 7.5), 30% (v/v) glycerol, -mercaptoethanol (2 mM), 
phenylmethylsulfonyl fluoride (0.1 mM), benzamidine hydrochloride (0.1 mM), and 
ethylenediaminetetraacetic acid (EDTA, 1 mM). The resulting cell suspension was 
dropped into liquid N2 using Pasteur pipette to make small frozen balls and stored at −80 
ºC until use. The frozen balls (5 g) were cryogenically ground to a fine powder by using 
a Mixer Mill MM 300. The ground cells were gently resuspended in the protein-
extraction buffer for 2 h at 4 °C. The mixture was centrifuged at 20,000  g for 20 min at 
4 °C, and the supernatant was dialyzed against 2  0.5 L of 50 mM potassium phosphate 
buffer (pH 7.5) and used as the cell fee extracts. 
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Pull-down assay 
The purified C-His6-BexX or N-His6-BexX protein solution (50 μL; final 
concentration of the protein was 25 μM) was mixed with 580 L of the cell free extract 
and 0.1 mL of Ni-NTA suspension pre-washed with the lysis buffer (50 mM phosphate 
buffer, pH 7.5 containing 10% (v/v) glycerol and 10 mM imidazole) in 50 mM potassium 
phosphate buffer. The resulting mixture (1 mL) was incubated at 4 ºC for 1 or 4 h. 
Following centrifugation, the supernatant was discarded. The resin was washed with 
wash buffer containing 20 mM imidazole and 10% (v/v) glycerol. The bound proteins 
were eluted with 100 L of elution buffer containing 250 mM imidazole and 10% (v/v) 
glycerol. The eluted solution was subjected to SDS-PAGE and transblotted onto a 
polyvinylidene fluoride (PVDF) membrane. A protein band shown at < 10 kDa on the 
membrane was further subjected to N-terminal protein sequencing analysis.  
4.2.18  Whole Genome Sequencing and Analysis. 
Spores of A. orientalis were inoculated into 10 mL of soybean-casein digest 
(TSB) medium and grown in a rotary incubator at 30 °C and 250 rpm for 2 days. The 
resultant seed culture (4 mL) was transferred to 100 mL of TSB medium and grown 
under the same conditions for 2 days. The growth culture (25 mL) was centrifuged at 
5,000  g for 20 min at 4 °C, and the cells were washed with 25 mL of 10 mM EDTA. 
After another centrifugation, the cells were stored at −80 ºC until use. The cells were 
resuspended in 5 mL of 1 mM EDTA, and the suspension was divided into 1.5 mL-tubes 
(0.4 mL each).  The genomic DNA was extracted using the PureLink Genomic DNA 
Mini Kit according to the manufacturer‟s instructions. The resultant DNA solution (0.5 
g/L, 50 L from each tube) was frozen and sent to the Genomics Research Center of 
Academia Sinica (Taiwan). The de novo sequencing was performed using Roche 454 and 
the open reading frames were predicted by using Glimmer (Gene Locator and 
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Interpolated Markov ModelER) version 3.0.
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 Homologous protein sequences were 
identified in the NCBI database using the basic local alignment search tool (BLAST). 
4.2.19  Cloning of ThiS, MoaD, CysO, MoaD2, MoeZ, Cd1, Cd2, Cd3, Cd4, and Cd5. 
The thiS (orf13974), moaD (orf13839), cysO (orf06461), maD2 (orf10102), moeZ 
(orf02110), cd1 (orf10706), cd2 (orf11099), cd3 (orf14916), cd4 (orf04763), and cd5 
(orf09299) genes were PCR-amplified from A. oreintalis genomic DNA using primers 
with engineered NdeI and HindIII, or XhoI for cd1, restriction sites. The sequences of the 
primers are shown in Table 4-4. The PCR-amplified gene fragments were purified, 
digested with NdeI and HindIII, or NdeI and XhoI for cd1, and ligated into pET28b (+) 
vector that was also digested with the same enzymes. The resultant plasmids, 
thiS/pET28b(+), moaD/pET28b(+), cysO/pET28b(+), moaD2/pET28b(+), 
moeZ/pET28b(+), cd1/pET28b(+), cd2/pET28b(+), cd3/pET28b(+), cd4/pET28b(+), and 
cd5/pET28b(+) were sequenced using the T7 or T7 terminal universal primer and used to 




4.2.20  Expression and Purification of N-His6-ThiS, N-His6-MoaD, N-His6-CysO, N-
His6-MoeZ, N-His6-CD1, N-His6-CD2, N-His6-CD3, N-His6-CD4, and N-His6-CD5. 
The overexpression and protein purification of the N-His6-tagged sulfur carrier 
proteins (ThiS, MoaD, CysO, and MoaD2), MoeZ, and cysteine desulfurases (CD1, CD2, 
CD3, CD4, and CD5) were performed using the plasmids constructed above according to 
the same procedure described for N-His6-BexX enzyme. The yields of N-His6-BexX, N-
His6-CysO, and N-His6-MoaD2 were 30 mg, 15 mg, and 20 mg, respectively, from 1 L 
Table 4-4. Primers used for constructing thiS/pET28b(+), moaD/pET28b(+), 
cysO/pET28b(+), moaD2/pET28b(+), moeZ/pET28b(+), cd1/pET28b(+), 




The engineered restriction sites are shown in bold, the start codon is shown in bold and also underlined, 
and the stop codon is italic. 
Primer name Sequence
thiS for pET28b(+)-forward 5'-TCTATAACATATGGAGATCAAGCTCAACGG-3'
thiS for pET28b(+)-reverse 5'-TTACAAGCTTCAGCCTCCCTGGACGG-3'
moaD for pET28b(+)-forward 5'-TCTATAACATATGACCACCCTGACCATCG-3'
moaD for pET28b(+)-reverse 5'-TTACAAGCTTAGAGAAGCCTCAGCCGC-3'
cysO for pET28b(+)-forward 5'-TCTATAACATATGGCCGTGACCGTCTCC-3'
cysO for pET28b(+)-reverse 5'-TTACAAGCTTCAGCCACCGGCCACG-3'
moaD2 for pET28b(+)-forward 5'-TCTATAACATATGACCGTGCGGATCACC-3'
moaD2 for pET28b(+)-reverse 5'-TTACAAGCTTCAGCCTCCCGCGACC-3'
moeZ for pET28b(+)-forward 5'-TCTATAACATATGGACGCGAACCGCGCGC-3'
moeZ for pET28b(+)-reverse 5'-TTACAAGCTTCAGTAGGTCGGCAGGCTCGG-3'
cd1 for pET28b(+)-forward 5'-TCTATAACATATGTACCTGGACTCCGGAGC-3'
cd1 for pET28b(+)-reverse 5'-TCAACTCGAGGTTCACTGCGCCACC-3'
cd2 for pET28b(+)-forward 5'-TCTATAACATATGACTCTCGCCATCGACC-3'
cd2 for pET28b(+)-reverse 5'-TTACAAGCTTCAGCAGAACGGCGGG-3'
cd3 for pET28b(+)-forward 5'-TCTATAACATATGAGTTCCGCGCTCGGC-3'
cd3 for pET28b(+)-reverse 5'-TTACAAGCTTCAGCGGGGGAGCGACG-3'
cd4 for pET28b(+)-forward 5'-TCTATAACATATGACCTATCTCGACCACGCG-3'
cd4 for pET28b(+)-reverse 5„-TTACAAGCTTACACCTCTTGCTTCTGGG-3'
cd5 for pET28b(+)-forward 5'-TCTATAACATATGGCGTTCGACGTCGC-3'
cd5 for pET28b(+)-reverse 5'-TTACAAGCTTAGCGGAGTTCTTCCAGC-3'
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culture. Protein expression of N-His6-MoaD was much poorer than the other sulfur carrier 
proteins, and the yield was < 5 mg from 1 L culture. The yield of N-His6-MoeZ was 40 
mg from 1 L culture. The yields of cysteine desulfurases, N-His6-CD1, N-His6-CD2, N-
His6-CD3, and N-His6-CD4 were 50 mg, 60 mg, 30 mg, and 100 mg, respectively, from 1 
L culture. Protein N-His6-CD5 was expressed as inclusion bodies and, thus, was not 
purified. The molecular mass and purity (> 90% except N-His6-MoaD) of the proteins 
were estimated by SDS-PAGE analyses. 
4.2.21  MoeZ-Catalyzed Activation of ThiS and its ESI-MS Analyses. 
ESI-MS Analysis of ThiS 
The purified N-His6-ThiS protein (90 μM) in 5 mM Tris·HCl buffer (pH 8.0) was 
subjected to ESI-MS analysis.  
ESI-MS Analysis of ThiS with MoeZ 
The purified N-His6-ThiS (90 μM) was incubated with N-His6-MoeZ (80 μM) and 
ATP (5 mM) in 100 mM Tris·HCl buffer (pH 8.0) containing MgCl2 (5 mM) at 30 ºC for 
0.5 h. The resultant solution was subjected to ESI-MS analysis. Additionally, to aliquotes 
of the above solution was added sodium sulfide (NaSH, 10 mM) or sodium thiosulfate 
(Na2S2O3, 10 mM) and the resulting mixture was subjected to ESI-MS analysis after 
incubation at 30 ºC for 0.5 h. Finally, a control reaction containing only N-His6-ThiS (90 
μM) and NaSH (5 mM) in 100 mM Tris·HCl buffer (pH 8.0) was similarly incubated and 
subjected to ESI-MS analysis. 
4.2.22  Investigation of Sulfur Transfer from ThiS-Thiocarboxylate to the 
BexX−sugar complex by ESI-MS Analysis. 
The purified protein mixture containing C-His6-BexX (100 μM), N-His6-ThiS (90 
μM), and N-His6-MoeZ (7 μM) was incubated with ATP (5 mM) and NaSH (10 mM) in 
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50 mM Tris·HCl buffer (pH 8.0) containing MgCl2 (5 mM) at 30 ºC for 0.5 h. The 
resultant solution was subjected to ESI-MS analysis. 
4.2.23  MoeZ-Catalyzed Activation of MoaD, CysO, and MoaD2 and their ESI-MS 
Analyses. 
ESI-MS Analysis of MoaD, CysO and MoaD2 
The purified N-His6-MoaD (50 μM), N-His6-CysO (60 μM), or N-His6-MoaD2 
(90 μM) in 100 mM Tris·HCl buffer (pH 8.0) was subjected to ESI-MS analysis.  
ESI-MS Analysis of MoaD, CysO and MoaD2 with MoeZ 
The purified N-His6-MoaD (50 μM), N-His6-CysO (60 μM), or N-His6-MoaD2 
(90 μM) was incubated with N-His6-MoeZ (7 μM), ATP (5 mM), and NaSH (10 mM) in 
50 mM Tris·HCl buffer (pH 8.0) containing MgCl2 (5 mM) at 30 ºC for 0.5 h. The 
resultant solution was subjected to ESI-MS anayslsis. 
4.2.24  Investigation of Sulfur Transfer from CysO- or MoaD2-Thiocarboxylate to 
the BexX−sugar complex by ESI-MS Analysis. 
The purified protein N-His6-CysO (60 μM) or, N-His6-MoaD2 (90 μM) was 
incubated with C-His6-BexX (100 μM), N-His6-MoeZ (7 μM), ATP (5 mM), and NaSH 
(10 mM) in 50 mM Tris·HCl buffer (pH 8.0) containing MgCl2 (5 mM) at 30 ºC for 0.5 
h. The resultant solution was subjected to ESI-MS analysis. 
4.2.25  Coupled Enzymatic Assay to Detect the Formation of AMP Upon Activation 
of the Sulfur Carrier Proteins. 
AMP formation upon activation of sulfur carrier proteins was detected 
spectrophotometrically using commercially available adenylate kinase (AK), pyruvate 
kinase (PK), and lactate dehydrogenase (LDH) in the presence of ATP, 
phosphoenolpyruvate (PEP), and nicotinamide adenine dinucleotide (reduced form, 
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NADH). The typical reaction solution (99 L) using N-His6-MoaD2 (9 M) contained C-
His6-BexX (10 M), N-His6-MoeZ (3 M), G6P (5 mM), NaSH (5 mM), PEP (0.3 mM), 
NADH (0.1 mM), AK (2 units), PK (0.3 units), and LDH (0.5 units), in 50 mM Tris·HCl 
buffer (pH 8) containing MgCl2 (5 mM). Absorbance at 340 nm of the resulting solution 
was monitored at room temperature using UV−vis spectrophotometer. The reaction was 
initiated by adding 1 L of 100 mM ATP stock solution (final concentration of ATP was 
1 mM). Similarly, N-His6-MoaD2 was substituted in a series of analogous experiments 
with N-His6-ThiS (10 or 20 M), N-His6-CysO (6 M), or N-His6-MoaD (9 M) and the 
absorbance at 340 nm was monitored. Various control reactions were also performed by 
omitting one of the coupling enzymes or substrates.  
4.2.26  Enzymatic 2-Thiosugar Formation and its Detection. 
BexX Reaction Using Bisulfide 
The typical BexX reaction mixture (50 L) contained C-His6-BexX (100 M), 
sulfur carrier proteins (N-His6-CysO (30 M), N-His6-MoaD2 (45 M), or N-His6-ThiS 
(45 M)), N-His6-MoeZ (15 M), ATP (2 mM), G6P (2 mM), NaSH (5 mM) in 50 mM 
NH4·HCO3 buffer (pH 8.0) containing MgCl2 (5 mM). The resulting reaction mixture 
was incubated at room temperature for 8 h and stored at −20 ºC for < 5 days until use. 
Direct mBBr Derivatization and HPLC and ESI-MS Analysis 
To the reaction mixture (10 L) prepared above was then added 10 L of 10 mM 
mBBr (4-66) methanol solution (final concentration of mBBr was 5 mM) and incubated 
at room temperature for 5 min. The mixture was centrifuged at 16,000  g for 5 min to 
remove the precipitant, and 10 L of the supernatant was transferred to a new tube. The 
solution was evaporated in vacuo using a Speedvac SC100 (Savant). The resulting 
compound mixture was redissolved in 100 L of 50 mM NH4·HCO3 buffer (pH 8.0) and 
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subjected to HPLC analysis using a Dionex CarboPac PA1 analytical column (4 × 250 
mm). The sample was eluted with a gradient of water (solvent A) and 1 M NH4OAc 
(solvent B). The gradient was run from 5 to 15% B over 5 min, 15−30% B over 15 min, 
30−100% B over 7 min with a 5 min wash at 100% B, and 100−5% B over 3 min, 
followed by re-equilibration at 5% B for 5 min. The flow rate was 1 mL/min, and the 
detector was set at 260 nm. The peak corresponding to the enzymatic reaction product 
was isolated and subjected to ESI-MS analysis.  
CIP Treatment, mBBr Derivatization, and HPLC and ESI-MS Analysis 
The BexX-reaction mixture prepared above was also analyzed by HPLC using a 
C18 column along with an authentic standard. The reaction mixture stored at −20 ºC was 
thawed and treated with calf intestinal alkaline phosphatase (CIP) (0.2 L, 2units) and 
incubated at 37 ºC for 1 h. The precipitant that appeared during the incubation was 
removed by centrifugation at 16,000  g for 2 min, and 2 L of a 100 mM 
monobromobimane (mBBr, 4-66) methanol solution was added to the reaction solution 
(final concentration of mBBr was 5 mM). The resulting mixture was incubated at room 
temperature for 5 min, and the supernatant (5 L) was diluted with deionized water (95 
L) prior to HPLC analysis using an analytical C18 column (4 × 250 mm). The sample 
(20 L) was eluted with a gradient of water (solvent A) and 80% acetonitrile (solvent B). 
The gradient was run from 5 to 30% B over 15 min, 30−80% B over 5 min, 80−5% B 
over 5 min, followed by re-equilibration at 5% B for 10 min. The flow rate was 1 
mL/min, and the detector was set at 260 nm. The 2-thio-D-glucose-bimane (4-69) 
standard (0.1 mM) was prepared from the chemically synthesized 2-thio-D-glucose (4-68, 
see Chapter 3 for the detail of synthesis) incubated with mBBr (4-66) at room 
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temperature for 5 min. The peak corresponding to the enzymatic reaction product was 
also isolated and subjected to ESI-MS analysis.  
BexX Reaction Using Thiosulfate 
BexX reaction was also prepared using sodium thiosulfate (NaS2O3, 5 mM) and 
dithiothreitol (DTT, 5 mM) instead of NaSH. The resultant reaction mixture was 
similarly analyzed by HPLC after derivatization.  
BexX Reaction Using Cysteine Desulfurases 
BexX reaction was also prepared using a cysteine desulfrase (N-His6-CD1 (40 
M), N-His6-CD2 (40 M), N-His6-CD3 (40 M), or N-His6-CD4 (40 M)), L-cysteine 
(4-26, 3 mM), pyridoxal-5‟-phosphate (PLP, 0.1 mM), and DTT (3 mM) instead of 
NaSH. The resultant reaction mixture was derivatized with mBBr (4-66) and subjected to 
HPLC analysis as described above. 
4.2.27  Protein Sequence Analyses of Sulfur Carrier Proteins. 
The protein sequences of sulfur carrier proteins, ubiquitin, and ubiquitin-like 
proteins were aligned using Vector NTI Advance 10.1.1. The protein sequences were 
obtained from the National Center for Biotechnology Information (NCBI) database. The 
four sulfur carrier proteins from A. orientalis and a PdtH homologue from Stigmatella 






4.3  RESULTS AND DISCUSSION 
4.3.1  Identification of the BexX Substrate. 
In order to verify the predicted function of the bexX gene, the corresponding 
protein, BexX, was heterologously overexpressed in E. coli and purified as a C-terminal 
His6-tagged protein (Figure 4-6, lane 2). Interestingly, electrospray ionization mass 
spectrometry (ESI-MS) of the isolated protein demonstrated two main peaks. The 
dominant peak corresponded to the expected His6-tagged BexX (calculated, 28488 Da; 
observed, 28485 Da), whereas the minor peak showed a mass increase of ∼240 Da 
relative to the dominant peak. Upon treatment with NaBH4, the intensity of the latter peak 
of the reduced enzyme became more apparent (observed, 28729 Da) (Figure 4-7A). The 
observed mass increase of 244 Da is consistent with formation of a reduced dehydration 
adduct between BexX and a hexose monophosphate substrate (e.g., reduced 4-8 or 4-14, 
Figure 4-3). It was thus hypothesized that a fraction of the purified BexX contains a 
reaction intermediate covalently bound in substrate−enzyme complex as an imine that 
can be stabilized by borohydride reduction. 
To test this hypothesis, the purified BexX was incubated with the putative 
substrate D-glucose 6-phosphate (4-2) and treated with NaBH4 prior to MS analysis. As 
shown in Figure 4-7B, the addition of 4-2 resulted in complete conversion of the peak at 
28485 Da to the new peak at 28729 Da. In contrast, no significant change in the peak 
distribution was discernible when D-fructose 6-phosphate (4-7), D-glucose (4-33), or 
DXP (4-4) was used instead of 4-2 (Figure 4-8). Thus, the observed covalent 
modification of BexX is clearly D-glucose 6-phosphate (4-2)-specific. These results 
indicate that 4-2 likely serves as the substrate for BexX and that formation of the imine 
intermediate 4-8 (Figure 4-3, pathway A) with an active-site lysine residue may be one of 







Figure 4-7. ESI-MS analysis of BexX with glucose 6-phosphate 
(A) Deconvoluted ESI-MS of C-His6-tagged BexX treated with NaBH4. (B) ESI-MS of 
C-His6-tagged BexX incubated with D-glucose 6-phosphate prior to NaBH4 treatment. 
The calculated molecular weights of C-His6-BexX (268 aa) and C-His6-BexX−D-














































Figure 4-6. SDS-PAGE gel of purified C-His6-tagged BexX (268 aa, 28.5 kDa, lane 2), 
N-His6-tagged BexX (275 aa, 29.1 kDa, lane 3), and C-His6-tagged 
K110A BexX (268 aa, 28.4 kDa, lane 4) 
The molecular weight marks are 220, 160, 120, 100, 90, 80, 70, 60, 50, 40, 30, 25, 20, 
15, and 10 kDa (top to bottom, lane 1). The protein band of ~ 80 kDa is a minor 












1        2          3          4
 151 
 
4.3.2  Identification of the Modification Site. 
Sequence alignment revealed that the catalytic lysine residue (Lys96) in ThiG 
from B. subtilis has a counterpart, Lys110, in BexX (Figure 4-9).
142,171
 To investigate 
whether Lys110 plays a direct role in BexX catalysis, the K110A mutant was 
constructed, heterologously expressed in E. coli, and purified as a C-terminal His6-tagged 
 
Figure 4-8. ESI-MS analysis of BexX with various sugars. 
Deconvoluted ESI-MS of C-His6-tagged BexX and each sugar mixture: (A) D-fructose 
6-phosphate (4-7), (B) D-glucose (4-33), and (C) DXP (4-4). Calculated molecular 
weights of C-His6-BexX (268 aa) and C-His6-BexX−D-glucose-6-phosphate (reduced) 
are 28488, and 28732, respectively. Calculated molecular weights of D-glucose-6-
phosphate (4-2), 4-7, 4-33, and 4-4 are 260, 260, 180 and 214, respectively. Since part 
of the as-isolated BexX contains varied amount of bound 4-2 (such as 4-11, Figure 4-3), 
which upon reduction, gives m/z signals at 28727 or 28730 (molecular weight of the 























































































protein (Figure 4-6, lane 4). ESI-MS of the purified mutant protein exhibited only one 
peak, the mass of which matched the calculated molecular mass for the unmodified 
K110A mutant (calculated, 28431 Da; observed, 28430 Da). No change in molecular 
mass was noted even after treatment with D-glucose 6-phosphate (4-2) and NaBH4 
(Figure 4-10). This finding strongly implicated Lys110 as the residue responsible for 
covalent adduct formation with D-glucose 6-phosphate (4-2). 
To verify that the modification occurs at Lys110, the wild-type BexX−D-glucose 
6-phosphate complex was reduced by NaBH4 and then subjected to proteolysis with 
trypsin. The tryptic-digested peptide fragments were analyzed by LC-MS/MS, and the 
peptide fragment D102–R114 [calculated, m/z 1714.89 ([M + H]
+
); observed, m/z 
1714.92] contained a D-glucose 6-phosphate (4-2) adduct (4-34, Figure 4-11). Further 
analysis of the observed b and y ions revealed the attachment of the hexose phosphate at 
K110. These results unambiguously demonstrate that the sugar modification indeed 
occurs at a specific lysine residue (i.e., Lys110), consistent with the proposed mechanism 







Figure 4-10. Deconvoluted ESI-MS of K110A BexX mutant. 
K110A BexX mutant was incubated with (A) or without (B) D-glucose 6-phosphate 
prior to the NaBH4 treatment. Calculated molecular weight of C-His6-tagged K110A 
BexX (268 aa) is 28431. 
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Figure 4-9. Protein sequence alignment of BexX and ThiG from Bacillus subtilis. 























4.3.3  Identification of the Ketone Intermediate. 
It was noted during the studies of the trypsin-digested BexX fragments that the 
BexX−D-glucose 6-phosphate adduct could be detected even without the addition of any 
 
 
Figure 4-11. Trypsin treatment and LC-MS/MS analysis. 
(A) The predicted digestion pattern of C-His6-tagged BexX. Lysine residues are shown 
in bold. The predicted active site lysine (K110) is shown with an asterisk. The detected 
peptide fragments by LC-ESI-MS are underlined. (B) LC-MS/MS of the identified 
peptide (D102-R114) with a D-glucose 6-phosphate (4-2) coupled to the active-site 
lysine (K110) (4-34). The calculated m/z value for 4-34 was 1714.89 ([M + H]
+
), and 
the observed value was 1714.92. 
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reducing reagent (NaBH4) to the reaction mixture [calculated, m/z 856.94 ([M + 2H]
2+
, z 
= 2); observed, m/z 856.84] (Figure 4-12B). This observation was surprising because it is 
unlikely that the proposed imine intermediate 4-8, without prior reduction, could survive 
the trypsin digestion as well as the conditions used for the LC-MS/MS analysis. This 
prompted us to reconsider the chemical nature of the trapped intermediate in the active 
site of BexX. The initially formed iminium intermediate 4-8 is predicted to equilibrate 
with 4-9 and 4-10 (Figure 4-3). A likely candidate for the stable covalent BexX−D-
glucose-6-phosphate adduct is compound 4-10, which does not readily hydrolyze in 
solution. Accordingly, the tryptic fragment 4-34 detected in the LC-MS/MS analysis 
could result from hydride reduction of the imine moiety in 4-8 and/or the 2-keto group in 
4-10 [calculated, m/z 857.95 ([M + 2H]
2+
, z = 2); observed, m/z 857.84] (Figure 4-12A). 
However, without prior reduction, the modified D102-R114 fragment shown in Figure 4-
12B likely corresponds to 4-35 (Figure 4-13). 
To test this hypothesis, the trypsin-digested BexX−D-glucose 6-phosphate sample 
was treated with a carbonyl-specific labeling reagent, 2,4-dinitrophenylhydrazine 
(DNPH, 4-36), and the resulting mixture was analyzed by LC-MS (Figure 4-14A). The 
observed m/z 946.96 ion ([M + 2H]
2+
, z = 2) is consistent with the modified peptide 
D102-R114 coupled with D-glucose 6-phosphate (4-2) and DNPH (4-37; Figure 4-13). In 
a separate experiment, the undigested BexX−D-glucose-6-phosphate complex was treated 
with another carbonyl-reactive reagent, NH2OH, and analyzed by ESI-MS. The observed 
signal at 28742 (Figure 4-14B) matches the predicted molecular mass of a BexX−D-
glucose 6-phosphate−NH2OH imine adduct (4-38; Figure 4-14). These results strongly 





Figure 4-12. LC-MS of trypsin-digested BexX-D-glucose-6-phosphate. 
(A) with and (B) without NaBH4 treatment (1; positive-, 2; negative-mode analysis). 
The calculated m/z values for 4-34 and its unreduced form 4-35 are 1; 857.95 ([M + 
2H]
2+
, z = 2), 2; 855.93 (M – 2H
+
, z = 2) and 1; 856.94 ([M + 2H]
2+
, z = 2), 2; 854.92 
(M – 2H
+
, z = 2), respectively. A21 and B21 show the target peak intensity 
chromatogram (854.9 ± 0.5 Da and 856.0 ± 2 Da, respectively, negative-mode). A22 
and B22 show the extracted LC-MS/MS chromatogram containing the target peak, 79 ± 
1 Da, which corresponds to PO
3– 
(negative-mode). Calculated monoisotopic mass of 
PO
3–





























































































































































Figure 4-14. C-2-Keto intermediate trapping experiments. 
(A) LC-MS of the modified peptide 4-37 derived from trypsin digested BexX−D-
glucose-6-phosphate after DNPH (4-36) treatment. The calculated m/z value of 4-37 is 
946.95 ([M + 2H]
2+
, Z =2). (B) Deconvoluted ESI-MS of the C-His6-BexX−D-glucose-
6-phosphate ketone intermediate trapped using NH2OH. The calculated molecular 


































































































































4.3.4  Bisulfide is not the Direct Sulfur Donor. 
In mechanism A of Figure 4-3, ketone intermediate (4-10) accepts sulfur from a 
donor such as bisulfide (4-25), a protein persulfide (4-28 or 4-30), or a protein 
thiocarboxylate (4-32; Figure 4-5). In the case of thiamin biosynthesis in B. subtilis 
(Figure 4-2), the physiological sulfur donor, ThiS-thiocarboxylate, could be substituted 
with bisulfide (1 mM) in vitro.
142
 Bisulfide (5 mM) has also been utilized as a substitute 
for the sulfur carrier protein, HcyS-thiocarboxylate, from Wolinella succinogenes in the 
methionin biosynthetic pathway.
85
 Such a substitution is also possible with ThiI 
persulfide from E. coli, which acts as a sulfur donor in the biosynthesis of 4-thiouridine.
63
 
Based on these reports, we hypothesized that bisulfide may also act as a sulfur donor for 
the BexX-bound sugar substrate although it may not necessarily be the physiological 
sulfur donor. 
To test this hypothesis, a solution containing the C-His6-BexX−D-glucose 6-
phosphate ketone complex (4-10, 13 M) and free D-glucose-6-phosphate (4-2, 20 M) 
was incubated with an excess amount of bisulfide (4-25, 50 mM) followed by treatment 
with NaBH4 prior to MS analysis. If incubation with bisulfide leads to incorporation of a 
sulfur atom at C-2, then the molecular weight of the protein should be altered (either free 
enzyme or enzyme−thiosugar complex should be found). However, the observed MS 
signal from this mixture was identical to that of the reduced 4-10 (Figure 4-15A). Two 
other sulfur-containing compounds, thioacetate (4-39, 50 mM) and glutathione (GSH, 4-
40, 20 mM), were also tested, but similarly failed to produce significant changes in the 
molecular weight of the protein–substrate complex. (Figure 4-15B, C). Since NH2OH 
could react with 4-10 and produced BexX−D-glucose-6-phosphate−NH2OH imine adduct 
(4-38; Figure 4-14), the smaller bisulfide (4-25) should be able to access the C-2 ketone 
intermediate (4-11; Figure 4-3). Thus, the results shown here suggest that sulfur transfer 
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is likely protein-mediated and sulfur incorporation in the presence of a sulfur delivery 
protein is essential to push the intermediate 4-11 forward to release the expected 
thiosugar product (4-3). Otherwise, the transiently formed 4-11 by reacting with bisulfide 




Figure 4-15. C-2-Keto Intermediate with sulfur-containing small molecules. 
Deconvoluted ESI-MS of the C-His6-BexX−D-glucose 6-phosphate ketone intermediate 
(4-10) with (A) bisulfide (4-25), (B) thioacetate (4-39), or (C) GSH (4-40). *The 
reaction mixture of (C) contains both C-His6- and N-His6-enzymes. The calculated 
























































































4.3.5  Expected H/D exchange at the C-2 position. 
The apparent inertness of the C-His6-BexX−D-glucose-6-phosphate ketone 
intermediate (4-10) in the presence of high concentration of bisulfide (4-25) was 
surprising. It suggests that sulfur incorporation must be coupled with the enzyme-
mediated product sugar release to drive the reaction to completion. The proposed 
mechanism of the thiosugar release from the predicted thioketone intermediate (Figure 4-
3; 4-12  4-13  4-3) is the reverse reaction of substrate binding to form the 
corresponding ketone (4-2  4-8  4-9  4-10). This process involves a series of 
isomerization reactions, which are supposed to be in equilibrium, and thus is reversible. 
In fact, similar reversibility had been demonstrated in ThiG-catalyzed reaction in which 
H/D exchange at C-3 position of DXP (4-4) was observed when the incubation was 
carried out in a solution containing D2O.
168
 
To test the reversibility of the early isomerization steps of the BexX-catalyzed 
reaction, D-glucose-6-phosphate (4-2, 1 mM) was incubated with C-His6-BexX and N-
His6-BexX (0.1 mM each) in a buffer solution prepared with D2O. The expected H/D 
exchange at C-2 position is shown in Figure 4-16. The solution was then subjected to MS 
analysis, however, the spectrum displayed only the signal of 4-2 (ESI
−
 calculated for 
C6H12O9P
−
 [M – H
+
] 259.0, observed 259.2), and no deuterium incorporation was 
observed. This result is not expected, but appears to be consistent with the 
aforementioned observation that BexX can not produce thiosugar product in the presence 
of bisulfide. It suggests that the enzyme-ketosubstrate adduct (4-10) is a 
thermodynamically stable species whos formation from 4-8 is practically irreversible. 




4.3.6  Efforts to Find a Sulfur Transfer Protein by Pull-Down Assay. 
Since BexX shares sequence similarity to ThiG, ThiS or a ThiS-like protein 
carrying a thiocarboxylate group at C-terminal is likely a candidate of sulfur donor in the 
thiosugar biosynthetic reaction. ThiG is known to form a stable complex with ThiS such 
that they can be copurified.
143
. If BexX also employs a protein partner as sulfur donor 
with which it forms a similarly stable complex, then such a complex formation could 
potentially be exploited to isolate the corresponding sulfur carrier protein using a pull-
down assay. 
In this attempt, both C-His6-BexX and N-His6-BexX were used as the bait 
proteins for the pull-down assay. The proteins were incubated with cell free extracts 
prepared from A. orientalis and purified using Ni-NTA resin. The proteins forming 
complexes with BexX could then be coeluted with BexX from the Ni-NTA column. 
Indeed, SDS-PAGE analysis showed multiple protein bands when N-His6-BexX was used 
as the bait (Figure 4-17). The protein of particular interest are in the small molecular 
weight region (<10 kDa), because the ThiS protein is small with a molecular weight of 7 
kDa. Thus, N-terminal protein sequencing of the intense band cut from this region of 
 
















































SDS-PAGE was performed. However, the sequence obtained corresponded to the His-tag 
(N-GSSHHHHHH). This result indicates that BexX was degraded during the incubation 
with the cell free extracts even though the mixture contained protease inhibitors. Other 
bands shown in the gel are also likely the degradation products of proteins, and thus, 
were not subjected to further analysis. 
 
 
4.3.7  Whole Genome Sequencing and its Analysis. 
Whole Genome Sequencing 
Since the pull-down approach was unsuccessful to identify the sulfur donor, it 
became necessary to individually express and purify the candidate proteins including 
 
Figure 4-17. SDS-PAGE (PVDF membrane) analysis of the pull-down assay 
lane1; molecular weight marks, lane 2; C-His6-tagged BexX (268 aa, 28.5 kDa) as the 
bait, 4 h incubation, lane 2; N-His6-tagged BexX (275 aa, 29.1 kDa) as the bait, 4 h 
incubation, lane 3; C-His6-tagged BexX as the bait, 1 h incubation, lane 4; N-His6-
tagged BexX as the bait, 1 h incubation. The protein band subjected to N-terminal 
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ThiS as well as other sulfur carrier proteins, cysteine desulfurases, and rhodanese-type 
proteins, and then test their ability to incorporate sulfur into the BexX-D-glucose 6-
phosphate complex in vitro. For this purpose, whole genome sequencing of A. orientalis 
was performed. 
The genome analysis of A. orientalis identified 9210 coding open reading frames 
from approximately 9.8 Mb genomic DNA (71% GC content), which is slightly larger 
than the reported genome sizes of other Actinomycetes (8.7 Mb for Streptomyces 
coelicolor A3(2),
176
 9.0 Mb for Streptomyces avermitilis,
156
 8.2 Mb for 
Saccharopolyspora erythraea NRRL23338,
157




Genes Related to Sulfur Carrier Proteins 
We first focused on sulfur carrier proteins such as ThiS. Sulfur carrier proteins are 
small proteins (65-100 aa) containing a characteristic GG sequence at their C-terminus. 
They are known to be involved in several biosynthetic pathways of sulfur-containing 
biomolecules such as thiamin, and are also known to be evolutionally related to 
eukaryotic ubiquitin or ubiquitin-like proteins (UBLs).
73,74
 The BLAST analyses using 
the obtained A. orientalis genomic DNA led to four genes encoding putative sulfur carrier 
proteins. One of these is found in the putative thiamin biosynthetic gene cluster (thiS, 
Table 4-4), and two others are in the putative molybdopterin biosynthetic gene cluster 
(moaD, Table 4-5), or the putative cysteine biosynthetic gene cluster (cysO, Table 4-6). 
The fourth gene is similar to moaD from the molybdopterin biosynthetic pathway, and is 
thus named as moaD2. The moaD2 gene is found in the absence of nearby genes related 
to any particular biosynthetic pathway (Table 4-6). The proposed biosynthetic pathways 
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for each product in A. orientalis are shown in Figure 4-18−20.
65,68,84,178,179
 The gene 
organization near the moaD2 gene is shown in Figure 4-21. 
Surprisingly, unlike the well studied thiamin biosynthetic pathway of E. coli or B 
subtilis,
65
 the thiamin biosynthetic gene cluster of A. orientalis does not contain thiF, the 
product of which is necessary to activate the C-terminus of ThiS to acquire a 
thiocarboxylate group. Similary, gene encoding the MoaD-activating enzyme, MoeB, is 
not present in the molybdopterin biosynthetic gene cluster of A. orientalis. Instead, the 
BLAST analysis identified a gene encoding an enzyme, MoeZ, composed of an N-
terminal ThiF_MoeB_HesA_family domain and a C-terminal rhodanese homology 
domain (Figure 4-22). Notably, MoeZ from Mycobacterium tuberculosis can be utilized 
to activate CysO in the cysteine biosynthetic pathway.
84
 Thus, we proposed that MoeZ 
may be the endogenous enzyme responsible for the activation of all sulfur carrier proteins 









The ThiS homologue is shown in red. The other putative thiamin biosynthetic proteins are shown in blue.  
gene 
number
proposed function in 
thiamin biosynthesis






thiamine biosynthesis protein ThiC [Amycolatopsis mediterranei
U32]
96 / 98 YP_003770668
13947 ThiD
phosphomethylpyrimidine kinase [Amycolatopsis mediterranei 
U32]
93 / 96 YP_003770669
13950 No significant similarity found
13952 No significant similarity found
13954
transcriptional regulator, HxlR family protein [Streptomyces
bingchenggensis BCW-1]
60 / 74 ADI04334
13957
alcohol dehydrogenase zinc-binding domain-containing protein  
[Stackebrandtia nassauensis DSM 44728]
63 / 75 YP_003511248
13960 ThiD
phosphomethylpyrimidine kinase [Amycolatopsis mediterranei
U32]
96 / 97 YP_003770671
13961 lipoprotein [Amycolatopsis mediterranei U32] 95 / 97 YP_003770670
13964
voltage-gated sodium channel [Saccharopolyspora erythraea
NRRL 2338]
57 / 73 ZP_06564131
13966 NmrA family protein  [Catenulispora acidiphila DSM 44928] 78 / 89 YP_003115375
13967 transcriptional regulatory protein [Streptomyces sp. Mg1] 85 / 93 ZP_04996370
13971
MarR family transcriptional regulator  [Amycolatopsis 
mediterranei U32]
97 / 99 YP_003770672
13972 ThiG
thiamine biosynthesis protein ThiG [Amycolatopsis mediterranei 
U32]
97 / 99 YP_003770673
13974 ThiS
thiamine biosynthesis protein ThiS [Amycolatopsis mediterranei
U32]
88 / 93 YP_003770674
13975 ThiO glycine oxidase  [Amycolatopsis mediterranei U32] 89 / 93 YP_003770675
13976 ThiE
tthiamine-phosphate pyrophosphorylase [Amycolatopsis 
mediterranei U32]





Figure 4-18. Proposed thiamin biosynthetic pathway in A. orientalis. 
(A) Organization of the putative thiamin biosynthetic gene cluster found in the A. 
orientalis genome. (B) Proposed thiamin biosynthetic pathway in A. orientalis. *
1 
The 
genes encoding MoeZ and ThiL are not found in the gene cluster. The gene encoding 
the ThiS-activating enzyme, ThiF, is also absent in the genome. *
2 
Two genes encoding 
proteins homologous to ThiD are found in the gene cluster. 
1 kb
orf 13945 13947 13950 
13952 
13954 13957 13961 13960




























































































The MoaD homologue is shown in red. The other putative molybdopterin biosynthetic proteins are 
shown in blue.  
gene 
number
proposed function in 
molybdopterin
biosynthesis






ABC transport system ATP-binding protein [Amycolatopsis 
mediterranei U32]
91 / 94 YP_003770609
13830
L- permease component of ABC-type molybdate transport 
system   [Amycolatopsis mediterranei U32]
65 / 98 YP_003770610
13831
eriplasmic substrate-binding component of ABC-type molybdate 
transport system [Amycolatopsis mediterranei U32]
84 / 89 YP_003770611
13832
molybdate ABC molybdate transporter substrate-binding protein  
[Streptomyces sp. AA4]
98 / 99 ZP_07282910
13835
MarR family transcriptional regulator  [Amycolatopsis 
mediterranei U32] 
89 / 92 YP_003770613
13837 MoaA
molybdenum cofactor biosynthesis protein A [Amycolatopsis 
mediterranei U32] 
93 / 98 YP_003770614
13839 MoaD ThiS/MoaD family protein [Amycolatopsis mediterranei U32] 82 / 90 YP_003770615
13840 secreted protein [Amycolatopsis mediterranei U32] 86 / 90 YP_003770616
13842 MogA-MoaE
molybdenum cofactor biosynthesis protein B [Amycolatopsis 
mediterranei U32]
92 / 97 YP_003770618
13843 MoaC
molybdenum cofactor biosynthesis protein C [Amycolatopsis
mediterranei U32]
96 / 97 YP_003770619
13846
prevent-host-death family protein [Frankia symbiont of Datisca 
glomerata]
48 / 70 ZP_06476571
13848
PilT protein domain protein [Frankia symbiont of Datisca 
glomerata]
50 / 68 ZP_06473004
13851 malic enzyme [Amycolatopsis mediterranei U32] 97 / 99 YP_003770620
13854
hypothetical protein AMED_8524  [Amycolatopsis mediterranei 
U32]
88 / 99 YP_003770621
13856
hypothetical protein AMED_8525 [Amycolatopsis mediterranei 
U32]
64 / 97 YP_003770622
13859
hypothetical protein AMED_8526  [Amycolatopsis mediterranei 
U32]





Figure 4-19. Proposed molybdenum cofactor biosynthetic pathway in A. orientalis. 
(A) Organization of the putative molybdopterin biosynthetic gene cluster found in the 
A. orientalis genome. (B) Proposed molybdenum cofactor biosynthetic pathway in A. 
orientalis. *
1 
The genes encoding MoeZ and MoeA were not found in the gene cluster. 
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proposed function in 
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94 / 96 YP_003769825
06456 No significant similarity found
06457 Mec+
Mov34/MPN/PAD-1 family protein [Amycolatopsis mediterranei
U32] 
65 / 98 YP_003769823
06461 CysO ThiS/MoaD family protein  [Amycolatopsis mediterranei U32] 97 / 100 YP_003769822
06462 CysM cysteine synthase [Amycolatopsis mediterranei U32] 98 / 99 YP_003769821
06464 aspartate racemase [Amycolatopsis mediterranei U32] 89 / 93 YP_003769819
06465 hypothetical protein RHA1_ro01207  [Rhodococcus jostii RHA1] 50 / 64 YP_701191
06467
hypothetical protein AMED_7707 [Amycolatopsis mediterranei 
U32]





Figure 4-20. Proposed cysteine biosynthetic pathway in A. orientalis. 
(A) Organization of the putative cysteine biosynthetic gene cluster found in the A. 
orientalis genome. (B) Proposed cysteine biosynthetic pathway in A. orientalis. *
1 
The 
































































The MoaD homologue is shown in red.  
gene
number





10086 enoyl-CoA hydratase  [Amycolatopsis mediterranei U32] 88 / 93 YP_003764230
10087 No significant similarity found
10090 cold shock protein CspA [Amycolatopsis mediterranei U32] 99 / 99 YP_003767860
10092
hypothetical protein AMED_2018 [Amycolatopsis mediterranei
U32]
85 / 93 YP_003764228
10093
RNA polymerase ECF-subfamily sigma factor [Amycolatopsis
mediterranei U32] 
91 / 93 YP_003764229
10094
hypothetical protein AMED_2017 [Amycolatopsis mediterranei
U32] 
82 / 90 YP_003764227
10095
XRE family transcriptional regulator [Amycolatopsis mediterranei
U32]
94 / 100 YP_003764226
10096
NADPH:quinone reductase and related Zn-dependent 
oxidoreductase [Amycolatopsis mediterranei U32]
84 / 89 YP_003764225
10099
hypothetical protein AMED_2012 [Amycolatopsis mediterranei
U32]
88 / 96 YP_003764222
10100
hypothetical protein AMED_2011 [Amycolatopsis mediterranei
U32]
90 / 95 YP_003764221
10102 MoaD2 ThiS/MoaD family protein [Amycolatopsis mediterranei U32] 91 / 94 YP_003764220
10106
MerR family transcriptional regulator [Amycolatopsis
mediterranei U32]
92 / 98 YP_003764218
10107
intradiol ring-cleavage dioxygenase [Geodermatophilus obscurus
DSM 43160]
45 / 52 YP_003408862
10108 major facilitator transporter [Amycolatopsis mediterranei U32] 85 / 90 YP_003764219
10110 oxidoreductase [Streptomyces bingchenggensis BCW-1] 73 / 80 ADI09540
10111 No significant similarity found
10113
hypothetical protein Mvan_5028 [Mycobacterium vanbaalenii 
PYR-1]
40 / 54 YP_955806
10114
conserved hypothetical protein [Streptomyces pristinaespiralis 
ATCC 25486]
25 / 38 ZP_06913769
10116
hypothetical protein AMED_2005 [Amycolatopsis mediterranei
U32] 
81 / 85 YP_003764215
10117
hypothetical protein AMED_2004  [Amycolatopsis mediterranei
U32]
86 / 92 YP_003764214





Genes Related to Cysteine Desulfurases 
Cysteine desulfurases are another important class of sulfur transfer proteins that 
utilize pyridoxal-5‟-phosphate (PLP) and L-cysteine to generate a reactive protein 
persulfide. The BLAST analyses of the A. orientalis genomic DNA led to the 
identification of five cysteine desulfurase homologues (CD1−5, Table 4-8). This class of 
enzymes was considered for their potential to participate directly in donating sulfur to the 
BexX-D-glucose 6-phosphate ketone intermediate (4-10, Figure 4-5) or indirectly by 
serving a source of sulfur for the sulfur carrier proteins mentioned above. In fact, cysteine 
desulfurases have been, in many cases, proposed as the in vivo sulfur source for 





Figure 4-22. Putative conserved domains found in MoeZ. 




Figure 4-21. Organization near the moaD, homologue, moaD2, found in the A. 
orientalis genome. 
orf 10086 10087 1009310090 10092 10094
10095








4.3.8  Investigation of ThiS as the Sulfur Donor. 
MoeZ-Catalyzed ThiS Activation. 
A. orientalis ThiS and MoeZ carring an N-terminal His6-tag were heterologously 
expressed in E. coli (see also Figure 4-25), and the MoeZ-catalyzed ThiS-activating 
reaction (Figure 4-23A) was analyzed by ESI-MS. The purified N-His6-ThiS from Ni 
affinity chromatography exhibited two mass signals corresponding to the calculated 
molecular weights of the recombinant enzyme (4-56) and its N-gluconoylated derivative 
(4-60; Figure 4-23B). Spontaneous modification of the N-terminal His6-tag by D-
glucono-1,5-lactone (4-59) is a previously reported phenomenon for proteins expressed in 
E. coli.
180
 This modification is not expected to affect the enzyme activity of ThiS, 
because the predicted active site for ThiS is located at the C-terminus. 
When N-His6-ThiS was incubated with N-His6-MoeZ and ATP in Tris (100 mM) 
buffer containing 6% glycerol, a signal consistent with the adenylated N-His6-ThiS (4-57) 
was found along with other signals likely derived from nonenzymatic modification of the 
adenylated enzyme (4-61 and 4-62; Figure 4-23C) by the buffer components. In the 
presence of bisulfide (4-25), complete conversion of the enzyme to the corresponding 
thiocarboxylate (4-58; Figure 4-23D) was observed. Control experiments using bisulfide 












cysteine desulfurase/selenocysteine lyase [Amycolatopsis
mediterranei U32]
97 / 98 YP_003765029
11099 CD2 cysteine desulfurase [Amycolatopsis mediterranei U32] 87 / 91 YP_003765163
14916 CD3 cysteine desulfurase [Amycolatopsis mediterranei U32] 88 / 93 YP_003766645
04763 CD4 cysteine desulfurase [Amycolatopsis mediterranei U32] 92 / 96 YP_003763873
09299 CD5 cysteine desulfurase [Amycolatopsis mediterranei U32] 97 / 99 YP_003762467
 174 
in the absence of N-His6-MoeZ displays no alteration of the original ThiS signals, 
consistent with the proposal that thiocarboxylate formation proceeds in a MoeZ-catalyzed 
adenylation-dependent manner (Figure 4-23E). Together, these data support our 





Figure 4-23.EIS-MS analyses of the MoeZ-catalyzed activation of ThiS 
(A) Reaction scheme of the MoeZ-catalyzed activation of ThiS. (B) Deconvoluted ESI-
MS of as isolated ThiS, (C) ThiS in the presence of MoeZ and ATP, (D) ThiS in the 
presence of MoeZ, ATP, and bisulfide (4-25), and (E) ThiS in the presence of bisulfide 











































































































































Calculated molecular weights of ThiS derivatives           (gluconoylated
derivatives)
 176 
Consideration of ThiS as the Sulfur Donor. 
The N-His6-ThiS-COS
−
 (4-58) obtained from the previous step was incubated 
with C-His6-BexX, which forms a stable complex with D-glucose 6-phosphate (4-2) as 
described above. If sulfur transfer occurs and the 2-thiosugar product is released from the 
enzyme, then a mass signal corresponding to the C-His6-BexX-D-glucose 6-phosphate 
should be converted to that of the free enzyme (Figure 4-24A). The protein C-His6-BexX 
was freshly prepared, and most protein in this batch was found to be the 
enzyme−substrate complex (Figure 4-24B), thus, additional D-glucose 6-phosphate (4-2) 
was not added in this experiment. To our disappointment, we did not observe an increase 
of the free C-His6-BexX in the presence of N-His6-ThiS-COS
−
 (4-58; Figure 4-24 C and 
D). Instead, the C-His6-BexX-G6P signal was stable even in the presence of ThiS, MoeZ, 
ATP and high concentrations of bisulfide (4-25, 10 mM). Although ThiS was originally 
considered to be the most likely candidate as the sulfur donor because of the protein 
sequence similarity between BexX and ThiG, our current result clearly ruled out this 






Figure 4-24. Investigation of potential sulfur transfer from ThiS-thiocarboxylate to 
BexX−D-glucose-6-phosphate complex (4-10). 
(A) Reaction scheme of the expected sulfur transfer reaction. (B) Deconvoluted ESI-
MS of the as-isolated C-His6-BexX shows that the BexX−D-glucose-6-phosphate 
complex (4-10) is the main species. The calculated molecular weights of C-His6-BexX 
(258 aa) and its glucose 6-phosphate complex (4-10) are 28488 and 29730, 
respectively. (C) 1, Deconvoluted ESI-MS of the reaction mixture showing the mass 
range for BexX. Observed mass signals are consistent with C-His6-BexX [28488 
(calculated), 28484 (observed)] and C-His6-BexX−D-glucose-6-phosphate [29730 
(calculated), 29727 (observed)]. Conversion of the 4-10 to free BexX was not observed 
under these conditions, suggesting the proposed sulfur transfer does not occur from 
ThiS-thiocarboxylate. 2, Deconvoluted ESI-MS of the same reaction mixture showing 
the mass range for ThiS. Observed mass signals are consistent with N-His6-ThiS-COSH 
[8663 (calculated), 8662 (observed)] and N-gluconoyl-His6-ThiS-COSH [8841 
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4.3.9  Investigation of Other Sulfur Carrier Proteins. 
MoeZ-Catalyzed Activation of Sulfur Carrier Proteins 
As discussed above, three other sulfur carrier proteins, MoaD, CysO, and MoaD2, 





 biosyntheses, respectively (Figure 4-19 and 4-20), the 
physiological function of MoaD2 (MoaD homologue) is unknown. Although their native 
partner proteins, CysM and MoaE, do not show sequence similarities with BexX, one 
cannot predict the structure of the sulfur carrier protein-binding sites based simply on 
sequence analysis. Thus, it remains possible that MoaD, CysO, or MoaD2 may be able to 
interact with BexX and transfer its sulfur atom to the BexX–D-glucose 6-phosphate 
complex (4-10). 
To test this hypothesis, we expressed and purified recombinant N-His6-MoaD, N-
His6-CysO and N-His6-MoaD2. While the latter two proteins were purified in good yields 
and quality (Figure 4-25, lane lane 2 and 3), N-His6-MoaD was not expressed well in E. 
coli, and the latter protein was obtained in much less quantity and lower purity as 
compared to the former proteins (Figure 4-25, lane 7). ESI-MS analyses showed mass 
signals consistent with those expected for the corresponding enzymes and their N-
gluconoylated derivatives as were seen in the case of N-His6-ThiS (Figure 4-26B and C), 
though it was possible to obtain N-His6-MoaD in the unmodified form (Figure 4-26A). 
Since a thiF-like gene does not exist near moaD, cysO or moaD2 in the A. orientalis 
genome, MoeZ was again proposed to be the activating enzyme, instead of ThiF or its 
equivalents, for these sulfur carrier proteins (Figure 4-19−21). 
Thiocarboxylate formation on MoaD, CysO and MoaD2 in the presence of MoeZ, 
ATP and NaSH was confirmed in each case by MS (Figure 4-26D−F). These results 
suggest that MoeZ may act as a universal sulfur carrier protein-activating enzyme in A. 
 179 
orientalis (Figure 4-27). Similar multifunctionality of a single ThiF-like protein in 
prokaryotes was recently predicted based on genome analyses.
181
 Notably, TtuB, a ThiF-
like enzyme from Thermus thermophilus, has been experimentally verified to contribute 
to both the thiamin and molybdopterin biosynthetic pathways as well as the tRNA 
thiouridine modification pathway.
86
 Taken together, a common sulfur carrier protein 
activating-enzyme contributing to several independent biosynthetic pathways may be a 




Figure 4-25. SDS-PAGE gel of purified sulfur carrier proteins and MoeZ. 
N-His6-ThiS (85 aa, 8.7 kDa, lane 2), N-His6-CysO (109 aa, 11.7 kDa, lane 3), N-His6-
MoaD2 (115 aa, 12.5 kDa, lane 4), N-His6- MoeZ (421 aa, 45.0 kDa, lane 5), and N-
His6-MoaD (105 aa, 11.0 kDa, lane 7). The molecular weight marks are 220, 160, 120, 
100, 90, 80, 70, 60, 50, 40, 30, 25, 20, 15, and 10 kDa (top to bottom, lane 1 and 6). 
The protein MoaD was not expressed well, and the partially purified protein solution 
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Figure 4-26. ESI-MS analyses of the MoeZ-catalyzed activation of sulfur carrier 
proteins 
(A) Deconvoluted ESI-MS of as-isolated MoaD (the calculated molecular weight of N-
His6-MoaD (105 aa) is 11022 Da), (B) as-isolated CysO (the calculated molecular 
weight of N-His6-CysO (109 aa) and its N-gluconoylated derivative are 11688 and 
11866, respectively), (C) as-isolated MoaD2 (the calculated molecular weights of N-
His6-MoaD2 (115 aa) and its N-gluconoylated derivative are 12473 and 12651, 
respectively), (D) MoaD incubated with MoeZ, ATP, and NaSH (the calculated 
molecular weight of N-His6-MoaD-COSH is 11038 Da), (E) CysO incubated with 
MoeZ, ATP, and NaSH (the calculated molecular weights of N-His6-CysO-COSH and 
its N-gluconoylated derivative are 11704 and 11882, respectively), (F) MoaD2 
incubated with MoeZ, ATP, and NaSH (the calculated molecular weights of N-His6-











































































































Investigation of Sulfur Carrier Protein-Mediated Sulfur Incorporation 
With activated CysO and MoaD2 in hand, we next examined the proposed sulfur 
transfer reaction from these enzymes to the BexX–D-glucose 6-phosphate complex (4-
10). MoaD was not used for this assay because of its low concentration and purities 
(Figure 4-25, lane 7). Relative intensities of mass signals corresponding to 4-10 and the 
free enzyme were monitored before and after addition of the activated sulfur carrier 
proteins. In contrast to the analogous experiment using N-His6-ThiS-COS
−
 (Figure 4-24), 
we observed the free C-His6-BexX after addition of these sulfur carrier proteins (Figure 
4-28). This indicates that the anticipated sulfur transfer followed by the thiosugar product 






Figure 4-27. Multifunctionality of MoeZ observed in A. orientalis. 
MoeZ appears to be a universal activator of sulfur carrier proteins in A. orientalis. 
These sulfur carrier proteins are involved in the biosynthetic pathways of thiamin, 

















































Figure 4-28. Sulfur transfer from CysO- or MoaD2-COS
−
 to BexX-D-glucose-6-
phosphate complex (4-10). 
(A) Reaction scheme of the expected sulfur transfer reaction. (B) Deconvoluted ESI-
MS of the as-isolated C-His6-BexX shows that 4-10 is the main species. The calculated 
molecular weights of C-His6-BexX (258 aa) and 4-10 are 28488 and 29730, 
respectively. (C) Deconvoluted ESI-MS of the reaction mixture using CysO. 1, showing 
only the free form of C-His6-BexX, suggesting the expected sulfur transfer and 2, 
showing fully activated CysO-COS
−
 and its N-gluconoylated derivative. (D) 
Deconvoluted ESI-MS of the reaction mixture using MoaD2 also shows 1, only the free 





















































































































Spectrophotometric Analysis of the Sulfur Transfer 
MoeZ-catalyzed sulfur carrier-protein activation and the following sulfur transfer 
to the BexX−D-glucose-6-phosphate complex (4-10) were also analyzed 
spectrophotometrically using adenylate kinase (AK), pyruvate kinase (PK), and lactate 
dehydratase (LDH) to assay for the formation of AMP. As shown in Figure 4-29, one 
molecule of AMP is released upon formation of one molecule of sulfur carrier protein-
thiocarboxylate. AK converts the produced AMP and another molecule of ATP to two 
molecules of ADP, which leads to the consumption of two molecules of NADH via the 
coupled enzymatic reactions. The consumption of NADH can be conveniently monitored 




Figure 4-29. Spectrophotometric analysis of AMP production during the course of 
sulfur carrier protein activation by MoeZ and its sulfur transfer to BexX-































































 When N-His6-CysO or N-His6-MoaD2 was used, consumption of NADH was 
faster in the presence of C-His6-BexX (Figure 4-30, trace 1 or 2) compared to the control 
reaction without added BexX (Figure 4-30, trace 5 or 6). In contrast, addition of BexX 
did not affect the rate of NADH consumption when N-His6-ThiS was used (Figure 4-30, 
trace 3 and 7). These observations are consistent with the ESI-MS analysis described 
above that N-His6-CysO and N-His6-MoaD2 produced the free form of C-His6-BexX 
(Figure 4-28) while N-His6-ThiS-COS
–
 did not (Figure 4-24). The observed decrease of 
absorbance at 340 nm in the first 2–3 min was mainly caused by a small amount of AMP 
contamination found in the ATP solution used for this experiment (Figure 4-30, trace 4). 
The single turnover of the MoeZ-catalyzed sulfur carrier protein-activation reaction was 
deduced by observing the greater decrease in absorbance in the first 2–3 min when sulfur 
carrier proteins were added (Figure 4-30, trace 5–7). 
 Although the purified N-His6-MoaD contained impurities, a similar experiment 
was performed for this enzyme. The preliminary data suggested that N-His6-MoaD 
cannot transfer its sulfur atom to the BexX-D-glucose-6-phosphate complex (4-10) as 
seen for N-His6-ThiS. 
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4.3.10  Accomplishment of the Enzymatic 2-Thiosugar Formation. 
Encouraged by the results described above, direct detection of the product 
thiosugar was then pursued. The purified sulfur carrier protein, N-His6-CysO, N-His6-
MoaD2 or N-His6-ThiS was incubated with C-His6-BexX and N-His6-MoeZ in the 
 
Figure 4-30. Spectrophotometric analysis of AMP production using sulfur carrier 
proteins, MoeZ, and BexX with the AK, PK, and LDH-coupled reaction 
system. 
Reaction conditions of used enzymes are shown in the table. C-His6-BexX (+): 10 M, 
N-His6-MoaD2 (+): 9 M, N-His6-CysO (+): 6 M, N-His6-ThiS (++): 20 M, N-His6-
ThiS (+): 10 M. The reaction mixture also contained MoeZ (3 M), ATP (1 mM), D-
glucose 6-phosphate (5 mM), NaSH (5 mM), PEP (0.3 mM), NADH (0.1 mM), AK, 
PK, LDH, and MgCl2 (5 mM) in 50 mM Tris·HCl buffer (pH 8.0). ATP was added to 
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presence of D-glucose 6-phospahte (4-2), ATP and NaSH. If the expected sulfur transfer 
occurs, the single catalytic cycle should produce one molecule of AMP and one molecule 
of 2-thio-D-glucose-6-phosphate (4-3) (Figure 4-29, solid line). 
The reaction products were analyzed by HPLC after derivatizing the predicted 
thiosugar with the thiol reactive chromophore, monobromobimane
182,183
 (mBBr, 4-66; 
Figure 4-31A). When N-His6-ThiS was used, the extent of AMP was similar to that 
observed with the control having no sulfur carrier protein, suggesting the detected AMP 
is likely derived from self degradation of ATP during the incubation (Figure 4-31B, 
traces 5 and 6). On the other hand, when N-His6-CysO or N-His6-MoaD2 was used, a 
clear increase in AMP formation was observed along with the appearance of a new peak 
(product peak) (Figure 4-31B, trace 3 or 4). In addition, control experiments showed that 
formation of AMP and the product peak were BexX- and MoeZ-dependent (Figure 4-
31B, trace 1 and 2). The product peak was isolated and analyzed by ESI-MS. The 
observed signal (m/z 465.0741) matched the calculated value for 2-thio-D-glucose 6-
phosphate-bimane (4-67, C16H22N2O10PS
–
 [M – H
+
] 465.0738; Figure 4-31C). 
To further evaluate the assignment of the new product peak, each reaction was 
also treated with alkaline phosphatase prior to the addition of mBBr (4-66) and similarly 
analyzed by HPLC (Figure 4-32A). The retention time of the product peak was identical 
to that of the synthetic standard of the 2-thio-D-glucose-bimane derivative (4-69, Figure 
4-32B). The product peak was also isolated and analyzed by ESI-MS. The observed 
signal (m/z 409.1038) indeed matches the calculated value (m/z 409.1040; Figure 4-32C). 
Taken together, we can conclude that BexX-catalyzed 2-thiosugar formation proceeds in 




 but not ThiS-COS
–
. These results 





Figure 4-31. BexX-catalyzed 2-thio-D-glucose 6-phosphate formation with mBBr 
derivatization. 
(A) Reaction scheme to make the expected bimane derivative (4-67). (B) HPLC traces 
of the C-His6-BexX-catalyzed reactions utilizing N-His6-ThiS, N-His6-CysO or N-His6-
MoaD2 and the control reactions. The thiosugar product was derivatized with mBBr (4-
66). (C) ESI-MS of the isolated peak (4-67). HRMS (ESI
–
) calculated for 
C16H22N2O10PS
–
 [M – H
+
] 465.0738, observed 465.0741. 
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Figure 4-32. BexX-catalyzed 2-thio-D-glucose 6-phosphate formation with alkaline 
phosphatase (CIP) and mBBr. 
(A) Reaction scheme to make the expected bimane derivative (4-69). (B) HPLC traces 
of the C-His6-BexX-catalyzed reactions utilizing N-His6-ThiS, N-His6-CysO or N-His6-
MoaD2 and the control reactions. The thiosugar product was derivatized with mBBr (4-
66). The synthetic standard of 4-69 is shown on the bottom trace (trace 7). (C) ESI-MS 
of the isolated peak (4-69). HRMS (ESI
+
) calculated for C16H22N2NaO7S
+
 [M + Na]
+
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4.3.11  Sequence Analysis of Sulfur Carrier Proteins. 
It is surprising that BexX can utilize either CysO or MoaD2 but not ThiS (and 
MoaD) as its partner despite the sequence similarity between BexX and ThiG (58% 
identity and 75% similarity to ThiG from Stigmatella aurantiaca DW4/3-1 
(ZP_01459245),
141
 38% identity and 59% similarity to ThiG from Bacillus subtilis subsp. 
subtilis str 168
142
). Confirmation that BexX is the desired 2-thioglucose 6-phosphate 
synthase, prompted us to consider that the relatively high sequence similarity found 
between BexX and ThiG from S. aurantiaca (ZP_01459245) may be an indication of the 
latter enzyme as a possible thiosugar synthase rather than a thioazole synthase. 
Furthermore, analysis of the sequence surrounding the putative thiG gene in S. 
aurantiaca failed to locate any other genes related to thiamin biosynthesis. Instead, a 
putative sulfur carrier protein annotated as PdtH homologue (ZP_01459250) can be 
located nearby. This leads to the proposal that the PdtH homologue (ZP_01459250) may 
be responsible for providing a sulfur atom to a complex involving the ThiG homologue 
(ZP_01459245) and its unknown substrate. 
To gain more insights into the specific interaction between BexX and the sulfur 
carrier proteins, the protein sequences of the four sulfur carrier proteins from A. orientalis 
were compared with those of other previously reported sulfur carrier proteins and the 
related proteins as well as the PdtH homologue from S. aurantiaca (Figure 4-33). In 
addition, the secondary structures of the sulfur carrier proteins from A. orientalis and the 
PdtH homologue from S. aurantiaca were also analyzed (Figure 4-34). Although the 
former analysis did not provide significant information to explain the observed 
interaction between BexX and CysO or MoaD2, the latter analysis revealed a similar 
organization of the predicted secondary structures in CysO, MoaD2, and PdtH from S. 
aurantiaca. This suggests that such a structural organization may be necessary for the 
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interaction with BexX (or with the ThiG homologue from S. aurantiaca) and sulfur 
transfer. Further experiments are clearly required to address these hypotheses, and the 




Figure 4-33. Protein sequence similarity analysis of sulfur carrier proteins, ubiquitin, 
and ubiquitin-like proteins. 
The sulfur carrier proteins from A. orientalis and the PdtH homologue from S. 
aurantiaca are labeled with asterisks.   
 
CysO [A. orientalis] orf06461
CysO [M. tuberculosis H37Rv] NP_215851
PdtH [P. stutzeri] AAF33132
QbsE [P. fluorescens] AAL65287
PdtH homologue [S. aurantiaca DW4/3-1] ZP_01459250
MoaD-Wco (TTC1835) [T. thermophilus HB27] YP_005804
ThiS [E. coli str. K-12 substr. MG1655] YP_026279
ThiS [A. orientalis] orf13974
ThiS [M. tuberculosis H37Rv] NP_214930
ThiS[S. erythraea NRRL 2338] YP_001102779
MoaD2 [A. orientalis] orf10102
MoaD [M. tuberculosis H37Rv] YP_177928
MoaD-MoaE (TTC1947) [T. thermophilus HB27] YP_005916
MoaD [A. orientalis] orf13839
MOCS2A [Homo sapiens] NP_789776
MoaD [B. subtilis subsp. subtilis str. 168] NP_389314
MoaD [E. coli str. K-12 substr. MG1655] NP_415305
ThiS [B. subtilis subsp. subtilis str. 168] NP_389050
ThiS (TTC0316) [T. thermophilus HB27] YP_004291
TtuB (TTC0105) [T. thermophilus HB27] YP_004080
Ubiquitin [Homo sapiens] CAA44911








4.3.12  In vivo Sulfur Source of the Sulfur Carrier Proteins. 
Although CysO and MoaD2 can act as the sulfur donor for the 2-thiosugar 
biosynthetic pathway, the in vivo sulfur donor required to activate these enzymes remains 
unknown. Since the sulfur carrier protein-acyl adenylate intermediate formed by MoeZ 
(Figure 4-23A) was shown to be labile in the solution (Figure 4-23C) it must be orderly 
attacked by bisulfide or its equivalent as soon as it forms. In many cases, cysteine 
desulfurases has been implicated as the sulfur donors for the sulfur carrier proteins (see 
Chapter 1). Thus, the sulfur carrier proteins found in A. orientalis may interact with the 
endogenous cysteine desulfurases in vivo. Another possible candidate for the sulfur 
 
Figure 4-34. Predicted secondary structures of sulfur carrier proteins from A. orientalis 
and the PdtH homologue from S. aurantiaca. 
(A) ThiS from A. orentalis (orf13974). (B) MoaD from A. orentalis (orf13839). (C) 
CysO from A. orentalis (orf06461). (D) MoaD2 from A. orentalis (orf10102). (E) PdtH 
homologue from S. orientalis (ZP_01459250). Prediction contains three states: alpha 
helix (H), beta strand (S) and coil (C), with confidence scores for each residue, in which 







source is a rhodanese-type enzyme. Interestingly, the C-terminal domain of MoeZ display 
good characteristics of a rhodanese-type enzyme (Figure 4-22). If this domain exhibits 
rhodanse activity, then the formed protein persulfide may be transferred to the adenylated 
sulfur carrier proteins, which may still be bound to the N-terminal adenylation domain of 
the same enzyme. In this last section, a preliminary investigation of the BexX-catalyzed 
2-thiosugar formation utilizing MoeZ and thiosulfate, or cysteine desulfurases and L-
cysteine instead of exogenous bisulfide is described. 
Rhodanese Activity of MoeZ 
The sulfur carrier protein, N-His6-CysO was incubated with C-His6-BexX and N-
His6-MoeZ in the presence of D-glucose 6-phospahte (4-2), ATP, thiosulfate, and DTT. 
The reaction was analyzed by HPLC after derivatization with mBBr as described above. 
The product peaks corresponding to 2-thio-D-glucose 6-phosphate-bimane (4-67) and 2-
thio-D-glucose-bimane (4-69; with CIP treatment) were similarly observed as the reaction 
using sodium bisulfide (Figure 4-31B and 4-32B). This suggests that MoeZ does possess 
the expected rhodanese activity (Figure 4-35). At this point, however, whether the protein 
persulfide formed in MoeZ can directly attack the acyl adenylate group of the sulfur 
carrier protein is not known because the generated persulfide can be easily reduced by 




Cysteine Desulfrases in A. Oreintalis 
Whole genome analysis of A. orientalis led to the identification of five cysteine 
desulfurase homologues (Table 4-8). These enzymes with N-terminal His6-tag were 
purified except CD5, which was expressed as inclusion bodies (Figure 4-36). The sulfur 
carrier protein, N-His6-MoaD2 was then incubated with one of the purified cysteine 
desulfurases (CD1–4), C-His6-BexX and N-His6-MoeZ in the presence of D-glucose 6-
phospahte (4-2), ATP, L-cysteine (4-26), PLP, and DTT. The reaction was analyzed by 
HPLC after derivatization with mBBr as described above. 
The product peak corresponding to 2-thio-D-glucose 6-phosphate-bimane (4-67) 
was observed, as in the control reaction, using exogenous bisulfide and N-His6-CD2 and 
N-His6-CD4. The reaction mixture containing N-His6-CD1 did not produce a detectable 
amount of 4-67, and the N-His6-CD3 reaction gave a significantly lower yield of 4-67 
than those of N-His6-CD2 and N-His6-CD4 reactions. When DTT was omitted, the yields 
of 4-67 from N-His6-CD2 and N-His6-CD4 reaction mixtures were dramatically 
decreased. This is consistent with the expected cysteine desulfurase activities of the 
 

























enzymes, which require a reducing agent for multi-turnovers (Figure 4-37A). Thus, the 
results of these experiments fully established the cysteine desulfurase activities of CD2 
and CD4. 
In contrast, the reaction mixture containing N-His6-CD3 in the absence of DTT 
produced similar amount of 4-67 as the control reaction using exogenous bisulfide. This 
suggests that CD3 is not a cysteine desulfurase but may be a cystine lyase, which utilizes 
PLP to produce cysteine persulfide and pyruvate (4-64) from cystine (4-70; Figure 4-
37B).
184,185
 Indeed, production of 4-64 was confirmed spectrophotometrically using 
lactate dehydrogenase by monitoring the decrease of NADH (absorbance at 340 nm) 





Figure 4-36. SDS-PAGE gel of purified cysteine desulfurases. 
N-His6-CD1 (415 aa, 44.1 kDa, lane 2), N-His6-CD2 (485 aa, 51.4 kDa, lane 3), N-His6-
CD3 (432 aa, 44.8 kDa, lane 4), and N-His6-CD4 (417 aa, 43.3 kDa, lane 5). The 
molecular weight marks are 220, 160, 120, 100, 90, 80, 70, 60, 50, 40, 30, 25, 20, 15, 












In summary, rhodanese activity of MoeZ, cysteine desulfurase activity of CD2 
and CD4 and cystine lyase-like activity of CD3 were confirmed. They are potentially 
responsible for acting as sulfur donors for the sulfur carrier proteins in A. orientalis. 
However, whether a mechanism of direct sulfur transfer mediated by protein–protein 
interactions is involved or not is not fully understood. The resulting protein persulfides 
may also act as an indirect sulfur source because they can easily liberate bisulfide upon 
 
Figure 4-37. Cysteine desulfurase acitivity of CD2 and CD4 
(A), and the proposed cystine lyase activity of CD3 (B). Detection of pyruvate using 













































































reduction by endogenous reductants. Furthermore, major intracellular thiols in 
Streptomyces species have been determined using the mBBr derivatization method.
182,183
 
The identified species include cysteine, coenzyme A, sulfide, thiosulfate, and 
mycothiol.
182,186,187
 Thus, cysteine, thiosulfate, and sulfide considered above are all 
potential in vivo sulfur sources for the sulfur carrier proteins. 
 
4.4  CONCLUSIONS  
In this chapter, the biosynthetic pathway of the 2-thiosuar moiety of BE-7585A 
were investigated. BexX was characterized as the 2-thio-D-glucose 6-phoshate (4-3) 
synthase, which produces 4-3 from D-glucose 6-phoshate (4-2) through a mechanism 
reminiscent to that of thiazole synthase (ThiG). The BexX-catalyzed sulfur incorporation 
reaction requires a sulfur delivery protein, whose encoded gene is not in the BE-7585A 
biosynthetic gene cluster. Therefore, it must be recruited from the primary metabolite 
biosynthetic pathways. The desired enzyme was identified through a genome mining 
approach followed by in vitro characterization. A sulfur carrier protein found in the 
thiamin biosynthetic gene cluster (ThiS) is not the sulfur donor despite the high sequence 
similarity between BexX and ThiG. Instead, a sulfur carrier protein found in the cysteine 
biosynthetic gene cluster (CysO) and a sulfur carrier protein (MoaD2) similar to MoaD in 
molybdopterin biosynthesis were confirmed as productive sulfur donors for the BexX 
reaction. During the course of these studies, the non-pathway specific sulfur carrier 
protein-activating enzyme, MoeZ, was also discovered.  
The works presented here are significant for several reasons. First, this is the first 
report of the reconstitution of 2-thiosugar biosynthesis in vitro. Second, recruitment of a 
sulfur carrier protein from primary metabolism to be used in the biosynthesis of 
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secondary metabolites is an intriguing finding. Indeed, it is the first example of this type 
of enzymes to pair with a non-pathway protein which is encoded by a gene out of the 
biosynthetic gene cluster. Third, BexX is the first enzyme having ability to accept sulfur 
atom from multiple sulfur donor proteins. These results demonstrate that the 
collaboration interaction between the sulfur carrier protein and its acceptor protein is not 
always very specific. This implies that there may be more unidentified pairs of sulfur 
carrier and acceptor proteins. Namely, Nature may have evolved a combinational 
approach to match the sulfur carrier and the acceptor protein in different applications. For 
example, a pathway-independent sulfur carrier protein may play similar roles in the 
biosyntheses of other types of thio-containing compounds. Finally, MoeZ was identified 
as the universal sulfur carrier protein activator in A. orientalis. Based on the reported 
genome sequences of several Actinobacteria, this may be a common feature for this class 
of organisms. Moreover, the C-terminal rhodanese activity of the enzyme indicates that 
the in vivo sulfur source of sulfur carrier proteins may be thiosulfate although the 
possibility for utilizing bisulfide or an equivalent produced by other enzymes cannot be 
excluded. 
In terms of the mechanism, a stable C-2 keto form of the BexX–D-glucose-6-
phoshphate complex was identified as the key intermediate in this reaction. While 
NH2OH could specifically trap this carbonyl functional group without denaturing the 
enzyme, bisulfide alone cannot appear to facilitate sulfur incorporation at C-2. A sulfur 
carrier protein-thiocarboxylate terminal is essential for delivers sulfur to BexX2-
ketosugar complex to complete the catalytic cycle. Site specific covalent attachment of 
the sugar substrate to Lys110 of BexX was confirmed by mutagenesis studies and LC-
MS/MS analysis using trypsin digestion. Based on previous studies of ThiG, Asp112 and 
Glu194 were also predicted to be important for catalysis (Figure 4-9).
143
 The proposed 
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mechanism of BexX-catalyzed 2-thio-D-glucose 6-phoshate (4-3) formation is shown in 
Figure 4-38. The initial steps are likely several isomerization reactions to generate the C-
2 keto intermediate (4-8  4-9  4-10), priming the sugar substrate to accept the thiol 
group from a nucleophilic sulfur donor. Predicted active site residues, Asp112 and 
Glu194, likely play important roles in this process. A sulfur carrier protein CysO or 
MoaD2 is then recruited from the primary metabolite biosynthetic pathway to attack the 
C-2 keto intermediate (4-10) and introduce the thiofunctional group. Dehydration at C-2 
through hydrolysis of the thioester bond formed with sulfur carrier protein then occurs to 
form of the C-2 thioketone intermediate (4-12). Subsequent isomerization of the thiol 
intermediate gives the enamine (4-72) and finally the imine intermediate (4-13). This 
would then be hydrolyzed to yield the 2-thio-D-glucose 6-phosphate (4-3) product. 
Mutagenesis studies targeting Asp112 and Glu194 as well as BexX protein structural 


































































































































































Chapter 5:  Biosynthetic Studies of Lincomycin A: Functional 
Characterization of the Transaldolase, LmbR, and Isomerase, LmbN, to 
Construct the Octose 8-Phosphate Intermediate Towards the 
Biosynthesis of Methylthiolincosamide 
 
5.1  INTRODUCTION 
Lincomycin A (5-1) is a lincosamide antimicrobial agent isolated from 
Streptomyces lincolnensis var. lincolnensis in 1962.
188
 The lincosamide antibiotics, which 
bind to the 23S rRNA of the 50S subunit, act as the structural mimics of the 3‟-ends of L-
Pro-Met-tRNA and deacylated-tRNA in the initial phase of the peptide elongation 
cycle.
189
 Thus, lincomycin and its derivatives exhibit biological activity against Gram-
positive bacteria by blocking microbial protein synthesis.
190
 For example, the semi-
synthetic chlorinated lincomycin derivative, clindamycin (7-epichlorolincomycin, 5-3), 
possesses improved biological activitiy and is a clinically useful antibiotic.
191-193
 The 
structure of lincomycin A (5-1) is composed of an N-methyl-4-propyl-L-proline moiety 
and an unusual eight-carbon sugar, which contains a unique methylthio group at C-1, 
called methylthiolincosamide (MTL, 5-2; Figure 5-1).
28
 Despite the long-term use of this 
class of antibiotics and the identification of the biosynthetic gene cluster from the 
industrial overproduction strain S. lincolnensis 78-11,
46
 the biosynthetic pathway of 
lincomycin A (5-1), especially the MTL (5-2) moiety, remains poorly understood.
194
 







 which are involved in the biosynthesis of 
the N-methyl-4-propyl-L-proline moiety (Figure 5-2). No intermediate has been 




Figure 5-2. Proposed biosynthetic pathway of the 4-propyl-L-proline part of 
lincomycin A and its coupling with MTL to form lincomycin A. 
The functions of LmbB1, LmbB2 and LmbJ were reported experimentally. The 
functions of other enzymes were predicted based on the sequence similarity analyses 































































































































In 1984, before the biosynthetic gene cluster of lincomycin A (5-1) was 
discovered, feeding experiments using D-[
13
C6]glucose were performed to determine the 
origin of the C8 scaffold of MTL (5-2). The data suggested that 5-2 is assembled through 
condensation of a C5 and a C3 units.
198
 It was proposed that the C5 unit might be a pentose 
5-phosphate derived from the pentose phosphate pathway (Figure 5-3). On the other 
hand, the C3 unit was proposed to be transferred from sedoheptulose 7-phosphate (5-20) 
using a transaldolase reaction analogous to the reaction seen in the pentose phosphate 
pathway (5-20 + 5-21  5-23 + 5-22). The resulting octulose 8-phosphate was proposed 
to be further modified to form MTL (5-2) through an intermediate 5-24 (Figure 5-4, 
pathway A). 
Meanwhile, the biosynthetic gene cluster of lincomycin A (5-1) was sequenced in 
1995.
46
 A few genes, such as lmbO, lmbM, and lmbS, were found to share sequence 
similarities with those involved in well-studied NDP-6-deoxyhexose pathways. Thus, 
another route for the MTL biosynthesis starting from TDP-glucose (C6 unit) through a 
TDP-deoxyaminosugar intermediate (5-28), which might be then transferred to a C2 
extender unit via a C-glycosylation reaction, was proposed (Figure 5-4, pathway B). 
An alternative pathway to reconcile the two contradictory pathways mentioned 
above was suggested after finding a gene encoding a putative transaldolase, lmbR, in the 
biosynthetic gene cluster. As proposed in pathway A, the C8 carbon unit may be first 
formed from a C5 unit and a C3 unit via a transaldolase reaction. The resulting octulose 8-
phosphate would then be converted to an NDP-activated pyranosidic octose intermediate 






























































































































 In this chapter, sequence alignment of the genes in the lincomycin A biosynthetic 
gene cluster using the updated database are first described. The biosynthetic pathway of 
 
Figure 5-4. Proposed biosynthetic pathways for methylthiolincosamide (MTL, 5-2). 
(A) Pathway based on the D-[
13
C6]glucose feeding studies. (B) Pathway based on the 
putative NDP-hexose modification genes found in the lincomycin A biosynthetic gene 
cluster. (C) Pathway reconciling A and B based on the putative transaldolase gene 




























































































MTL (5-2) is proposed and discussed based on the sequence similarity results and recent 
reports of structurally similar NDP-heptose biosynthetic pathways. 
The overall pathway of our proposal is consistent with pathway C (Figure 5-4) but 
is described in more detail including possible functional assignments of each enzyme. 
Briefly, the C8 backbone was proposed to be constructed from a pentose 5-phosphate and 
a C3 unit derived either sedoheptulose 7-phosphate or fructose 6-phosphate using the 
transaldolase homologue, LmbR. The resulting octulose 8-phosphate may be isomerized 
by a sedoheptulose 7-phosphate isomerase homologue, LmbN, to produce octose 8-
phosphate. This must be further modified and activated by enzymes encoded by the genes 
similar to those involved in NDP-heptose biosynthetic pathways to yield NDP-octose. 
The subsequent modification steps for NDP-octose may be performed by enzymes 
homologous to well-studied NDP-hexose modification enzymes to generate the basic 
structure of MTL (5-2). Finally, C-1 sulfur incorporation is likely achieved via an S-
glycosyl transfer reaction analogous to the reaction observed in the glucosinolates 
biosyntheses (Chapter 1, Figure 1-12). 
To provide proof for the pathway proposed above, the LmbR-catalyzed 
transaldolase reaction is biochemically characterized since this is the key step to construct 
the unique C8 backbone and, thus, its validation could help establish the entire pathway. 
The characterization of the LmbR reaction along with with the following LmbN-
catalyzed isomerization reaction is presented. The products of enzymatic incubation were 
identified by comparing to the synthetic standards. In addition, enzymes involved in the 
later steps of MTL (5-2) biosynthesis were expressed, purified, and utilized for several 
model reactions to test their activities. 
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5.2  EXPERIMENTAL PROCEDURES  
5.2.1  General 
Materials 
All chemicals and reagents were purchased from Sigma-Aldrich Chemical Co. 
(St. Louis, MO) or Fisher Scientific (Pittsburgh, PA), and were used without further 
purification unless otherwise specified. Adenylate kinase (AK), pyruvate kinase (PK), 
lactate dehydrogenase (LDH), transketolase (TK), transaldolase (TA), glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) were purchased from Sigma-Aldrich Chemical Co. 
Calf intestinal alkaline phosphatase (CIP) was a product of New England Biolabs 
(Ipswich, MA). Materials used for molecular cloning were identical to those described in 
Chapter 2 except for the DNeasy Tissue Kit from Qiagen (Valencia, CA) used for 
genomic DNA extraction. Materials used for protein expression and purification were 
identical to those described in Chapter 3. The CarboPac PA1 high-performance liquid 
chromatography (HPLC) columns were obtained from Dionex (Sunnyvale, CA). 
Analytical C18 HPLC columns were purchased from Varian (Palo Alto, CA). 
Oligonucleotide primers were prepared by Invitrogen or Integrated DNA Technologies 
(Coralville, IA). 
Bacterial Strains and Plasmids 
Streptomyces lincolnensis NRRL ISP-5355 was obtained from the Agricultural 
Research Service (ARS) Culture Collection of the National Center for Agricultural 
Utilization Research (Peoria IL). Escherichia coli DH5, acquired from Bethesda 
Research Laboratories (Gaithersburg, MD), was used for routine cloning experiments. 
The protein overexpression host E. coli BL21 star (DE3) was obtained from Invitrogen. 
Vectors pET24b(+) and pET28b(+) for protein over-expression were purchased from 
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Novagen (Madison, WI). Chaperone protein expression plasmids, pG-KJE8, pGro7, and 
pKJE7 were products of Takara Bio (Shiga, Japan). Vector pWHM3 for protein 
expression in S. lividans was kindly provided by Dr. C. R. Hutchinson, and the ermE* 
promoter retrieved as a 279-bp KpnI–BamHI fragment was ligated into the same 
restriction sites of pWHM3 to generate pWHM3-ermEp.
202
 Standard genetic 
manipulations of E. coli and S. lividans were performed as described by Sambrook et 
al
107




UV–vis spectra were recorded using a Beckman DU 650 spectrophotometer. 
Evaporation of solution samples in 1.5 mL microcentfiguge-tubes was performed using a 
Savant Speedvac SC100 equipped with a Savant refrigerated condensation trap RT100 
and Gel Pump GP100. NMR spectra were acquired on a Varian Unity 500 MHz 
spectrometer, and chemical shifts (in ppm) are reported relative to that of the solvent 
peak (H = 7.24 for deuterated chloroform, H = 4.65 for deuterated water, H = 3.30 and 
C = 49.0 for deuterated methanol). HPLC was performed on a Beckman Coulter System 
Gold equipped with a UV detector or a Corona CAD (charged aerosol detector). DNA 
concentrations were measured using a NanoDrop ND-1000 UV−vis instrument from 
Thermo Fisher Scientific. DNA sequencing was performed by the core facility of the 
Institute of Cellular and Molecular Biology at the University of Texas, Austin. Vector 
NTI Advance 10.1.1 from Invitrogen was used for sequence alignments. Mass 
spectroscopy was performed at the Mass Spectrometry core facility in the Department of 
Chemistry and Biochemistry and in the College of Pharmacy at the University of Texas, 
Austin. 
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5.2.2  Protein Sequence Analyses and Functional Predictions. 
The protein sequences encoded in the lincomycin biosynthetic gene cluster from 
Streptomyces lincolnensis ATCC 25466 (accession number EU124663) were analyzed 
using the National Center for Biotechnology Information (NCBI) database by the basic 
local alignment search tool (BLAST). 
5.2.3  S. Lincolnensis Genomic DNA Extraction. 
Bacterial cells of S. lincolnensis NRRL ISP-5355 (identical to the ATCC 25466 
strain) in a dormant state were inoculated into 7 mL of International Streptomyces Project 
(ISP) medium 2 and grown in a rotary incubator at 30 °C and 250 rpm for 16 h. The 
resultant seed culture (1 mL) was transferred to 50 mL of ISP-2 medium and grown 
under the same conditions for 2 days. The mycelia were harvested by centrifugation at 
5000  g for 10 min. The cells were resuspended in 10 mL of TES buffer (25 mM Tris, 
25 mM EDTA, and 10.3% sucrose, pH8) and treated with lysozyme (15 mg) at 37 ºC and 
250 rpm for 1 h. To the resulting mixture was added SDS (final 0.3%) and proteinase K 
(1.5 mg) and the combined solution was incubated under the same conditions for an 
additional 1 h. The released genomic DNA and RNA mixture was isolated by phenol-
chloroform extraction followed by sodium acetate-isopropyl alcohol precipitation. The 
resulting solution was treated with ribonuclease (RNase), and the genomic DNA was 
isolated by another round of phenol-chloroform extraction and sodium acetate-isopropyl 
alcohol precipitation. The final concentration of the genomic DNA obtained was 160 
ng/L in 200 L of 10 mM Tris·HCl buffer (pH 8.5). 
5.2.4  Cloning of the Methylthiolincosamide Biosynthetic Genes. 
The lmbF, lmbG, lmbK, lmbL, lmbM, lmbN, lmbZ, lmbP, lmbO, lmbS, lmbR, 
lmbT, and lmbV genes was PCR-amplified from S. lincolnensis genomic DNA using 
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primers with engineered NdeI and HindIII restriction sites. The sequences of the primers 
are shown in Table 5-1. The PCR-amplified gene fragments were purified, digested with 
NdeI and HindIII, and ligated into both pET24b(+) and pET28b (+) vectors, which had 
also been digested with the same restriction enzymes. The resulting plasmids were 
sequenced using the T7 or T7 terminal universal primer and used to transform the E. coli 
BL21 star (DE3) strain for protein overexpression. 
The plasmids, lmbP/pET28b(+), lmbO/pET28b(+), lmbS/pET28b(+), 
lmbT/pET28b(+), and lmbV/pET28b(+), were digested with XbaI and HindIII restriction 
sites and ligated into pWHM3-ermEp vector that was also digested with the same 
enzymes. The resulting plasmids were used to transform S. lividans using a protoplast 











 The engineered restriction sites are shown in bold, the start codon is shown in bold and also underlined, 
and the stop codon is italic. 
 
Primer name Sequence
lmbF for pET24/28b(+)-forward 5'-TACTAACCATATGACCGCCACGGCGAGC-3'
lmbF for pET24b(+)-reverse 5'-AGATAAGCTTCCGGTACCGCCACTCGG-3'
lmbF for pET28b(+)-reverse 5'-ATATAAGCTTCACCGGTACCGCCACTCG-3'
lmbG for pET24/28b(+)-forward 5'-TACTAACCATATGCGGGACTACCGTCTCTGGC-3'
lmbG for pET24b(+)-reverse 5'-GGATAAGCTTTCGGGTCGCCCCCGCCG-3'
lmbG for pET28b(+)-reverse 5'-ATATAAGCTTGGATCAGCCAGCCGTCGTCG-3'
lmbK for pET24/28b(+)-forward 5'-ATGTGAACATATGGGACGCGAGGGACAGTCG-3'
lmbK for pET24b(+)-reverse 5'-AGATAAGCTTGCGGCCGCCGTGCCCG-3'
lmbK for pET28b(+)-reverse 5'-AGATAAGCTTGGTGACCGGTGCGCATGC-3'
lmbL for pET24/28b(+)-forward 5'-AGTTAAGCATATGACCGACGCGACGCACC-3'
lmbL for pET24b(+)-reverse 5'-ATATAAGCTTCGGGGCGGCATGCG-3'
lmbL for pET28b(+)-reverse 5'-GTACAAGCTTCACGGGGCGGCATGC-3'
lmbM for pET24/28b(+)-forward 5'-AGTTAAGCATATGAGCGGGCGGTACTGC-3'
lmbM for pET24b(+)-reverse 5'-ATATAAGCTTCGGCCGCTGCCACC-3'
lmbM for pET28b(+)-reverse 5'-GTACAAGCTTCACGGCCGCTGCC-3'
lmbN for pET24/28b(+)-forward 5'-ATCACAACATATGAGCACTCTGGACGAGGTCC-3'
lmbN for pET24b(+)-reverse 5'-ACATAAGCTTTGCCGGCTCCCCCGC-3'
lmbN for pET28b(+)-reverse 5„-AGATAAGCTTTCATGCCGGCTCCCCC-3'
lmbZ for pET24/28b(+)-forward 5'-ATCACAACATATGACCCACAGGTGCGGC-3'
lmbZ for pET24b(+)-reverse 5'-TGATAAGCTTCGGTTTCTCCCAGGTGAGG-3'
lmbZ for pET28b(+)-reverse 5'-ACATAAGCTTCACGGTTTCTCCCAGGTGAGG-3'
lmbP for pET24/28b(+)-forward 5'-ATCACTACATATGATCGACGTCACGGCGCC-3'
lmbP for pET24b(+)-reverse 5'-TCATAAGCTTTGCCCGCCCCTCTCCG-3'
lmbP for pET28b(+)-reverse 5'-TCATAAGCTTTCATGCCCGCCCCTCTCC-3'
lmbO for pET24/28b(+)-forward 5'-ATCACTACATATGGTCGCGTCGACCGAACC-3'
lmbO for pET24b(+)-reverse 5'-ATCTAAGCTTTTTCTCACCTGTCCGCAGATAGC-3'
lmbO for pET28b(+)-reverse 5'-TCATAAGCTTCGATCATTTCTCACCTGTCCGC-3'
lmbS for pET24/28b(+)-forward 5'-GGCTAAGCATATGAGCGACTACATCCCCTTCG-3'
lmbS for pET24b(+)-reverse 5'-ATAAAAGCTTCCGTCCCGCCTCGTCG-3'
lmbS for pET28b(+)-reverse 5'-ATAAAAGCTTCACCGTCCCGCCTCG-3'
lmbR for pET24/28b(+)-forward 5'-AACCGCCCATATGAAGATCTTTCTGGATACGCC-3'
lmbR for pET24b(+)-reverse 5'-AACTAAGCTTCTCGTACTTCACCCCCGC-3'
lmbR for pET28b(+)-reverse 5'-ATTCAAGCTTCACTCGTACTTCACCCCCG-3'
lmbT for pET24/28b(+)-forward 5'-AGTTAAGCATATGACGGCGCGGACGG-3'
lmbT for pET24b(+)-reverse 5'-GGATAAGCTTTGACACCTCCGCCAGC-3'
lmbT for pET28b(+)-reverse 5'-GTCGAAGCTTCATGACACCTCCGCCAGC-3'
lmbV for pET24/28b(+)-forward 5'-AGTTAAGCATATGCAGCGCAAGGGACTGG-3'
lmbV for pET24b(+)-reverse 5'-ATATAAGCTTCGGCCCCACCAGCACC-3'
lmbV for pET28b(+)-reverse 5'-GTAAAAGCTTCACGGCCCCACCAGC-3'
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5.2.5  Expression and Purification of the Methylthiolincosamide Biosynthetic 
Proteins. 
Protein Overexpression in E. Coli 
A typical procedure for the overexpression and protein purification of the N-His6-
tagged or C-His6-tagged MTL (5-2) biosynthetic proteins are shown below. An overnight 
culture of an E. coli BL21 star (DE3) transformant, grown in the LB medium (10 mL) 
containing 50 g/mL of kanamycin at 37 °C, was used to inoculate 1 L of the same 
growth medium. The culture was incubated at 37 °C with shaking (230 rpm) until the 
OD600 reached ~0.5. Protein expression was then induced by the addition of isopropyl β-
D-1-thiogalactopyranoside (IPTG) to a final concentration of 0.1 mM, and the cells were 
allowed to grow at 18 °C and 125 rpm for an additional 24 h. The cells were harvested by 
centrifugation at 4500  g for 15 min and stored at –80 °C until lysis. All purification 
steps were carried out at 4 °C using Ni-NTA resin according to the manufacturer‟s 
protocol with minor modifications. Specifically, the thawed cells (~5 g) were 
resuspended in the lysis buffer (20 mL) containing 10% (v/v) glycerol and 10 mM 
imidazole. After incubation with lysozyme (20 mg) for 30 min, the cells were disrupted 
by sonication using 10 × 10-s pulses with a 30-s cooling pause between each pulse. The 
resulting lysate was centrifuged at 20,000  g for 20 min, and the supernatant was 
subjected to Ni-NTA chromatography. Bound protein was eluted using 250 mM 
imidazole buffer containing 10% glycerol. The collected protein solution was dialyzed 
against 3 × 1-L of 50 mM Tris·HCl buffer (pH 8) containing 300 mM NaCl and 15% 
glycerol. The protein solution was then flash-frozen in liquid nitrogen and stored at 
−80 °C until use. Protein concentration was determined by the Bradford assay using 
bovine serum albumin as the standard.
149
 The proteins purified according to this method 
and their yields from 1 L cultures are N-His6-LmbF (~10 mg), N-His6-LmbG (~20 mg), 
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N-His6-LmbK (~10 mg), C-His6-LmbL (~15 mg), C-His6-LmbM (~15 mg), and C-His6-
LmbN (~40 mg). The molecular mass and purity of the proteins were determined by 
SDS-PAGE analysis. 
Protein Coexpression with Chaperone Proteins in E. Coli 
Since protein overexpression of LmbZ, LmbP, LmbO, LmbS, LmbR, LmbT, and 
LmbV led to the formation of inclusion bodies, they were not further purified. Instead, 
coexpression with the chaperone proteins was tried for these proteins. Plasmids pG-KJE8 
(encoding chaperones, DnaK, DnaJ, GrpE, GroES and GroEL), pGro7 (encoding 
chaperones, GroES and GroEL), or pKJE7 (encoding chaperones, DnaK, DnaJ, and 
GrpE) were used to cotransform E. coli BL21 star (DE3) strain with the target protein 
overexpression plasmids. The overexpression of chaperone proteins was induced by L-
arabinose and tetracycline according to the manufacture‟s instructions. C-His6-LmbR was 
obtained in soluble form by this method and was purified using Ni-NTA resin as 
described above. However, the other proteins remained practically insoluble under the 
conditions. The yield of C-His6-LmbR was ~40 mg from 1 L culture. The molecular mass 
and purity of the protein were determined by SDS-PAGE analysis. 
Protein Overexpression in S. Lividans 
LmbP, LmbO, LmbS, LmbT, and LmbV proteins were also heterologously 
expressed with an N-terminal His6 tag in S lividans using a plasmid constructed from 
pWHM3-ermEp as described above. The S. lividans transformants selected by 
thiostrepton on the R1R2 agar plates were used to inoculate YEME medium (10 mL) 
containing 10 g/mL of thiostrepton, and the culture was incubated at 30 °C and 230 rpm 
for 3 days. The resulting seed culture was transferred to 1 L of YEME medium 
containing 5 g/mL of thiostrepton, and incubated under the same conditions for 3 days. 
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The cells were harvested by centrifugation at 6000  g for 20 min and stored at –80 °C 
until lysis. All purification steps were similarly carried out at 4 °C using Ni-NTA resin as 
described for the protein purification from E. coli. While N-His6-LmbS and N-His6-LmbT 
were obtained in good purity, the other proteins were either not expressed well or were 
difficult to purify. The yields of N-His6-LmbS and N-His6-LmbT were ~10 mg and ~6 mg 
from 1 L cultures, respectively. The molecular mass and purity of the protein were 
determined by SDS-PAGE analysis. 
5.2.6  ESI-MS Analysis of LmbR. 
The purified C-His6-LmbR protein stock solution was added to 50 mM Tris·HCl 
buffer (pH 8.0) (final concentration of protein was 40 μM) and incubated with D-fructose 
6-phosphate (5-22) at 30 °C for 15 min. The resulting solution (200 μL) was cooled on 
ice. To this solution was added 20 μL of cold NaBH4 solution in methanol (530 mM; 
final concentration of NaBH4 was 50 mM). The mixture was incubated on ice for 1 h. 
The excess salts and glycerol were removed at 4 °C using an Amicon ultrafiltration unit 
through a YM-10 membrane. The resulting protein solution was subjected to ESI-MS 
analysis. As a control, the purified C-His6-LmbR protein (40 M) in 50 mM Tris·HCl 
buffer (pH 8.0) in the absence of 5-22 was subjected to ESI-MS analysis without NaBH4 
treatment. 
5.2.7  Synthesis of D-Xylose 5-Phospahte. 
As shown in Figure 5-5, D-xylose 5-phospahte (5-29) was synthesized following 
previously reported procedures. The 
1
H NMR spectral data of 5-29 and all the synthetic 





5.2.8  LmbR and LmbN Reaction Assays. 
LmbR Reaction Using D-Ribiose 5-Phospahte and D-Fructose 6-Phosphate 
The purified C-His6-LmbR protein (40 μM final concentration) was incubated 
with D-ribose 5-phosphate (5-18, 10 mM), D-fructose 6-phosphate (5-22, 10 mM), and 
MgCl2 (1 mM) in 50 mM glycylglycine buffer (pH 8.0) at 30 °C for 6 h. A series of 
control reactions omitting the enzyme, 5-18, or 5-22 was similarly prepared. The reaction 
mixture (50 L each) was filtered through a YM-10 membrane using an Amicon 
ultrafiltration unit to remove the protein. HPLC analysis was performed using a Dionex 
CarboPac PA1 analytical column (4 × 250 mm). The sample (6 L each) was eluted with 
100 mM NH4OAc at 1 mL/min and monitored by a Corona CAD. The HPLC fraction 
containing the product peak (retention time ~10 min) was collected (6 L  5 injections). 
The collected fraction was lyophilized and redissolved in deionized water (250 L) prior 
to ESI-MS analysis (negative ion detection mode). 
 













































































LmbN Reaction Using D-Ribiose 5-Phospahte and D-Fructose 6-Phosphate 
The LmbR reaction prepared as described above was filtered through a YM-10 
membrane using an Amicon ultrafiltration unit to remove the protein. To the resulting 
mixture was added purified C-His6-LmbN (50 M final concentration), and this reaction 
was incubated at 30 °C for 3 h. The reaction mixture was filtered through a YM-10 
membrane to remove the protein prior to HPLC analysis. The HPLC conditions were the 
same as described for the LmbR reaction. The LmbN product peak (retention time ~8 
min) was similarly collected and subjected to ESI-MS analysis (negative ion detection 
mode). 
LmbR and LmbN Reaction Using D-Xylose 5-Phospahte and D-Fructose 6-Phosphate 
The purified C-His6-LmbR protein (40 μM final concentration) was incubated 
with D-xylose 5-phosphate (5-29, 10 mM), D-fructose 6-phosphate (5-22, 10 mM), and 
MgCl2 (2 mM) in 50 mM glycylglycine buffer (pH 8.0) at 30 °C for 9 h. Similarly, both 
C-His6-LmbR (40 μM) and C-His6-LmbN (50 μM) were incubated together with D-
xylose 5-phosphate (5-29, 10 mM), D-fructose 6-phosphate (5-22, 10 mM) and MgCl2 
under the same conditions. As a control, 5-29 was also replaced by D-ribose 5-phosphate 
(5-18, 10 mM). Each reaction mixture was filtered through a YM-10 membrane using an 
Amicon ultrafiltration unit to remove the protein. The samples were subjected to HPLC 
analyses under the same conditions as described above. The LmbR product peak 
(retention time ~7.5 min) was collected and subjected to ESI-MS analysis (negative ion 
detection mode). 
LmbR Reaction Using Other Substrates 
Dihydroxyacetone (5-35), D-fructose (5-36), and D-sedoheptulose 7-phosphate (5-
20) were investigated as alternative C3 sugar donors for the LmbR reaction. The former 
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two compounds (10 mM or 50 mM each) simply replaced D-fructose 6-phosphate (5-22, 
10 mM) in the standard LmbR reaction described above. In the latter case, D-
sedoheptulose 7-phosphate (5-20) was prepared from D-fructose 6-phosphate (5-22, 10 
mM) and -hydroxypyruvate (5-37, 10 mM) using transketolase from E. coli (0.04 units) 
in 50 mM glycylglycine buffer (pH 8.0) containing MgCl2 (1 mM) and thiamine 
pyrophosphate (0.5 mM). The reaction mixture (50 L) was incubated at 30 ºC for 8 h 
and filtered through a YM-10 membrane using an Amicon ultrafiltration unit to remove 
the protein. To this solution containing the transketolase product, D-sedoheptulose 7-
phosphate (5-20, final 2.5 mM), was added C-His6-LmbR (40 M) and D-ribose 5-
phosphate (5-18, 6.6 mM), and this reaction was incubated at 30 ºC for 3 h. HPLC 
analyses were similarly performed as described for the standard LmbR reaction. 
LmbN Reaction Using D-Sedoheptulose 7-Phosphate 
The LmbN reaction was also investigated using D-sedoheptulose 7-phosphate (5-
20) as a potential substrate. Compound 5-20 was produced in situ from D-fructose 6-
phosphate (5-22, 10 mM) and -hydroxypyruvate (5-37, 20 mM) using transketolase 
from E. coli (0.04 units) and thiamine pyrophosphate (0.5 mM) in 100 mM glycylglycine 
buffer (pH 8.0) containing MgCl2 (1 mM) and LmbN (50 M). The reaction mixture (50 
L) was incubated at 30 ºC for 2 h. and filtered through a YM-10 membrane to remove 
the proteins prior to HPLC analysis. The HPLC conditions were the same as described 
above. 
5.2.9  Acetyl derivatization of the LmbR and LmbN Products. 
The purified enzymes C-His6-LmbR and C-His6-LmbN were dialyzed against 100 
mM NH4·HCO3 buffer (pH 8.0) containing 10 mM MgCl2 at 4 ºC to remove glycerol and 
salts present in the enzyme stock solution. To this enzyme solution were added D-ribose 
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5-phosphate (5-18, 10 mM) and D-fructose 6-phosphate (5-22, 50 mM). The final 
concentration of C-His6-LmbR and C-His6-LmbN were 40 M and 50 M, respectively. 
As a control, the reaction containing only C-His6-LmbR and the sugar substrates was 
similarly prepared. Each reaction mixture (400 L) was incubated at 30 °C for 4.5 h and 
an additional 3.5 h at 37 °C. To the mixture was then added calf intestinal alkaline 
phosphatase (CIP) (4 L, 40 units), and the reaction was incubated at 37 °C for 12 h. To 
the resulting solution was added MeOH (400 L) and CH3CN (800 L), and then it was 
mixed well. The resultant precipitates were removed by centrifugation at 16,000  g for 5 
min. The solution (400 L) was evaporated in vacuo using a Speedvac SC100 (Savant). 
The resultant residue was completely dried and then treated with anhydrous pyridine (20 
L) and acetic anhydride (20 L). This mixture was incubated at room temperature for 
12 h, and quenched by the addition of deionized water (150 L). As a control, D-fructose 
(5-36, 1 mg, ~5 mol) was similarly treated with pyridine and acetic anhydride. The 
acetylated products were extracted with ethyl acetate (150 L) and subjected to HPLC 
analysis using an analytical C18 column (4 × 250 mm). The sample (5 L) was eluted 
with a gradient of water (solvent A) and 80% acetonitrile (solvent B). The gradient was 
run from 40 to 60% B over 15 min, 60−100% B over 5 min with a 3 min wash at 100% 
B, 100−40% B over 2 min, followed by re-equilibration at 40% B for 5 min. The flow 
rate was 1 mL/min, and a corona CAD was used for the detection. Authentic standards of 
heptaacetyl octose derivatives were synthesized by another graduate student, Chia-I Lin, 
and the procedure will be published elsewhere. The peaks corresponding to the enzymatic 
reaction products were isolated and subjected to ESI-MS analyses.  
 218 
5.2.10  Spectrophotometric Analysis of the LmbR Reaction. 
LmbR or an authentic transaldolase (TA) from yeast was used for the assay. The 
reaction solution (100 L) contained a sugar acceptor (D-ribose 5-phosphate (5-18) or D-
erythrose 4-phosphate (5-23), 150 M), D-fructose 6-phosphate (5-20, 150 M), 
nicotinamide adenine dinucleotide (oxidized form, NAD
+
, 500 M), and glyceraldehyde 
3-phosphate dehydrogenase (GAPDH, 1 unit) in 50 mM sodium phosphate buffer (pH 
7.8) comtaining 10 mM MgCl2. The reaction was initiated by the addition of LmbR (1 
L, 5 M final) or TA (1 L, 0.05 units) into the reaction mixture. Absorbance at 340 nm 
was monitored by a UV-vis spectrophotometer for 5 min.  
5.2.11  LmbM Reaction Assay. 
LmbM reaction 
The typical LmbM reaction mixture (100 L) contained purified C-His6-LmbM 
(final 20 M), UDP-glucuronic acid (5-38, 5 mM), and nicotinamide adenine 
dinucleotide (oxidized form, NAD
+
, 12 mM) in 100 mM Tris·HCl (pH 7.5). The mixture 
was incubated at room temperature for 1h. A half of the mixture (50 L) was filtered 
through a YM-10 membrane using an Amicon ultrafiltration unit to remove the protein. 
The remaining half was incubated at room temperature for additional 11 h and then 
filtered through a YM-10 membrane. HPLC analysis was performed using a Dionex 
CarboPac PA1 analytical column (4 × 250 mm). The samples (5 L each) were eluted 
with a gradient of water (solvent A) and 1 M NH4OAc (solvent B). The gradient was run 
from 0 to 100% B over 15 min and 100−0% B over 5 min, followed by re-equilibration at 
0% B for 5 min. The flow rate was 1 mL/min, and the detector was set at 260 nm. 
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Isolation of the LmbM Product 
A large scale reaction (3 mL) was prepared as described above. HPLC analysis 
was performed using a Dionex CarboPac PA1 semiprep column (9 × 250 mm). The 
sample (300 L  8 injections) was eluted with a gradient of water (solvent A) and 1 M 
NH4·HCO3 (solvent B). The gradient program was as follows: 20% B for 10 min, 
20−100% B over 10 min, and 100−20% B over 5 min, followed by re-equilibration at 
20% B for 5 min. The flow rate was 5 mL/min, and the detector was set at 260 nm. The 
HPLC fraction containing the product peak (retention time ~8 min) was collected. The 
collected fraction was lyophilized, redissolved in D2O (650 L), and subjected to 
1
H-
NMR and ESI-MS (negative mode) analyses. 
Hydroxylamine Derivatization 
The LmbR reaction prepared above (12 h incubation) was filtered through a YM-
10 membrane to remove the protein and treated with hydroxylamine (300 mM final 
concentration). The resulting mixture was incubated at room temperature for 1 h and 
subjected to HPLC anlaysis. The HPLC conditions were the same as described above. 
   
5.3  RESULTS AND DISCUSSION 
5.3.1  Proposal of the Biosynthetic Pathway. 
Lincomycin Biosynthetic Gene Cluster and BLAST Analyses 
The biosynthetic gene cluster of lincomycin A (5-1) was first identified from the 
genomic DNA of the industrial overproduction strain S. lincolnensis 78-11 in 1995.
46
 The 
gene cluster was also found in another S. lincolnensis strain ATCC 25466, reported in 
2008 (Figure 5-6A).
208
 Overall, the organization of the two reported gene clusters is very 
similar although several hundred point mutations were found. Integration of the cosmid 
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bearing the latter gene cluster into the chromosomes of S. coelicolor CH 999 and S. 
coelicolor M 145 led to the heterologous production of lincomycin A (5-1) in these non-
producing strains, suggesting that the genes in the cloned cluster should be sufficient to 
enable lincomycin A production. Moreover, hybridization analysis of the biosynthetic 
gene cluster of the structurally similar celesticetin (5-39) from S. caelestis strain ATCC 
1584 was successfully performed using probes designed according to the lincomycin 
biosynthetic gene sequences.
47
 Recently, the complete sequence of the celesticetin gene 
cluster became available in the NCBI database (Figure 5-6B). Since 1-thiolincosamide is 
a common structural component shared by lincomycin A (5-1) and celeticetin (5-39), the 
genes responsible for the construction of this moiety likely exist in both biosynthetic gene 
clusters (shared genes are shown in blue in Figure 5-6, sequence identities and 





Figure 5-6. Organization of the lincomycin and celesticetin biosynthetic gene clusters. 
(A) The lincomycin biosynthetic gene cluster from S. lincolnensis ATCC 25466 
(EU124663, 38217 bp). (B) The celesticetin biosynthetic gene cluster from S. caelestis 
strain ATCC 1584 (GQ844764, 36543 bp). Homologous genes found in both clusters 
are shown in blue. (C) Structures of lincomycin A and celesticetin. The 1-
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Next, we repeated BLAST analyses of the genes found in the lincomycin A 
biosynthetic gene cluster using the updated database. Table 5-2 shows similar genes 
found from the NCBI database excluding strains of S. lincolensis and S. caelestis to 
predict the functions of the deduced gene products. The proposed biosynthetic pathways 
of the N-methyl-4-propyl-L-proline moiety and the MTL moiety are shown in Table 5-3, 
and Figure 5-7, respectively. 
Table 5-2. Seqeuce similarity analysis of putative 1-thiolincosamide biosynthetic 




 Putative lincomycin A biosynthetic proteins found in S. lincolensis ATCC 25466 strain. 
b
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identity / similarity (%)
LmbC ABX00600 CcbC ADB92568 57 / 67
LmbD ABX00601 CcbD ADB92567 56 / 65
LmbE ABX00602 CcbE ADB92566 60 / 71
LmbF ABX00603 CcbF ADB92565 40 / 55
LmbIH ABX00605 CcbIH ADB92568 63 / 72
LmbJ ABX00606 CcbJ ADB92568 60 / 71
LmbK ABX00607 CcbK ADB92557 64 / 72
LmbL ABX00608 CcbL ADB92558 63 / 75
LmbM ABX00609 CcbM ADB92560 74 / 83
LmbN ABX00610 CcbN ADB92561 72 / 80
LmbZ ABX00611 CcbZ ADB92562 64 / 75
LmbP ABX00612 CcbP ADB92563 59 / 70
LmbO ABX00613 CcbO ADB92564 65 / 75
LmbS ABX00614 CcbS ADB92571 74 / 81
LmbR ABX00615 CcbR ADB92572 69 / 80
LmbQ ABX00616 CcbQ ADB92573 44 / 54
LmbT ABX00617 CcbT ADB92574 65 / 76
LmbV ABX00618 CcbV ADB92575 57 / 69
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The homologous proteins were searched in organisms excluding strains of S. lincolensis and S. 
caelestis. 
b.
 The gene products shared with the lincomycin A and the celesticetin biosynthetic gene 
clusters are shown in blue. The gene products shared with lincomycin A, anthramycin, and sibiromycin 












LmrA ABX00596 major facilitator superfamily permease [Streptomyces cf. griseus XylebKG-1] 54 / 67 ZP_08226252
LmbA ABX00597 gamma-glutamyltranspeptidase [Streptomyces griseoflavus Tu4000] 65 / 75 ZP_07314001
LmbB1 ABX00598 putative L-DOPA-2,3-dioxygenase [Streptomyces achromogenes] 59 / 66 ACN39021
LmbB2 ABX00599 putative tyrosine hydroxylase [Streptomyces achromogenes] 42 / 53 ACN39022
LmbC ABX00600 amino acid adenyltransferase [Streptomyces clavuligerus ATCC 27064] 41 / 50 ZP_05004791
LmbD ABX00601 No significant similarity found
LmbE ABX00602 mycothiol conjugate amidase Mca [Saccharomonospora viridis DSM 43017] 39 / 53 YP_003134979
LmbF ABX00603 class I and II aminotransferase [Stackebrandtia nassauensis DSM 44728] 28 / 43 YP_003511287
LmbG ABX00604 methyltransferase [Chlorobium ferrooxidans DSM 13031] 34 / 47 ZP_01385426
LmbIH ABX00605 peptidase U62 modulator of DNA gyrase [Dictyoglomus turgidum DSM 6724] 37 / 53 YP_002352129
LmbJ ABX00606 Methyltransferase [Micromonospora aurantiaca ATCC 27029] 41 / 56 YP_003836969
LmbK ABX00607
D-alpha,beta-D-heptose 1,7-bisphosphate phosphatase [Candidatus Solibacter
usitatus Ellin6076]
52 / 62 YP_821716
LmbL ABX00608 UDP-glucose 6-dehydrogenase [Lawsonia intracellularis PHE/MN1-00] 35 / 50 YP_595630
LmbM ABX00609 NAD-dependent epimerase/dehydratase [Aciduliprofundum boonei T469] 42 / 62 YP_003482522
LmbN ABX00610 sedoheptulose 7-phosphate isomerase [Sorangium cellulosum 'So ce 56'] 42 / 57 YP_001614387
LmbZ ABX00611 oxidoreductase domain protein [Chthoniobacter flavus Ellin428] 35 / 51 ZP_03129380
LmbP ABX00612 GHMP kinase [Candidatus Solibacter usitatus Ellin6076] 36 / 51 YP_821713
LmbO ABX00613 putative nucleotidyl transferase [Leptospirillum rubarum] 35 / 50 EAY57000
LmbS ABX00614 glutamine–scyllo-inositol transaminase [Caldicellulosiruptor kristjanssonii 177R1B] 42 / 61 YP_004027350
LmbR ABX00615 Transaldolase [Cellulomonas flavigena DSM 20109] 45 / 62 YP_003638673
LmbQ ABX00616 peptidase U62 modulator of DNA gyrase [Thermotoga lettingae TMO] 29 / 44 YP_001471158
LmbT ABX00617 glycosyltransferase [Yersinia aldovae ATCC 35236] 24 / 44 ZP_04619711
LmbV ABX00618 hypothetical protein Tbis_3508 [Thermobispora bispora DSM 43833] 44 / 53 YP_003654089
LmbW ABX00619 methyltransferase [Streptomyces refuineus subsp. thermotolerans] 78 / 86 ABW71836
LmrB ABX00620 rRNA methyltransferase PikR2 [Streptomyces venezuelae] 61 / 74 AAC69327
LmbX ABX00621
phenazine biosynthesis protein PhzF family [Micromonospora aurantiaca ATCC 
27029]
46 / 58 YP_003833811
LmbY ABX00622 putative F-420 dependent reductase [Streptomyces achromogenes] 55 / 68 ACN39023
LmbU ABX00623 hypothetical protein FRAAL4627 [Frankia alni ACN14a] 56 / 71 YP_714812
LmrC ABX00624
putative ABC transporter ATP-binding protein [Streptomyces ambofaciens ATCC 
23877]
63 / 77 CAJ88384
Sli2 ABX00625
pentapeptide repeat-containing protein  [Streptomyces viridochromogenes DSM 
40736]
31 / 45 ZP_07308783
Sli3 ABX00626 hypothetical protein SGR_277 [Streptomyces griseus subsp. Griseus NBRC 13350] 80 / 87 YP_001821789
Sli4 ABX00627 amino acid permease [Streptomyces roseosporus NRRL 15998] 83 / 90 ZP_06586134
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Biosynthetic Pathway of the 4-Propyl-L-Proline Moiety 
Previous feeding studies using 
14
C-labeled tyrosine reveled that besides the N-
methyl and terminal aliphatic side chain, the carbon skeleton of this moiety is derived 
from tyrosine.
209
 The first two steps of the pathway catalyzed by LmbB2 (L-tyrosine 3-
hydroxylase) and LmbB1 (L-DOPA 2,3-dioxygenase) were biochemically verified 
(Figure 5-2; 5-4  5-5  5-6).
195,196
 Although in vitro characterization of the 
corresponding steps in the lincomycin A (5-1) pathway remains to be investigated, a 
similar route has been proposed as key reactions in the biosyntheses of the 
pyrrolo[1,4]benzodiazepine antibiotics anthramycin (5-50), sibiromycin (5-51) and 
tomaymycin (5-52).
210,211
 Notably, the biosynthetic gene clusters of 5-50–5-52 were 
recently sequenced.
212-214
  Sequence comparison of these gene clusters led to the 
 
Figure 5-7. Proposed biosynthetic pathway of methylthiolincosamide (MTL). 













































































































































functional assignments of LmbX (C–C hydrolase), LmbW (methyltransferase), LmbA (-
glutamyltransferase, likely involved in the synthesis of F-420), and LmbY (F-420-




Construction of the C8 Backbone 
As mentioned above, a transaldolase homologue, LmbR, was proposed to 
construct the C8 backbone of MTL (5-2) from a C5 and a C3 units according to the early 
feeding experiments.
198
 A candidate for the C5 unit is D-ribose 5-phosphate (5-18) from 
 
Figure 5-8. Shared pathways to produce 4-propyl-L-proline derivatives in the 
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the pentose phosphate pathway. The C3 unit donor may be D-sedoheptulose 7-phosphate 
(5-20) or D-fructose 6-phosphate (5-22) as observed in the physiological transaldolase 
reaction in the pentose phosphate pathway (Figure 5-3). The expected octulose 8-
phosphate product (5-40a) likely inherits the stereochemistry at the C-3 and C-4 positions 
from the corresponding positions of the C3 unit donor, a well-trait of the aldolase-type 
reactions.
215
 Although aldolase-catalyzed reactions giving inversed stereochemistry in the 
products are also known, they are very rare.
216
 The expected product possessing the 
retained stereochemistry would be converted to a pyranosidic octose intermediate in the 
later step having an equatorial hydroxyl groups at both C-3 with the (S)-configuration and 
C-4 with the (R)-configuration, such as seen in 5-42 (Figure 5-9). Although the final 
MTL (5-2) structure has an axial hydroxyl group with the (S)-configuration at C-4, a C-4 
epimerization reaction catalyzed by LmbM could account for this mismatch (5-44  5-
45). On the other hand, the C-6 hydroxyl group of 5-42 is expected to be replaced by an 
amino group via the transamination reaction by LmbT via the corresponding ketone (5-
46). Since the stereochemical information at the C-6 position would be lost during this 
process, D-xylose 5-phosphate (5-29), which is a C-3 epimer of 5-18, is another possible 
C5 unit for the LmbR reaction yielding 5-40b (C-6 epimer of 5-40a; Figure 5-9). 
Although D-xylose 5-phosphate (5-29) is not a common chemical entity produced in 
primary metabolism, it may be derived from D-xylulose 5-phosphate (5-19) in the 




Formation of NDP-Octose 
NDP-octose has never been identified as a precursor/intermediate in a natural 
product biosynthetic pathway. In contrast, NDP-heptose has been established as an 
 
Figure 5-9. Proposed LmbR-catalyzed reaction and its stereochemical consideration. 
Pathway A: using D-robiose 5-phosphate as the starting C5 unit. Pathway B: using D-


















































































































intermediate in the biosynthesis of the inner core of lipopolysaccharide (LPS), which is a 
major component of the outer membrane of Gram-negative bacteria.
217
 Two pathways 
from D-sedoheptulose 7-phosphate (5-20) to either GDP-D-glycero--D-mannno-heptose 
(5-58) or ADP-D-glycero--L-mannno-heptose (5-61) have been characterized for the 
biosyntheses of NDP-heptoses (Figure 5-10).
218,219
 Sequence analyses using the 
lincomycin A biosynthetic gene cluster from S. lincolnensis ATCC 25466 (accession 
number EU124663), S-layer (cell surface layer) glycan glycosylation gene cluster from 
Aneurinibacillus thermoaerophilus strain DSM 10155/G+ (accession number 
AF324836), and the corresponding genes from E. coli str. K-12 substr. MG1655 
(accession number NC_000913) led to the proposed NDP-activation pathway starting 




As shown in Figure 5-7, LmbN was proposed to catalyze the C-1–C-2 
isomerization of 5-40 to produce the corresponding octose 8-phosphate (5-41) in a 
reaction analogous to the GmhA-catalyzed isomerization (5-20  5-55). Sequence 
identities and similarities of LmbN to GmhA from A. thermoaerophilus and E. coli are 
26% / 43% and 31% / 47%, respectively (Table 5-4). GmhA is known to produce the 
product 5-55 with a (S)-configuration at C-2.
218,220,221
 In contrast, based on the 
stereochemistry at C-2 in MTL (5-2), the LmbN-catalyzed reaction is proposed to 
produce a product with an (R)-configuration at the C-2 position (5-41; Figure 5-7). 
 
Figure 5-10. NDP-heptose biosynthetic pathways 
(A) GDP-D-glycero--D-mannno-heptose biosynthetic pathway from Aneurinibacillus 
thermoaerophilus. (B) ADP-D-glycero--L-mannno-heptose biosynthetic pathway from 
E. coli. 
a 
A bifunctional enzyme, HldE, from E. coli is replaced by HldA and HldC in 







































































































The following steps in the NDP-heptose biosynthetic pathway are 
phosphorylation, dephosphorylation, and nucleotidyl transfer reactions (Figure 5-10). The 
NDP-octose biosynthetic pathway may follow the same reaction sequence using LmbP, 
LmbK and LmbO, which are the putative kinase, phosphatase, and nucleotidyl 
transferase, respectively (Table 5-3). While LmbK displays moderate sequence 
similarities to GmhB in the NDP-heptose biosynthetic pathways, LmbP and LmbO 
showed similarities to the corresponding proteins only in the GDP-D-glycero--D-
mannno-heptose (5-58) biosynthetic pathway (Table 5-4). Thus, phosphorylation and 
nucleotidyl transfer reactions in the MTL (5-2) biosynthetic pathway resemble those of 
the 5-58 biosynthetic pathway (Figure 5-7), and the product is predicted to be GDP--
octose (5-44), not the ADP--derivative. However, formation of other 
phosphodinucleotide derivatives cannot be ruled out.  
 
 
Table 5-4. Sequence similarity analysis of lincomycin A biosynthetic proteins and the 
corresponding proteins in NDP-heptose biosynthetic pathways.
 
 
* HldE from E. coli is a bifunctional enzyme. 

























NDP-Octose Modification Pathway 
The proposed GDP--octose (5-44) intermediate would be then modified through 
C-4 epimerization, C-6 amination, and C-8 dehydration as well as C-1 sulfur 
incorporation, to produce MTL (5-2) (see Figure 5-7). An epimerase homologue, LmbM, 
is proposed to be responsible for the C-4 epimerization (5-44  5-45). The C-6 oxidation 
and C-8 dehydration (5-45  5-46) are possibly catalyzed by a nucleotide sugar 
dehydrogenase homologue, LmbL, or an oxidoreductase homologue, LmbZ. The 
proposed reaction mechanism is analogous to that of the reaction catalyzed by TDP--D-
glucose 4,6-dehydratase, which converts TDP--D-glucose (5-63) to TDP-4-keto-6-
deoxy--D-glucose (5-64; Figure 5-11).
14,222
 Finally, an aminotransferase homologue, 




Figure 5-11. (A) Proposed mechanism of GDP--D-octose 6,8-dehydratase reaction 

























































































Proposed Pathway of the C-1 Sulfur Incorporation 
A glycosyltransferase homologue, LmbT, is proposed as a key enzyme for the 
sulfur incorporation at C-1 in the MTL (5-2) biosynthetic pathway. The enzyme may act 
as an S-glycosyltransferase to form an S-conujugate at C-1. A candidate for the glycosyl 
acceptor is L-cysteine (5-47 5-48; Figure 5-7). Notably, similar C-1 thioglycoside is 
known for glucosinolates and sublancin (see Chapter 1, Figure 1-12, 1-13). To expose a 
free thiol group at C-1, an aminotransferase homologue, LmbF, is proposed to act as a C–
S lyase to produce 5-49 using pyridoxal-5‟-phosphate (PLP). A methyl transferase 
homologue, LmbG, would then transfer a methyl group to the C-1 thiol group to 
complete the MTL biosynthetic pathway (5-49 5-2; Figure 5-7). Alternatively, the S-
glycosyl acceptor of the LmbT reaction may be mycothiol (5-65) rather than L-cysteine, 
because the deduced gene product of lmbE displays moderate sequence similarity (33% 
identity and 48% similarity) to a mycothiol S-conjugate amidase (Mca) from 
Mycobacterium tuberculosis H37Rv (Figure 5-12).
223
 Additionally, a conserved domain 
search revealed that the protein sequence of LmbV contains a putative mycothiol 
maleylpyruvate isomerase N-terminal domain. Although the function of LmbV is not 





5.3.2  Functional Characterizations of LmbR. 
To verify the proposed C8 backbone construction catalyzed by LmbR (Figure 5-
9), the recombinant LmbR with a C-terminal His6-tag was overexpressed in E. coli and 
partially purified (Figure 5-13). 
 
 
Figure 5-12. (A) Reaction scheme of mycothiol S-conjugate amidase and (B) the 

































































































































Mechanism of the transaldolase reaction catalyzed by LmbR was proposed to 
involve iminium bond formation between a lysine residue of the enzyme and C-2 ketone 
of the substrate sugar (5-68; Figure 5-14). To address this hypothesis, the purified C-
His6-LmbR was incubated with a putative substrate, D-fructose 6-phosphate (5-22), and 
treated with sodium borohydride prior to the MS analysis. Under this condition, the 
molecular masses observed are consistent with those of the reduced form of C-His6-
LmbR–D-glyceraldehyde 3-phosphate conjugate (5-69, caluculated 25024 Da, observed 
25024 Da), the reduced C-His6-LmbR–D-fructose 6-phosphate conjugate (5-68, 
calculated 25194 Da, observed 25193 Da), and the unmodified enzyme (caluculated 
24952 Da, observed 24952 Da; Figure 5-15). These results suggest that D-fructose 6-
phosphate (5-22) is indeed a possible substrate of LmbR and a proposed mechanism 
through formation of the iminium intermediate (5-68) followed by C–C bond cleavage 
via retro aldol reaction (5-68  5-69) could occur. 
 
Figure 5-13. SDS-PAGE gel of the partially purified LmbR. 
C-His6 tagged LmbR (233 aa, 25.0 kDa) is shown in lane 2. Minor impurities are likely 
coexpressed chaperone proteins (DnaK ~70 kDa, GroEL ~60 kDa and DnaJ ~40 kDa). 















Figure 5-14. Proposed mechanism of the LmbR-catalyzed tranaldolase reaction using D-














































































The proposed transaldolase activity of LmbR was further investigated using D-
fructose 6-phosphate (5-22) and D-ribose 5-phosphate (5-18) as the C3 unit donor and 
acceptor, respectively. HPLC analysis of the reaction mixture showed the decrease of the 
substrates and appearance of two new peaks (Figure 5-16, trace a). Control reactions 
omitting the enzyme or one of each substrate gave no product peaks (trace b–d). The 
reaction is clearly LmbR-dependent, and the results support the proposed transaldolase 
reaction. The new peak with a shorter retention time was isolated and subjected to ESI-
MS analysis. The molecular weight of the observed mass signal is consistent with the 
proposed octulose 8-phosphate product (5-40a; ESI
−
 calculated for C8H16O11P
−
 [M – H
+
] 
319.0436, observed 319.0431). 
 
 
Figure 5-15. ESI-MS analyses of the LmbR reaction. 
Deconvoluted ESI-MS of the C-His6-LmbR. (A) C-His6-LmbR in the absence of 
substrate. (B) C-His6-LmbR in the presence of D-fructose 6-phosphate treated with 
sodium borohydride. The calculated molecular weight of C-His6-LmbR (233 aa) is 
24952 Da.  The calculated molecular weights of C-His6-LmbR–D-glyceraldehyde 3-
phosphate conjugate (reduced) and C-His6-LmbR–D-fructose 6-phosphate conjugate are 
















































5.3.3  Functional Characterizations of LmbN. 
To verify the proposed isomerization activity of LmbN (5-40  5-41; Figure 5-
8), the recombinant enzyme with a C-terminal His6-tag was overexpressed in E. coli and 
purified (Figure 5-17). The purified C-His6-LmbN protein was added to the LmbR 
reaction containing D-fructose 6-phosphate (5-22) and D-ribose 5-phosphate (5-18). The 
HPLC trace of the LmbN reaction shows the appearance of a product peak which has a 
shorter retention time than that of the LmbR product (Figure 5-18, trace d). A control 
reaction without LmbR did not yield this product peak (trace c). These results suggest 
that the LmbN product is indeed derived from the LmbR product, whose structure is 
proposed as 5-40a, and not from D-fructose 6-phosphate (5-22) or D-ribose 5-phosphate 
(5-18) present in the reaction solution. In the absence of the LmbR product, minor peaks 
 
Figure 5-16. HPLC analysis of the LmbR reaction. 
(a) Reaction containing C-His6-LmbR 40 M), D-fructose 6-phosphate (5-22, 10 mM) 
and D-ribose 5-phosphate (5-18, 10 mM). *
1
 Product peak corresponding to octulose 8-
phosphate (5-40a) based on the MS analysis). *
2
 Product peak predicted as 
glyceraldehyde 3-phosphate (5-21). (b) No enzyme control. (c) No D-ribose 5-
phosphate control. (d) No D-fructose 6-phosphate control. Signals at 9, 13, 20 min are 




















likely derived from D-fructose 6-phosphate (5-22) and D-ribose 5-phosphate (5-18) were 
observed (trace c). These peaks might be arised from the C1–C2 isomerized products of 
5-22 and 5-18, namely, D-glucose 6-phosphate (5-14) and D-ribulose 5-phosphate (5-17), 
respectively, although they were not characterized. The LmbN product peak was isolated 
and subjected to ESI-MS analysis. The molecular weight of the observed mass signal is 
consistent with the proposed octose 8-phosphate structure (5-41a; ESI
−
 calculated for 
C8H16O11P
−
 [M – H
+
] 319.0436, observed 319.0431). 
   
 
 
Figure 5-17. SDS-PAGE gel of the purified LmbN. 
C-His6 tagged LmbN (304 aa, 31.9 kDa) is shown in lane 2. The molecular weight 
marks are 220, 160, 120, 100, 90, 80, 70, 60, 50, 40, 30, 25, 20, 15, and 10 kDa (top to 
bottom, lane 1). 










5.3.4  LmbR and LmbN Reactions Using D-Xylose 5-Phosphate. 
 Initial investigation of LmbR and LmbN in vitro assays showed that D-ribose 5-
phosphate (5-18) and D-fructose 6-phosphate (5-22) are the potential substrates in the 
early stage of the MTL biosynthetic pathway. The proposed structures of these enzyme 
reaction products are 5-40a and 5-41a (Figure 5-9). However, D-xylose 5-phosphate (5-
29) is another possible C5 unit for the LmbR reaction, and the predicted product is 5-40b, 
namely, a C-6 epimer of 5-40a, in this case. 
 
Figure 5-18. HPLC analysis of the LmbN reaction. 
(a) Mixture of D-fructose 6-phosphate (5-22, 10 mM) and D-ribose 5-phosphate (5-18, 
10 mM) substrates. (b) LmbR reaction using 5-22 and 5-18.  *
1
 LmbR product peak 
corresponding to octulose 8-phosphate (5-40a). *
2
 LmbR product peak predicted as 
glyceraldehyde 3-phosphate (5-21). (c) LmbN (50 M) was added to the reaction a. *
3 
Uncharacterized minor product possibly D-glucose 6-phosphate (5-14). (The retention 
time is consistent with the authentic standard of 5-14.) *
4 
Uncharacterized minor 
product possibly D-ribulose 5-phosphate (5-17). (d) LmbN (50 M) was added to the 
reaction b after removing LmbR. *
5
 LmbN product peak corresponding to octose 8-


















To test this alternative pathway, D-xylose 5-phosphate (5-29) was chemically 
synthesized according to a reported method. The purified C-His6-LmbR protein was then 
incubated with 5-29 and D-fructose 6-phosphate (5-22), and the reaction mixture was 
analyzed by HPLC. A new peak having a shorter retention time than that of 5-41a was 
observed (Figure 5-19, trace b). This peak was isolated and subjected to ESI-MS analysis. 
The molecular weight of the observed mass signal is consistent with the proposed 
octulose 8-phosphate (5-40b; ESI
−
 calculated for C8H16O11P
−
 [M – H
+
] 319.0, observed 
319.1). These results indicate that LmbR can accept both D-ribose 5-phosphate (5-18) and 
D-xylose 5-phosphate (5-29) as the C3 sugar acceptor. The products from each substrate 
are clearly different based on the distinct retention times on the HPLC traces but possess 
the same molecular weight, consistent with the proposed octulose 8-phosphate C-6 
epimers, 5-40a and 5-40b. 
When C-His6-LmbN was incubated together with the LmbR reaction mixture 
containing D-xylose 5-phosphate (5-29) and D-fructose 6-phosphate (5-22), no change 
was observed of the LmbR product peak (predicted as 5-41b; Figure 5-19, trace b,c). This 
result suggests that LmbN cannot isomerize the LmbR product derived from 5-29, 
although it can isomerize the product resulting from D-ribose 5-phosphate (5-18) as 
described above. It is important to note that the proposed C1-C2 isomerization is a 
prerequisite for the formation of the pyranosidic octose intermediate in the proposed 
MTL biosynthetic pathway (Figure 5-7). Hence, the substrate specificity observed in the 
LmbN reaction suggests that the starting substrate of MTL biosynthetic pathway is likely 
D-ribose 5-phosphate (5-18) and not D-xylose 5-phosphate (5-29), even though both 




5.3.5  Characterization of the LmbR and LmbN Products. 
To further characterize the LmbR and LmbN reaction products, heptaacetyl 
octose derivatives 5-71a and 5-71b were chemically synthesized as the authentic 
standards. The compounds 5-71a and 5-71b possess the same stereochemistry at the C-2–
C-7 carbons as the proposed LmbR/LmbN reaction products derived from D-ribose 5-
phosphate (5-18) and D-xylose 5-phosphate (5-29), respectively (Figure 5-20). The 
enzymatic reaction mixture containing the LmbR product (5-40a, proposed structure) and 
the LmbN product (5-41a, proposed structure) from D-ribose 5-phosphate (5-18) and D-
 
Figure 5-19. HPLC analysis of the LmbR and LmbN reaction using D-xylose 5-
phosphate 
(a) Synthetic standard of D-xylose 5-phosphate (5-29). (b) LmbR (40 M) reaction 
using 5-29 (10 mM) and D-fructose 6-phosphate (5-22, 10 mM) as the substrates. *
1
 
LmbR product peak corresponding to octulose 8-phosphate (5-40b) based on the MS 
analysis. *
2
 Uncharacterized degradation peak. *
3
 LmbR product peak predicted as 
glyceraldehyde 3-phosphate (5-21). (c) Both LmbR (40 M) and LmbN (50 M) were 
incubated with 5-29 and 5-22. (d) Control reaction using D-ribose 5-phosphate (5-18) 
instead of D-xylose 5-phosphate (5-29). *
4 
LmbR product peak corresponding to 
octulose 8-phosphate (5-40a). *
5 
LmbN product peak corresponding to octose 8-
phosphate (5-41a). 
 




















fructose 6-phosphate (5-22) was treated with alkaline phosphatase. The resulting 
dephosphorylated sugar compounds were then reacted with acetic anhydride and pyridine 
to peracetylate the free alcohol groups. The derivatized enzymatic product mixture and 
the authentic standards were analyzed by HPLC.  
 
  
  As shown in Figure 5-21, four major signals were observed from the LmbR 
reactions (retention time ~13.5 min and ~17.5 min, trace b). The earlier two peaks 
matched the signals from the control reaction yielding pentaacetyl fructose (trace a). The 
MS data of the isolated peaks (mixture of the two peaks) were consistent with this 
 
Figure 5-20. Proposed structures of LmbR and LmbN products and structures of 













































Enzymatic synthesis (proposed stereochemistiry)







































































, calculated for C14H19O9
+
 [M - AcO

] 331.1, found 331.2), 
corresponding to penta-O-acetyl--D-fructose (5-74) and penta-O-acetyl--D-fructose 
(5-74, Figure 5-22). Similarly, the latter two peaks may correspond to C-1 anomers of 
furanosidic octulose heptaacetate, 5-75 and 5-75 (Figure 5-22). The MS data of the 
isolated peaks were consistent with this hypothesis (ESI
+
, calculated for C20H27O13
+
 [M - 
AcO

] 475.1, found 475.2). 
When both LmbR and LmbN were used, a new peak emerged (Figure 5-21, trace 
c, retention time ~19 min). Retention time of the authentic standard 5-71a matches this 
peak (trace d), and they were coeluted when coinjected (trace h). In contrast, the other 
stereoisomers of pyranosidic octose heptaacetate 5-71b and 5-72 show distinct retention 
times (trace f, g). The product peak (*3 in trace c) derived from the lmbN reaction was 
isolated and subjected to HRMS analysis. The observed mass signal is indeed consistent 
with the proposed heptaacetyl octose 8-phospahte product (ESI
+
, calculated for 
C22H30O15Na
+
 [M + Na]
+
 557.1477, found 557.1478).  
The results shown above support the proposed structures of the LmbR and LmbN 
products as 5-40a and 5-41a, respectively. The data are consistent with the proposed 
transaldolase reaction catalyzed by LmbR with retention of the configuration at the C-3 
and C-4 positions as well as the proposed C-1–C-2 isomerization catalyzed by LmbN 
yielding the (S)-configuration at the C-2 position. Importantly, the products 5-40a and 5-





Figure 5-21. HPLC analysis of the acetyl derivatized LmbR and LmbN products. 
(a) Control reaction using D-fructose (5-36). *
1 
The two peaks at ~13.5 min are 
expected to be / mixture of pentaacetyl D-fructose (5-74/). (b) LmbR reaction 
followed by dephosphorylation and acetylation. *
2
 The two peaks at ~17.5 min are 
expected to be / mixture of heptaactyl furanosidic octulose (5-75/). (c) LmbR and 
LmbN reactions followed by dephosphorylation and acetylation. *
3
 The peak at ~19 
min is expected to be heptaacetyl pyranosidic octose 5-71a. (d) Authentic standard of 5-
71a. *
4
 The peak at ~17 min is a synthetic intermediate 5-73 (detected by NMR, see 
Figure 5-20). (e) Authentic standard of 5-73. (f) Authentic standard of 5-71b. (g) 
Mixture of the authentic standards 5-71b and 5-72. (h) Coinjection of the sample 
derived from LmbR and LmbN reaction, and the authentic standard 5-71a. *
5
 LmbN 
reaction derived peak and the authentic standard of 5-71a were coeluted. (i) Coinjection 
of the sample derived from LmbR and LmbN reaction, and the authentic standard 5-
71b. 




























5.3.6  Substrate Specificity of the LmbR and LmbN Reactions. 
As described above, while LmbR could utilize both D-ribose 5-phosphate (5-18) 
and D-xylose 5-phosphate (5-29) as the C5 unit, only the product formed in the former 
reaction was accepted by LmbN. The observed substrate specificity of LmbN suggested 
that D-ribose 5-phosphate (5-18) is likely the physiological C5 unit substrate for the 
LmbR reaction. It was also confirmed that D-fructose 6-phosphate (5-22) could serve as 
the C3 unit donor for this reaction. 
As mentioned earlier, D-sedoheptulose 7-phosphate (5-20) from the pentose 
phosphate pathway (Figure 5-3) is also a possible C3 unit donor for the LmbR reaction 
(Figure 5-9). In addition, D-fructose (5-36) and dihydroxyacetone (5-35) are other 
possible C3 unit donors based on the proposed mechanism of the LmbR reaction (Figure 
5-14, 5-23). To test whether these C3 unit substrate candidates can be utilized by LmbR 
 






























































































in vitro, LmbR reaction assays followed by HPLC analyses were performed using these 
potential substrates. Moreover, LmbR-catalyzed transaldolase reaction to make a C8 
sugar was compared with the usual transaldolase reaction forming a C7 sugar. Finally, D-
sedoheptulose 7-phosphate (5-20) was also tested as a LmbN reaction substrate because it 
is the substrate of the homologous enzyme, GmhA, in the NDP-heptose biosynthetic 





















































































































LmbR Reaction Using D-Sedoheptulose 7-Phosphate 
To study the LmbR reaction with D-sedoheptulose 7-phosphate (5-20), compound 
5-20 was prepared from D-ribose 5-phosphate (5-18) and -hydroxypyruvate (5-37) using 
transketolase (TK) from E. coli (Figure 5-23).
215
 The peak corresponding to D-
sedoheptulose 7-phosphate (5-20) was detected by HPLC (Figure 5-24, trace a, retention 
time ~11 min). After removing the TK, LmbR and D-ribose 5-phosphate (5-18) were 
added to the reaction mixture. A new peak having a similar elution profile as the LmbR 
product (5-40a) generated in the reaction using D-fructose 6-phosphate (5-22) as the C3 
unit donor was observed (trace b, c). However, the retention time of the new peak is too 





Figure 5-24. HPLC analysis of the LmbR reaction using D-sedoheptulose 7-phosphate 
(5-20) 
(a) Transketolase (TK) reaction showing the formation of 5-20 as the product. (b) 
LmbR and D-ribose 5-phosphate (5-18) were added to the TK reaction. *
1
 LmbR 
product (5-40a) seems to be formed although it overlaps with 5-20. (c) Control LmbR 
reaction using D-ribose 5-phosphate (5-18) and D-fructose 6-phosphate (5-22) to yield 


















LmbR Reaction Using D-Fructose or Dihydroxyacetone 
Similarly, D-fructose (5-36) and dihydroxyacetone (5-35) were tested as potential 
C3 unit donors for the LmbR reaction (Figure 5-23). When D-fructose 6-phosphate (5-22) 
was substituted with D-fructose (5-36), a similar product peak was observed but the yield 
was much lower than that of the control reaction using 5-22 (Figure 5-25, trace a, d). The 
yield was slightly improved if a higher concentration (50 mM) of 5-36 was used (trace b). 
Similarly, the product peak was confirmed but formed in a lower yield when 
dihydroxyacetone (5-35, 50 mM) was utilized as the C3 unit donor (trace c). These results 
suggest that both D-fructose (5-36) and dihydroxyacetone (5-35) can serve as the 
substrate for LmbR in vitro, however, D-fructose 6-phosphate (5-22) is clearly the 




Figure 5-25. HPLC analysis of the LmbR reaction using D-fructose or 
dihydroxyacetone 
(a) D-Fructose (5-36, 10 mM); (b) 5-36 (50 mM); (c) dihydroxyacetone (5-35, 50 mM); 
(d) D-Fructose 6-phospahte (5-22, 10 mM). D-Ribose 5-phospahte (5-18, 10 mM) was 

















Comparison of LmbR with a Regular Transaldolase 
Transaldolase (TA) is an essential enzyme catalyzing the reversible reaction from 
D-sedoheptulose 7-phosphate (5-20, C7) and D-glyceraldehyde 3-phosphate (5-21, C3) to 
D-fructose 6-phosphate (5-22, C6) and D-erythrose 4-phosphate (5-23, C4) in the pentose 
phosphate pathway (Figure 5-3). LmbR is now confirmed to catalyze the reaction 
utilizing D-fructose 6-phosphate (5-22, C6) and D-ribose 5-phosphate (5-18, C5) to yield 
D-octulose 8-phosphate (5-40a, C8) and D-glyceraldehyde 3-phosphate (5-21, C3) (Figure 
5-9). Since LmbR showed relatively relaxed substrate specificity for the C3 sugar donor 
(D-fructose 6-phosphate (5-22), D-fructose (5-36), and dihydroxyacetone (5-35)) and also 
for the C3 sugar acceptor (D-ribose 5-phosphate (5-18) and D-xylose 5-phosphate (5-29)), 
it is possible that LmbR could catalyze the regular transaldolase reaction as well. In fact, 
there is an old report about a TA (from a special strain of Torula yeast) which is capable 
of catalyzing the same reaction to produce octulose 8-phosphate from D-ribose 5-
phosphate (5-18) and D-fructose 6-phosphate (5-22, C6) as LmbR.
224
 However, whether 
such observed activity is common for a general TA is not clear because detailed studies 
of the substrate specificity of TA have not been explored thus far.
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To address these questions, a series of reactions using LmbR or commercially 
available TA from yeast were investigated. The reactions were spectrophotometrically 
monitored by following the producton of D-glyceraldehyde 3-phosphate (5-21) using 
glyceraldehydes 3-phosphate dehydrogenase (GAPDH) (Figure 5-26). As expected, the 
increase in absorbance at 340 nm was observed for both the usual TA reaction and 
standard LmbR reactions (Figure 5-27, trace a, b). LmbR could also catalyze the 
physiological transaldolase reaction utilizing D-erythrose 4-phosphate (5-23) as the sugar 
acceptor (trace d). Surprisingly, TA (from yeast) could not catalyze the LmbR reaction 
utilizing D-ribose 5-phosphate (5-18) as the sugar acceptor (trace c). The increase in 
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absorbance at 340 nm for the control reaction using LmbR with only D-fructose 6-
phosphate (5-22) is likely caused by the retro-aldol reaction. This is consistent with the 
previous MS data showing the release of the LmbR reaction intermediate, a C3 unit (5-




Figure 5-26. Comparison of the LmbR reaction and the regular transaldolase reaction. 
(A) LmbR reaction. (B) Transaldolase (TA) reaction. The production of D-
glyceraldehyde 3-phosphate (5-21) was detected by the coupled GAPDH-catalyzed 






































































LmbN Reaction Using D-Sedoheptulose 7-Phosphate 
As described above, LmbN displays moderate sequence similarity to GmhA in the 
NDP-heptose biosynthetic pathways (Table 5-4), however it utilizes an octulose 8-
phosphate instead of a heptulose 7-phosphate as the substrate. Interestingly, the product 
of the GmhA reaction has an (R)-configuration of its C-2 hydroxyl group (Figure 5-10). 
In contrast, C-2 hydroxyl group of the LmbN reaction product (5-41a) has an (S)-
configuration based on HPLC comparison with an authentic standard (Figure 5-21). In 
order to learn more about the substrate specificity of LmbN reaction, D-sedoheptulose 7-
phosphate (5-20), which is the substrate of GmhA reaction, was tested as a possible 
substrate for the LmbN reaction. 
 
Figure 5-27. Investigation of the LmbR and TA reactions. 
(a) Usual TA reaction using D-erythrose 4-phosphate (5-23) and D-fructose 6-phosphate 
(5-22). (b) Standard LmbR reaction using D-ribose 5-phosphate (5-18) and 5-22. (c) TA 
with 5-18 and 5-22. (d) LmbR with 5-23 and 5-22. (e) Control reaction using TA and 5-



































Compound 5-20 was generated from D-ribose 5-phosphate (5-18) and -
hydroxypyruvate (5-37) using transketolase (TK) from E. coli as described above (Figure 
5-23). The HPLC trace did not show any change in this peak in the presence of LmbN 
(Figure 5-28). This result suggests that LmbN cannot take 5-18 as the substrate although, 
the possibility that the isomerized product might have an identical retention time as the 
substrate cannot be excluded. Together with the previous result that LmbN cannot take 
the LmbR product derived from D-xylose 5-phosphate as the substrate, it is clear that 
LmbN has more strict substrate specificity than LmbR. 
 
 
5.3.7  Preparation of Other Enzymes in the MTL Biosynthetic Pathway. 
As shown in Figure 5-7, it is proposed that the LmbR and LmbN reactions are 
followed by at least ten more enzymatic reactions in the MTL (5-2) biosynthetic pathway. 
To verify the proposed functions, each enzyme was expressed with a His6-tag in E. coli 
 
Figure 5-28. HPLC analysis of the LmbN reaction using D-sedoheptulose 7-phosphate. 
(a) LmbN and D-sedoheptulose 7-phosphate (5-20). The compound 5-20 was produced 
by transketolase (TK) using D-ribose 5-phosphate (5-18, 10 mM) and -















or S. lividans. Some enzymes were expressed as inclusion bodies, and, thus, could not be 
purified. The proteins purified from E. coli are N-His6-LmbF, N-His6-LmbG, N-His6-
LmbK, C-His6-LmbL and C-His6-LmbM, along with C-His6-LmbR and C-His6-LmbN 
described above. The proteins purified from S. lividans are N-His6-LmbS and N-His6-
LmbT. SDS-PAGE images of the isolated proteins are shown in Figure 5-29. In vitro 
functional characterizations of each enzyme using the proposed substrate or substrate 




5.3.8  Functional Investigation of LmbM. 
LmbM is proposed as the C-4 epimerase in the MTL biosynthetic pathway (5-44a 
 5-45a; Figure 5-30A, route A). Alternatively, the epimerization step may take place 
 
Figure 5-29. SDS-PAGE gel images of the purified enzymes in the MTL biosynthetic 
pathway. 
Calculated molecular weights of each protein are (1) N-His6-LmbF (446 aa, 48.8 kDa), 
(2) N-His6-LmbG (285 aa, 31.3 kDa), (3) N-His6-LmbK (210 aa, 22.5 kDa), (4) C-His6-
LmbL (449 aa, 47.4 kDa), (5) C-His6-LmbM (336 aa, 36.8 kDa), (6) N-His6-LmbS (401 
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after the 6,8-dehydration process, which is proposed to be catalyzed by LmbL or LmbZ 








 Since the proposed substrates, 5-44a and 5-77, are not 
readily available through either chemical or enzymatic synthesis, model reactions using 
commercially available NDP-sugars were tested. Interestingly, we found that LmbM 
could take UDP-D-glucuronic acid (5-38) as the substrate and produce UDP-4-keto-D-
xylose (5-78; Figure 5-30B). In this last section, the demonstrated UDP-4-keto-D-xylose 
synthase activity of LmbM is presented. 
Purified C-His6-LmbM was incubated with UDP-D-glucuronic acid (5-38) and 
NAD
+
, and the reaction was analyzed using HPLC. Two new peaks (retention time ~11 
min and ~19 min) appeared along with the consumption of 5-38 and NAD
+ 
(Figure 5-
31A, trace a, b). One was confirmed to have an identical retention time (~19 min) to 
NADH using an authentic standard. The other peak was, thus, suspected to be an 
oxidized product resulting from 5-38. This peak was isolated and subjected to MS and 
1
H-NMR analyses. The observed mass signals were consistent with the UDP-4-keto-D-
xylose (5-78; ESI
−
 calculated for C14H19N2O16P2 [M – H
+
] 533.0, observed 533.2) and its 
hydrated form (5-79; ESI
−
 calculated for C14H21N2O17P2 [M – H
+
] 551.0, observed 
551.1). The 
1
H-NMR data are also consistent with the previously reported values of 
UDP-4-keto-D-xylose (hydrate form) produced by ArnA in the biosynthetic pathway of 
4-amino-4-deoxy-L-arabinose.
228
 Compounds 5-78 and 5-79 are likely in equilibrium in 
aqueous solution. 
To further confirm the formation of 5-78, a carbonyl directing reagent, 
hydroxylamine, was added to the LmbM reaction mixture. If the keto form, 5-78, exists 
in the solution, it should be converted to the corresponding oxime, 5-82.
229,230
 In fact, 
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upon addition of hydroxylamine, almost complete disappearance of the 5-78/5-79 peak 
and the appearance of a new peak eluted with a longer retention time (~14 min) was 




Figure 5-30. LmbM reaction 
(A) Proposed LmbM reaction in the MTL biosynthetic pathway. (B) UDP-4-keto-D-








































































































 Although the LmbM reaction presented here is likely a side reaction, it is clear 
that the enzyme has the potential to oxidize the C-4 position of an NDP-sugar. In the 
MTL biosynthetic pathway, LmbM may oxidize the C-4 position of 5-44a or 5-77 and 
reduce it back to epimerize the position rather than perform the decarboxylation observed 
with UDP-D-glucuronic acid (5-38). 
  
5.4  CONCLUSIONS  
In this chapter, the biosynthetic pathway of lincomycin A (5-1), which possesses a 
unique C-1 thiosugar, methylthiolincosamide (MTL, 5-2), was studied. Previous feeding 
experiments and genetic information led us to propose the entire biosynthetic pathway of 
 
Figure 5-31. HPLC analysis of the LmbM-catalyzed model reaction. 
(a) LmbR reaction mixture using UDP-D-glucuronic acid (5-38) and NAD
+ 
(1-h 
incubation). New peaks corresponding to UDP-4-keto-D-xylose (5-78) or its hydrated 
form (5-79) and NADH were observed. (b) LmbR reaction mixture (12-h incubation). 
(b) The reaction was treated with NH4OH (5-78  5-82). 
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MTL (5-2). As a key reaction, the C8 backbone construction catalyzed by LmbR has now 
been characterized in vitro. Our data show that LmbR has relatively relaxed substrate 
specificity for both the C3 sugar donors and acceptors. In contrast, LmbN shows rather 
strict substrate specificity, since only the octulose 8-phosphate resulting from the LmbR 
reaction with D-ribose 5-phosphate (5-18) can be recognized and processed by LmbN. 
These results are consistent with the proposed biosynthetic pathway involving octulose 8-
phosphate 5-40a and octose 8-phospahte 5-41a as the early intermediates (Figure 5-7 and 
5-20). The MS data and the HPLC analyses using the chemically synthesized standards 
fully support these assignments. 
This work represents the first biochemical verification of 5-40a and 5-41a as key 
intermediates in the MTL (5-2) biosynthetic pathway. Identification of the unique C8 
back bone construction mechanism provides important information shedding light on the 
latter stage of the MTL biosynthesis. The next key intermediate proposed is a GDP-
activated octose (5-44). Although similar NDP-heptoses are known in the biosynthesis of 
the inner core of lipopolysaccharide (LPS), the involvement of NDP-octose in a 
biosynthetic pathway is unique and has never been reported. As far as we know, the 
aminoglycoside antibiotic apramycin is the only other type of a natural product that may 
potentially be biosynthesized through an NDP-octose intermediate (gene cluster 
accession number: AJ875019 and AJ629123). Finally, C-1 thio incorporation mechanism 
is the most intriguing question in the biosynthesis of lincomycin A (5-1). Gene analysis 
led us to propose a pathway involving a putative S-glycosyltransferase, lmbT, and a CS 
lyase, lmbF. Sulfur donor may be cysteine or mycothiol (5-65) as discussed above 
(Figure 5-12). The recombinant proteins, N-His6-LmbT and N-His6-LmbS, as well as 
several other proteins in the MTL biosynthetic pathway have been purified. Substrate 
preparation for these enzymes is in progress to elucidate the C-1 thiosugar biosynthesis. 
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Appendix: List of Abbreviations 
ACP Acyl carrier protein 
ADP Adenosine diphosphate 
AK Adenylate kinase 
AMP Adenosine monophosphate 
A. orientalis Amycolatopsis orientalis 
ARS Agricultural Research Service 
Asp Aspartic acid 
A. thermoaerophilus 
 Aneurinibacillus thermoaerophilus 
ATP Adenosine triphosphate 
bex cluster BE-7585A biosynthetic gene cluster 
BLAST Basic local alignment search tool 
B. subtilis Bacillus subtilis 
CAD Charged aerosol detector 
CD Cysteine desulfurase 
CDP Cytidine diphosphate 
CIP Calf intestinal alkaline phosphatase 
CoA Coenzyme A 
COSY Correlated spectroscopy 
Cys Cysteine 
DEPT Distortionless enhancement by polarization transfer 
DMSO Dimethyl sulfoxide 





DXP 1-Deoxy-D-xylulose 5-phosphate 
E. coli Escherichia coli 
EDTA Ethylenediaminetetraacetic acid 
ESI Electrospray ionization 
FDA Food and drug administration 
FMN Flavin mononucleotide 
GAPDH Glyceraldehydes 3-phosphate dehydrogenase 
GDP Guanosine diphosphate 
Glu Glutamic acid 
Gly Glycine 
GSH Glutathione 
HMBC Heteronuclear multiple bond correlation 
HPLC High performance liquid chromatography 
HR High resolution 
HSQC Heteronuclear single quantum coherence 
INADEQUATE Incredible natural abundance double quantum transfer experiment 
IPTG Isopropyl -D-1-thiogalactopyranoside 
ISP International Streptomyces Project 
KS -ketoacyl synthase  subunit 
KS -ketoacyl synthase  subunit 
LB Luria-Bertani broth 
LC Liquid chromatography 
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MS Mass spectrometry 
MTL Methylthiolincosamide 
M. tuberculosis Mycobacterium tuberculosis 
NAD
+ 
nicotinamide adenine dinucleotide (oxidized form) 
NADH nicotinamide adenine dinucleotide (reduced form) 
NADPH Nicotinamide adenine dinucleotide phosphate (reduced form) 
NCBI National center for biotechnology information 
NDP Nucleoside diphosphate 
Ni-NTA Nickel-nitrilotriacetic acid 
NMP Nucleoside monophosphate 
NMR Nuclear magnetic resonance 
NOESY Nuclear Overhauser enhancement spectroscopy 
OASS O-acetylserine sulfhydrylase 
ORF Open reading frame 
PAGE Polyacrylamide gel electrophoresis 
PCR Polymerase chain reaction 
PDA Photodiode array 
Pdtc Prydine dithiocarboxylic acid 
PEP Phosphoenolpyruvate 
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PK Pyruvate kinase 
PKS Polyketide synthase 
PLP Pyridoxal 5‟-phosphate 
Pro Proline 
PVDF Polyvinylidene fluoride 
RNA Ribonucleic acid 
rRNA Ribosomal ribonucleic acid 
SAM S-adenosyl-L-methionine 
S. aurantiaca Stigmatella aurantiaca 
S. caelestis Streptomyces caelestis 
S. coelicolor Streptomyces coelicolor 
S. fradiae Streptomyces fradiae 
S. lincolnensis Streptomyces lincolnensis 
S. lividans Streptomyces lividans 
SDS Sodium dodecyl sulphate 
TA Transaldolase 
TDP Thymidine diphosphate 
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
TK Transketolase 
TPP Trehalose 6-phosphate phosphatase 
TPS Trehalose 6-phosphate synthases 
tRNA Transfer ribonucleic acid 
TSB Tryptone soya broth 
T. thermophilus Thermus thermophilus 
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UDP Uridine diphosphate 
UV Ultraviolet 
UV−vis Ultraviolet−visible spectroscopy 
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